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Abstract 
Fragile X syndrome (FXS), caused by the silencing of the FMR1 gene, is the most common heritable form 
of intellectual disability and autism. In both FXS and autism, the auditory cortex is of particular interest 
because of its crucial role in language development, communication, and auditory processing, all of which 
are hallmark deficits in patients. In the FXS animal model of the Fmr1 knockout (KO) mouse, numerous 
auditory-related phenotypes have also been described related to abnormal auditory processing and an 
impaired auditory cortex critical period. While such phenotypes are suggestive of altered excitatory-
inhibitory balance in the auditory circuit, few studies have examined synaptic dysregulation in the auditory 
cortex. Here, we investigate the postnatal maturation of ionotropic glutamate and GABA-mediated 
synaptic transmission across key developmental ages in auditory forebrain maturation. We first 
characterized wild-type mice, establishing clear developmental patterns in the naturally developing 
auditory cortex. We subsequently identified a broad dysregulation of these maturational patterns in the 
Fmr1 KO mice. Cellular and molecular expression studies of the developmental expression of ionotropic 
receptor subunits in Chapter 2 revealed altered expression patterns that manifest before ear canal 
opening, suggestive of dysregulation that manifests before auditory circuits are fully in sync with 
environmental input. In Chapter 3, we examined the functional maturation of the L4 to L2/3 auditory 
intracortical circuit, with Fmr1 KO mice revealing aberrant developmental patterns of basal synaptic 
transmission excitability and synaptic plasticity. In Chapters 4 and 5, we directly investigate the functional 
maturation of GABAergic and glutamatergic synapses in L2/3 pyramidal neurons in Fmr1 KO mice. Taken 
together, our results suggest that the loss of FMRP causes an altered regulation and coordination of 
inhibitory and excitatory synaptic maturation in the auditory cortex, which in part underlie the circuit 
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EXCITATORY-INHIBITORY CIRCUIT DYSREGULATION DURING THE AUDITORY 
CORTEX CRITICAL PERIOD IN THE FRAGILE X SYNDROME MOUSE MODEL 
 
Yeri J. Song 
Frances E. Jensen 
 
Fragile X syndrome (FXS), caused by the silencing of the FMR1 gene, is the most common 
heritable form of intellectual disability and autism. In both FXS and autism, the auditory 
cortex is of particular interest because of its crucial role in language development, 
communication, and auditory processing, all of which are hallmark deficits in patients. In 
the FXS animal model of the Fmr1 knockout (KO) mouse, numerous auditory-related 
phenotypes have also been described related to abnormal auditory processing and an 
impaired auditory cortex critical period. While such phenotypes are suggestive of altered 
excitatory-inhibitory balance in the auditory circuit, few studies have examined synaptic 
dysregulation in the auditory cortex. Here, we investigate the postnatal maturation of 
ionotropic glutamate and GABA-mediated synaptic transmission across key 
developmental ages in auditory forebrain maturation. We first characterized wild-type 
mice, establishing clear developmental patterns in the naturally developing auditory 
cortex. We subsequently identified a broad dysregulation of these maturational patterns 
in the Fmr1 KO mice. Cellular and molecular expression studies of the developmental 
expression of ionotropic receptor subunits in Chapter 2 revealed altered expression 
patterns that manifest before ear canal opening, suggestive of dysregulation that 
manifests before auditory circuits are fully in sync with environmental input. In Chapter 3, 
we examined the functional maturation of the L4 to L2/3 auditory intracortical circuit, with 
Fmr1 KO mice revealing aberrant developmental patterns of basal synaptic transmission 
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excitability and synaptic plasticity. In Chapters 4 and 5, we directly investigate the 
functional maturation of GABAergic and glutamatergic synapses in L2/3 pyramidal 
neurons in Fmr1 KO mice. Taken together, our results suggest that the loss of FMRP 
causes an altered regulation and coordination of inhibitory and excitatory synaptic 
maturation in the auditory cortex, which in part underlie the circuit dysregulation that 
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Neurodevelopmental disorders are multi-faceted conditions characterized by impaired 
brain development and function, with symptom onset during early developmental periods 
and a well-documented clinical association between intellectual disability, autism, and 
epilepsy. About 33% of autistic children have intellectual disability (Maenner et al., 2020), 
and up to 35% of autistic children suffer from seizures (Tuchman and Cuccaro, 2011; El 
Achkar and Spence, 2015). Additionally, patients with severe intellectual disability are at 
a higher risk for epilepsy (Tuchman, 2015), and about 40% of patients with early-life 
seizures suffer from cognitive deficits or autism later in life (Ronen et al., 2007; Tuchman, 
2015). Despite being multivariate and heterogeneous in cause, neurodevelopmental 
disorders frequently share features of language development and communication 
impairments, as well as auditory and other sensory processing deficits, making the 
auditory cortex a brain region of interest.  
 
Fragile X syndrome (FXS), the leading monogenic cause of intellectual disability, is one 
such disorder where patients exhibit a clinical co-occurrence with autism and epilepsy, 
and have impaired language and sensory-related impairments (Hersh et al., 2011; 
Hagerman et al., 2017). In FXS, silencing of Fmr1 causes loss of expression of the Fragile 
X mental retardation protein (FMRP), a regulator of synaptic activity-dependent translation 
and modulator of excitatory-inhibitory (E-I) balance (Darnell et al., 2011; Tang et al., 2015). 
Interestingly, FMRP expression and function is developmentally regulated and also found 
to be altered in autism spectrum disorders and epilepsy (Bernard et al., 2013; Fernandez 
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et al., 2013; Folsom et al., 2015). Therefore, understanding the pathway in which FMRP 
regulates proper synaptic maturation and circuit development in the brain, both broadly as 
well as specifically within the auditory cortex, is important for elucidating mechanisms 
related to impaired language development and auditory processing in FXS. Furthermore, 
understanding shared mechanisms between intellectual disability, autism, and epilepsy 
pathology can aid in the development of refined targeted treatments and therapeutics.   
 
The remainder of this chapter will provide an overview of generalized features and 
symptoms of FXS in patients, with a particular focus on auditory-related symptoms 
(Section I), and review the recapitulation of the various phenotypes in the FXS animal 
model, the Fmr1 knockout (KO) mouse (Section II). Auditory cortex maturation and critical 
period regulation will be reviewed (Section III), with a particular focus on excitation and 
inhibition their alterations in development and disease (Section IV), and then experimental 
treatments that have been or are currently being explored for FXS will be presented 
(Section V). Finally, the evolution of the FXS field will be discussed with consideration for 
understanding pathomechanisms of the disorder and the open questions that remain, and 
how the work presented herein can elucidate brain maturation patterns that underlie the 
commonalities of neurodevelopmental disorders.  
 
I. Fragile X Syndrome 
Fragile X syndrome (FXS) is the leading monogenic form of intellectual disability and 
autism caused by the absence or highly deficient levels of the Fragile X mental retardation 
protein (FMRP) (Hersh et al., 2011; Hagerman et al., 2017). The mutation identified in 
FXS is the hypermethylation of the CGG trinucleotide repeat expansion (>200) in the 
promoter region of FMR1, located on the X chromosome (Xq27.3), causing its 
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transcriptional silencing and loss of FMRP expression. The estimated incidence of FXS is 
1:5000 in males and 1:8000 in females (Hagerman et al., 2017), with the clinical severity 
of FXS and intellectual disability highly correlated with the levels of FMRP due to the 
mosaicism related to being an X-linked disorder (Kazdoba et al., 2014).  
 
FXS patients exhibit a range of cognitive deficits related to learning, attention, and 
memory. Patients often present with several stereotypical physical features including 
prominent ears and long face, along with macro-orchidism in males. Symptoms of FXS 
typically manifest during the 2nd year of life, where patients noticeably exhibit language 
development delays, and further present with hyperactivity, anxiety, and sensory 
hypersensitivity (Hagerman et al., 2017). Seizures occur in up to 16% of patients, with 
typical onset within the first 5 years of life when communication and speech deficits 
become more apparent (Nelson and Valakh, 2015; Hagerman et al., 2017). Behavioral 
issues persist from childhood through adolescence, with patients often exhibiting 
impulsivity, aggression, tantrums, anxiety, poor attention, and perseveration (Hersh et al., 
2011; Hagerman et al., 2017).  
 
Across the various clinical features of FXS, there is a high incidence of symptoms that 
specifically relate to auditory dysregulation, which are of particular interest given that many 
of these phenotypes are shared across autism and epilepsy. As noted earlier, FXS 
patients have communication abnormalities that begin with delayed language 
development (Hoffmann et al., 2020). Children may not speak until 2-3 years of age, often 
even having delayed use of prelinguistic communication (Finestack et al., 2009; Hersh et 
al., 2011). FXS children have continued deficits in speech and literacy, with cognition 
strongly correlated with language capabilities (Hoffmann et al., 2020). Specifically, 
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patients have poor expressive and receptive language, deficits in comprehension and 
articulation, and limited use of vocabulary (Finestack et al., 2009; Rotschafer and Razak, 
2014). Patients additionally exhibit further deficits in auditory processing (Rotschafer and 
Razak, 2014), characterized using event-related potential (ERP) measures where the 
activity of neuronal populations are analyzed in response to specific auditory stimuli and 
tasks. In FXS, patients typically have abnormally large sensory ERPs to simple auditory 
stimuli and abnormal habituation to repeated stimuli (Miller et al., 1999; Castren et al., 
2003; Frankland et al., 2004). Patients also perform poorly to auditory discrimination tasks 
(Van der Molen et al., 2012), and EEG analysis within the auditory cortex also shows 
decreased ability to synchronize neural network oscillations to patterns of chirps (Ethridge 
et al., 2017). Such deficits in auditory processing and language and communication are 
highly suggestive of altered auditory cortex development, function, and plasticity in FXS, 
and provided a basis for the hypothesis included in this thesis. 
 
II. FMRP and the Fmr1 KO mouse model 
Molecular overview of FMRP 
FMRP is most well-characterized for its role as a translational regulator, specifically acting 
as a translational repressor by its association with polyribosomes. FMRP typically inhibits 
ribosomal translocation and also stalls ribosome elongation on target mRNAs, thereby 
blocking translation (Darnell et al., 2011; Darnell and Klann, 2013). The phosphorylation 
status of FMRP determines whether FMRP is in its active repressive or inactive de-
repressed state. Specifically, phosphorylated FMRP, via the ribosomal S6 kinase (S6K), 
is associated with stalled polyribosomes that blocks translational activity, whereas 
dephosphorylation by protein phosphatase 2A (PP2A) causes the dissociation of FMRP 
from polyribosomes to allow translation (Narayanan et al., 2007; Bassell and Warren, 
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2008) (Figure 1.1). FMRP is also capable of blocking translation at the level of initiation 
by associating with translational machinery proteins (Bagni and Greenough, 2005; Bassell 
and Warren, 2008).  
 
FMRP & synaptic proteome. FMRP is ubiquitously expressed in all neurons and found 
throughout all of its neuronal compartments. High levels of FMRP are found in both the 
nucleus and cytoplasm with further localization in dendrites and spines, typically in 
messenger ribonucleoprotein granules consisting of clusters of mRNAs, ribosomes, 
FMRP, and other translational machinery (Bagni and Greenough, 2005). In the developing 
mouse brain, over 800 mRNAs are found to be targets of FMRP, with a high enrichment 
for pre- and postsynaptic proteins (Darnell et al., 2011; Darnell and Klann, 2013; Banerjee 
et al., 2018). Direct presynaptic targets of FMRP include the mRNAs for scaffolding 
proteins bassoon and piccolo, the neurexin family of cell surface adhesion molecules, 
regulators of synaptic vesicle release, such as synapsins, synaptotagmins, and clathrin-
associated adaptor complex, as well as voltage-gated calcium channels. FMRP targets 
for postsynaptic mRNAs include subunits for NMDA receptors (NMDAR) including the 
obligate NR1 subunit and developmentally regulated NR2A and NR2B, the group I 
metabotropic glutamate receptor 5 (mGluR5), postsynaptic scaffolding proteins such as 
PSD-95, SAPAP1-4, Shank1-3, and Homer1, and cell-adhesion proteins like neuroligins 
1-3. Given the breadth and enrichment of FMRP-mRNA regulation of synaptic-related 
proteins, it is evident that the loss of FMRP expression yields the manifestation of synaptic 
dysfunction and impairments that likely results in impaired plasticity and cognition in FXS 
and other neurodevelopmental disorders in which FMRP expression has been described 
to be secondarily altered (Bernard et al., 2013; Fernandez et al., 2013; Folsom et al., 
2015). 
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FMRP & interacting proteins. Separate from the translational regulation of synaptic 
proteins, FMRP has also been found to directly bind and regulate the expression of mRNA 
for transcription-related proteins (Korb et al., 2017). Specifically, FMRP targets the 
mRNAs for several chromatin-associated proteins; thus, loss of FMRP expression can 
yield epigenetic dysregulation and elicit aberrant gene expression. Additionally, FMRP 
itself has been described to directly regulate chromatin, whereby it can directly function 
as a chromatin-binding protein that functions in the DNA damage response (Alpatov et al., 
2014), while also associate with non-coding RNAs and microRNAs for chromatin 
remodeling (Bagni and Greenough, 2005). Thus, FMRP has a far more extensive reach 
beyond the large set of mRNAs it directly regulates, thereby indicating that examining 
broader circuit development patterns, and consideration for whether changes are primary 
or secondary to the initial genetic mutation will be important to understanding the impaired 
neurodevelopment in FXS. 
 
Recapitulation of FXS phenotypes in the Fmr1 KO model 
Several mouse models have been developed for FXS, with the most extensively 
characterized model being the Fmr1 knockout (KO) mouse (Kooy et al., 2017). The Fmr1 
KO mouse was generated by the insertion of a neomycin resistance cassette into exon 5, 
blocking the production of FMRP. While some variability does exist that is related to the 
genetic background of the Fmr1 KO mice, there is indeed a recapitulation of some of the 
core FXS symptoms in the KO mouse model. Consistent with post-mortem analysis of 
FXS patients, Fmr1 KO mice exhibit an increased density of immature dendritic spines 
(Kazdoba et al., 2014; Hagerman et al., 2017). Additionally, behavioral phenotypes of 
Fmr1 KO mice include hyperactivity, mild deficits in spatial learning and working memory, 
increased anxiety-related responses, and altered startle responses (Frankland et al., 
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2004; Kazdoba et al., 2014; Kooy et al., 2017), similar to the behavioral deficits present in 
FXS patients.  
 
While the learning and memory deficits are relatively mild in the animal model, Fmr1 KO 
mice exhibit a strong, reproducible impairment in long-term depression (LTD), one of the 
major cellular mechanisms underlying learning and memory (Lynch, 2004; Malenka and 
Bear, 2004). Typically, mGluR-mediated LTD, a form of synaptic plasticity, is dependent 
on dendritic protein synthesis that generates proteins necessary for the internalization of 
AMPA receptors (AMPARs) to reduce synaptic strength. However, Fmr1 KO mice are 
characterized to have enhanced mGluR-LTD with exaggerated LTD occurring 
independent of activity-dependent protein synthesis, known as the mGluR theory of FXS 
(Huber et al., 2002; Nosyreva and Huber, 2006). Plasticity deficits are prevalent in the 
Fmr1 KO brain but are highly region-specific, with enhanced mGluR-LTD only observed 
in the hippocampus and cerebellum, and variable forms of long-term potentiation (LTP) 
deficits observed in regions of the cortex and other areas (Li et al., 2002; Larson et al., 
2005; Desai et al., 2006; Kim et al., 2013; Yang et al., 2014; Kooy et al., 2017).  
 
Auditory-specific phenotypes in the Fmr1 KO model 
Consistent with FXS patients, the Fmr1 KO mouse also exhibits many auditory-specific 
phenotypes that mirrors much of the impairments and deficiencies in FXS. While Fmr1 KO 
mice do not exhibit spontaneous seizures like patients, Fmr1 KO mice uniquely have a 
high susceptibility to audiogenic seizures, where intense auditory stimulation (>100dB) 
can induce seizures that quickly progress from wild-running to tonic-clonic seizures, often 
causing death (Musumeci et al., 2000; Chen and Toth, 2001). The audiogenic seizures 
are indicative of hyperexcitability within the auditory circuit, where loss of FMRP 
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expression from glutamatergic neurons of the auditory brainstem, specifically the inferior 
colliculus, is responsible for this robust seizure phenotype (Chen and Toth, 2001; 
Gonzalez et al., 2019). At the level of the auditory brainstem, additional deficits have been 
characterized in Fmr1 KO mice related to auditory processing. Specifically, Fmr1 KO mice 
have increased acoustic startle response (Chen and Toth, 2001; Frankland et al., 2004) 
and altered auditory brainstem responses to auditory stimulation, which are attributed to 
the altered cell sizes, and distribution and firing of excitatory and inhibitory synapses in 
the developing Fmr1 KO brainstem (Rotschafer et al., 2015; Garcia-Pino et al., 2017; 
Rotschafer and Cramer, 2017; Lu, 2019; McCullagh et al., 2020). 
 
Impairments are also prevalent in higher auditory processing centers, such as the auditory 
cortex. Fmr1 KO mice have been found to have altered cortical responses to tones during 
in vivo recordings of adult mice. Specifically, auditory cortex neurons have increased firing 
to tones, broader frequency tuning, reduced spectrotemporal selectivity, and increased 
variability in response latency (Rotschafer and Razak, 2013). Physiological differences 
have also been observed in developing Fmr1 KO mice, where both in vivo single-unit 
recordings and EEG analysis in the auditory cortex showed abnormalities both at baseline 
and following sound-evoked responses (Wen et al., 2018; Wen et al., 2019). (Developing 
Fmr1 KO mice further exhibit impairments in parvalbumin cell development and 
perineuronal net formation, with reduced cell numbers and perineuronal net co-localization 
during the second to third postnatal week of development before eventually normalizing 
adults (Wen et al., 2018). Developmental plasticity is also impacted in the auditory cortex. 
Fmr1 KO mice have failed stabilization of LTP, where there is a faster decay following 
potentiation in cortical layer IV (Yang et al., 2014), and additionally KO mice have impaired 
critical period plasticity in the primary auditory cortex, where Fmr1 KO mice fail to exhibit 
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tonotopic frequency re-mapping following tone-rearing during early development (Kim et 
al., 2013).   
 
III. Critical periods of development 
Altered critical periods in developing Fmr1 KO mice 
Critical periods are postnatal developmental windows characterized by heightened 
experience-dependent synaptogenesis and synaptic plasticity that establish stable neural 
circuits. With regards to the sensory modalities, critical periods are thought to enlarge the 
representation of behaviorally relevant sensory stimuli for optimal processing (Hensch, 
2005). Much of the seminal work related to the mechanisms underlying the regulation of 
sensory critical periods has focused on the visual cortex with ocular dominance and 
monocular deprivation studies (Wiesel and Hubel, 1963; Shatz and Stryker, 1978), and 
the somatosensory cortex with tactile representation (Woolsey and Van der Loos, 1970; 
Petersen, 2007). While tonotopic mapping of sound frequencies during the auditory cortex 
critical period has been studied within various mammals, relative to other sensory cortices, 
there have been fewer studies examining mechanisms of auditory critical period regulation 
until recently (Yun et al., 2006; de Villers-Sidani et al., 2007; Kalish et al., 2020).  
 
Interestingly, Fmr1 KO mice have been characterized to have a variety of alterations in 
critical periods for each of these sensory modalities. As described earlier, Fmr1 KO mice 
have impaired plasticity during the primary auditory cortex critical period (Kim et al., 2013). 
Within the visual cortex, monocular deprivation elicits substantial open-eye potentiation in 
a shorter period of time in Fmr1 KO mice compared to WT, indicative of faster ocular 
dominance plasticity responses (Dolen et al., 2007). Additionally, in the barrel cortex Fmr1 
KO mice have a delayed critical period window, where the start of plasticity and its peak 
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does not occur until a few days later compared to WT littermate mice (Harlow et al., 2010). 
A delayed maturation of both AMPAR-NMDAR synapses and a GABA polarity switch has 
been found to underlie the altered barrel cortex critical period (Harlow et al., 2010; He et 
al., 2014; He et al., 2019), indicating that FMRP expression is crucial for the proper 
development and progression of critical periods. In the auditory cortex, altered mGluR-
mediated signaling is suggested to contribute to the impaired plasticity (Kim et al., 2013; 
Yang et al., 2014); however, a more detailed developmental examination of alterations 
elicited by loss of FMRP expression in the auditory cortex has not been conducted. 
 
Neuronal circuits and the regulation of critical periods by changes in E-I balance 
The onset and closure of critical periods are regulated by the development and maturation 
of excitatory-inhibitory (E-I) circuitry, with the expression of molecular “brakes” and 
neuromodulatory factors, such as synaptic and structural proteins, epigenetic regulators, 
and second messenger molecules, that limit the extent of plasticity (Hensch, 2005; 
Takesian and Hensch, 2013). The maturation of inhibitory GABAergic signaling is 
necessary for the triggering of critical periods, identified using transgenic mice that have 
reduced GABAergic signaling and pharmacological manipulation using modulators of 
GABAA receptors (GABAARs) (Hensch, 2005). Specifically, Gad65-knockout mice, which 
have a deletion for the GABA synthetic enzyme that concentrates within axon terminals 
and synaptic vesicles, fail to undergo a critical period in both the visual and auditory cortex. 
GAD65 KO mice do not exhibit ocular dominance or tonotopic plasticity unless the visual 
or auditory cortex is locally infused with diazepam to engage and enhance local inhibitory 
circuits (Fagiolini and Hensch, 2000; Kalish et al., 2020). This diazepam-induced plasticity 
in the GAD65 KO mice is capable of occurring at any age through adulthood, suggesting 
that without proper GABA signaling GAD65 KO mice remain in a relatively immature pre-
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critical period-like state. In wild-type mice local benzodiazepine infusions to the brain can 
precociously induce critical periods prior to the typical window, but they are not capable of 
inducing plasticity after the window, further indicating the necessary and sufficient role of 
inhibitory GABAergic neurotransmission to regulate the onset of critical periods (Fagiolini 
and Hensch, 2000; Fagiolini et al., 2004; Kalish et al., 2020).  In addition to its induction 
of critical periods, inhibitory signaling also ultimately limits the extent of plasticity, as 
reducing intracortical inhibition in the adult visual or auditory cortex has been found to 
promote ocular or tonotopic plasticity, respectively (Harauzov et al., 2010; Cisneros-
Franco et al., 2018).   
 
Excitatory neurotransmission is also crucial for modulating plasticity during critical periods, 
driving developmental synaptogenesis and synaptic plasticity (Hensch, 2005; Mao et al., 
2006; Oswald and Reyes, 2008; Harlow et al., 2010). The excitatory thalamocortical 
projections from the thalamus to layer IV of the cortex are responsible for mediating 
sensory input from the periphery. Its synaptic plasticity is most tightly confined to early 
development before plasticity sequentially proceeds through the other cortical layers 
consistent with intracortical processing (Jiang et al., 2007). The maturation of 
thalamocortical synapses during the critical period involves the dynamic regulation of the 
glutamate receptors, whereby the activity-dependent insertion of AMPARs into immature 
NMDAR-only silent synapses governs thalamocortical synaptic strength and the capacity 
for plasticity (Crair and Malenka, 1995; Isaac et al., 1997; Daw et al., 2007; Huang et al., 
2015). Precociously unsilencing or delaying silent synapse conversion can limit plasticity. 
Hyperexcitability induced by early-life seizures has been found to prematurely unsilence 
synapses via AMPAR insertion that disrupts auditory tonotopic critical period plasticity in 
WT mice (Sun et al., 2018). Meanwhile, a persistence of silent synapses in the Fmr1 KO 
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mice leads to a temporal delay in the plasticity window within the barrel cortex to delay its 
critical period (Harlow et al., 2010). Thus, the dynamic modulation and maturation of 
excitatory and inhibitory neurotransmission levels during development are important for 
the regulation of critical periods and the capacity for plasticity. 
 
IV. Excitatory-inhibitory balance in development and disease 
E-I maturation in the auditory cortex 
In addition to the role of developmental maturation of E-I neurotransmission in regulating 
critical periods, achieving proper E-I balance is also necessary for optimal auditory 
processing within the auditory cortex, such as sound encoding and plasticity. Consistent 
with general brain maturation patterns, the relatively strong excitatory input early in 
development within the auditory cortex is thought to determine the overall responsiveness 
to sensory information and be permissive for mechanisms inducing long-term synaptic 
plasticity (Froemke and Jones, 2011). This is observed within the rodent auditory cortex 
where the development and sharpening of frequency tuning in excitatory neurons reaches 
adult levels by the 2nd postnatal week, whereas frequency tuning in the inhibitory 
population does not reach adult levels until the 3rd and 4th postnatal week of development 
(Dorrn et al., 2010). The maturation and function of synaptic inhibition within the auditory 
cortex is responsible for refining and increasing the specificity of auditory processing. The 
sharpening of auditory frequency, increasing of signal-to-noise ratio for enhanced 
discrimination, adaptation to stimuli, and precise temporal processing all require inhibitory 
synaptic transmission within the auditory circuit (Wehr and Zador, 2003; Froemke and 
Jones, 2011; Blackwell and Geffen, 2017).   
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Developmental regulation of E- I neurotransmitter receptors 
Excitatory and inhibitory neurotransmission can be modulated at multiple levels, but, at its 
core, is fundamentally regulated by neurotransmitters and glutamatergic and GABAergic 
receptors. The expression and function of the ionotropic AMPA, NMDA, and GABAA 
receptors determine E-I levels. Individual subunits for each of these ionotropic receptors, 
particularly during postnatal development when they are dynamically and differentially 
expressed, further regulate the kinetics, permeability, and other biophysical properties to 
additionally modulate neuronal excitability and plasticity (Rakhade and Jensen, 2009). 
 
AMPA and NMDA receptors are ionotropic glutamate receptors that mediate excitatory 
neurotransmission. As tetrameric structures, the assembly of the GluA1-4 subunits or 
GluN1, GluN2A-D and GluN3A-B subunits determines the receptor properties for AMPAR 
and NMDARs, respectively. AMPARs are distinct from NMDARs in that they are 
predominantly impermeable to calcium due to the inclusion of the GluA2 subunit. 
Compared to the other AMPAR subunits, GluA2 undergoes a distinct glutamine to arginine 
post-transcriptional modification, whereby the positively charged arginine residue in the 
ion channel blocks the passage of calcium ions (Isaac et al., 2007). However, at birth 
GluA2 is expressed at relatively low levels at birth compared to the other subunits before 
postnatally increasing in expression in the cortex and hippocampus (Monyer et al., 1991; 
Kumar et al., 2002). The presence of GluA2-lacking AMPARs during neonatal 
development renders AMPARs permeable to calcium, making neurons more excitable and 
capable of activating intracellular calcium-dependent signaling pathways to facilitate a 
period of heightened activity-dependent synaptic plasticity (Kumar et al., 2002; Isaac et 
al., 2007; Rakhade and Jensen, 2009).  
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Unlike AMPARs, all NMDARs are permeable to calcium and have a voltage-dependent 
magnesium block, which confers coincidence-detecting properties of pre- and 
postsynaptic activity (Lau and Zukin, 2007). NMDARs consist of the obligate GluN1 
subunit and most commonly the GluN2 subunits, with GluN2B and GluN2A most robustly 
expressed in the cortex and hippocampus (Lau and Zukin, 2007; Ewald and Cline, 2009). 
GluN2B is more highly expressed at birth in the immature brain, with GluN2A increasing 
postnatally to replace GluN2B as the dominant subunit (Monyer et al., 1994). These 
subunits exhibit different deactivation kinetics, with GluN2B having slower decay times 
compared to GluN2A-containing NMDARs (Cull-Candy et al., 2001), where their 
differential developmental expression governs the degree of synaptic calcium influx, 
postsynaptic density binding partners, and the directionality of plasticity, such as LTP or 
LTD (Liu et al., 2004; Cho et al., 2009).  
 
GABAARs are pentameric assemblies where synaptic receptors in the brain are commonly 
assembled with two a-subunits, two b-subunits, and one g-subunit to mediate GABAergic 
transmission and balance neuronal excitatory signaling. In particular, the developmental 
regulation of the a-subunits determines GABA sensitivity and the kinetics of chloride ion 
conductance (Okada et al., 2000; Bosman et al., 2005). In the cortex and hippocampus, 
the expression of the a3-subunit is high at birth and is subsequently postnatally 
downregulated while a1 is low and upregulated, with a3 associated with lower GABA 
sensitivity and slower decay times relative to a1 (Laurie et al., 1992; Picton and Fisher, 
2007; Galanopoulou, 2008a). Interestingly, GABAAR a1-mediated signaling is necessary 
for the induction of critical periods within the visual cortex (Fagiolini et al., 2004), indicative 
of the importance of developmental regulation of a1 expression. GABAergic maturation 
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also entails the transition from depolarizing responses in the neonatal brain to the classical 
hyperpolarizing GABA-mediated signaling that strengthens with postnatal age. The 
relative expression of the developmentally regulated chloride transporters NKCC1 and 
KCC2 establishes the chloride gradients to determine whether GABA elicits an excitatory 
or inhibitory response, with NKCC1 and KCC2 acting as importers and exporters of 
chloride ions, respectively (Ben-Ari, 2002; Dzhala et al., 2005; Rheims et al., 2008).  
 
Dynamic E-I subunit regulation in the auditory cortex 
Proper auditory processing and plasticity in the auditory cortex necessitates well-regulated 
E-I function. These aforementioned ionotropic receptor subunits are also dynamically 
regulated within the auditory cortex where their expression is highly sensitive to 
environmental exposure and aging, and further associated with altered neuronal firing and 
acoustic processing.  Early music exposure and rearing of rodents in enriched 
environments increased the expression of the relatively more developmentally mature 
subunits for AMPAR (GluA2), NMDAR (GluN2A), and GABAARs (a1) within the auditory 
cortex, while sharpening frequency tuning of the neurons (Xu et al., 2007; Cai et al., 2010). 
In contrast, adult rats that had early postnatal noise exposure to deteriorate frequency 
representations in the auditory cortex exhibited decreased levels of the mature ionotropic 
receptor subunits (Guo et al., 2012a). Similar patterns are observed with natural aging 
where aged rodents exhibit a clear decrease in spectral sensitivity and dysregulated 
plasticity that is associated with overall reduced GABAergic inhibition and altered a-
subunit expression, with decreased mature a1-subunit and increased a3-subunit 
expression, making it more similar to the immature brain (Caspary et al., 2013; Cisneros-
Franco et al., 2018). Overall, while changes in relative AMPAR and GABAAR expression 
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also occur to compensate for altered E-I levels in circumstances such as unilateral hearing 
loss (Balaram et al., 2019), the auditory cortex indeed exhibits subunit-specific alterations 
of ionotropic glutamate and GABAA receptors that relate to capabilities of auditory 
processing and plasticity.  
 
Alterations to E-I subunit expression in neurological disorders 
Neurotransmitter receptor subunit alterations are also consistently observed in epilepsy 
and neurodevelopmental disorders. Following seizures, GABAergic and glutamatergic 
receptors exhibit changes in subunit expression (Talos et al., 2006a; Rakhade and 
Jensen, 2009; Brooks-Kayal, 2011). Specifically, early-life hypoxia-induced seizures in 
rodents increased the levels of GluA2-lacking calcium-permeable AMPARs and 
prematurely diminished NMDAR-only silent synapses, yielding later-life hyperexcitability, 
and plasticity and behavioral deficits (Rakhade et al., 2008; Zhou et al., 2011; Lippman-
Bell et al., 2013). Chemoconvulsant-induced seizures in early-life cause increased 
GABAAR expression selectively for the a1-subunit, while seizures as adults decreased its 
expression, suggestive of age-dependent alterations from hyperexcitability (Brooks-Kayal, 
2011). Various monogenic forms of autism spectrum disorders such as Tuberous 
Sclerosis, CDKL5 deficiency disorder, Rett syndrome, and Dravet syndrome, further 
exhibit altered neurotransmitter receptor subunit expression and function across various 
brain regions (White et al., 2001; Braat and Kooy, 2015b; Li et al., 2016; Ruffolo et al., 
2018; Yennawar et al., 2019; Zhao and Yoshii, 2019). The altered subunit expression 
profiles across the neurodevelopmental disorders are indicative of E-I imbalance in the 




E-I imbalance in FXS 
Evidence suggesting an E-I imbalance in the FXS brain with patients is supported by their 
propensity to exhibit spontaneous seizures (Nelson and Valakh, 2015; Hagerman et al., 
2017), with hyperexcitability and impaired inhibition further confirmed from transcranial 
magnetic stimulation and EEG studies of FXS patients (Knoth et al., 2014; Ethridge et al., 
2017; Morin-Parent et al., 2019). Consistent with this, the Fmr1 KO mouse model has also 
been extensively described to exhibit neuronal and circuit hyperexcitability due to altered 
intrinsic excitability, action potential properties, voltage-gated channels, neurotransmitter 
receptors, and more (Goncalves et al., 2013; Contractor et al., 2015). However, changes 
resulting from the loss of FMRP expression are not uniform and are rather specific to the 
brain region and cell type (Contractor et al., 2015). For example, the enhanced mGluR-
mediated LTD and the associated AMPAR internalization are well-characterized in the 
cerebellum and hippocampus, with the hippocampus even further exhibiting prolonged 
epileptiform discharges in slice preparations (Huber et al., 2002; Bear et al., 2004; Chuang 
et al., 2005; Nakamoto et al., 2007). However, such plasticity impairments or epileptiform 
discharges are not observed in the cortex or other brain regions, with further differential 
expression of mRNAs and proteins pertaining to excitatory neurotransmission such as 
GluA1/2, synaptic scaffolding proteins, and CaMKIIa (Muddashetty et al., 2007; Schutt et 
al., 2009). Region-specific impairments in GABAergic signaling are also observed in the 
Fmr1 KO mouse, with varying degrees and directional changes of GABAAR subunit 
expression and function, GABA neurotransmitter levels, and numbers of inhibitory cells 
and synapses (Paluszkiewicz et al., 2011; Braat and Kooy, 2015a).  
 
While E-I imbalance has been described in the Fmr1 KO auditory circuit that is likely 
related to the auditory phenotypes in FXS patients, many of the studies to date have 
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focused on the lower auditory circuit with characterization of the auditory brainstem 
regions including the ventral cochlear nucleus, medial nucleus of the trapezoid body, and 
lateral superior olive (Chen and Toth, 2001; Rotschafer et al., 2015; Garcia-Pino et al., 
2017; Rotschafer and Cramer, 2017). Fewer studies have examined auditory circuit and 
E-I synaptic maturation at specific synaptic networks within the auditory cortex despite the 
plasticity and processing deficits described in the Fmr1 KO mouse. Given the role of 
glutamatergic and GABAergic neurotransmitter receptor maturation in both regulating 
critical period plasticity and auditory processing, and the region-specific alterations caused 
by global loss of FMRP expression, it is critical to evaluate E-I synaptic development in 
the FXS auditory cortex to further elucidate mechanisms underlying the auditory 
symptoms and identify new targets and therapeutics for the treatment of FXS.  
 
V. Therapeutic strategies for the treatment of FXS 
Limited success of past FXS clinical trials 
Numerous clinical trials have been conducted over the past 20 years using compounds 
from preclinical studies that had successfully reversed many of the behavioral, 
physiological, and pathological phenotypes in the Fmr1 KO mouse. Based on the 
aforementioned mGluR theory of FXS, antagonists and other negative modulators for 
mGluR5 were extensively tested; however, double-blind controlled studies using fenobam 
or mavoglurant showed no significant benefit of either compound in social behaviors 
despite even stratifying patients based on the methylation status of the mutation to reduce 
variability (Schaefer et al., 2015; Hagerman et al., 2017). Similarly, the GABAB agonist 
arbaclofen, which also had much preclinical success, went to Phase III trials but failed to 
improve the primary outcome measure of social avoidance and aberrant behaviors 
(Schaefer et al., 2015; Berry-Kravis et al., 2018). Broad modulators of the GABAergic 
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system have additionally been tested but have yielded limited success, including 
ganaxolone, which is thought to target both synaptic and extrasynaptic GABAA receptors, 
as well as metadoxine, which acts more presynaptically by targeting GABA transporters 
(Hagerman et al., 2017).  
 
Following the failed outcomes of these clinical trials, there has been much discussion 
pertaining to considerations for subsequent clinical trials and therapeutic development. 
Interestingly, while mGluR5 antagonists did not improve the primary behavioral outcome 
measures, single dose studies of fenobam did significantly improve alterations in 
sensorimotor gating in FXS patients, specifically prepulse inhibition deficits (Schaefer et 
al., 2015). This suggests that the clinical outcome measures utilized for clinical studies 
should be reconsidered to perhaps use measures that are more sensitive yet still feasible 
for FXS patients, more specific to the physiological alterations occurring in the brain, and 
less vulnerable to subjective scoring measures. Another consideration for future trials 
includes the use of younger cohorts with smaller age ranges and possible stratification 
based on the severity of the mutation. Given that FXS is a developmental disorder where 
the goal is to improve intellectual disability, plasticity and behavior, the ability to make 
changes and improvements in adults is likely limited, thus requiring a more refined 
treatment window (Mullard, 2015).  
 
Lastly, as new therapeutic agents are being explored, considerations must be made for 
the target mechanism of action. Is the function of FMRP to be directly modulated? (Darnell 
and Klann, 2013; Hagerman et al., 2017).  Is the target a protein that is under the direct 
translational regulation of FMRP? Or is the broad modulation of E-I imbalance during 
discreet developmental time windows capable of eliciting beneficial outcomes. 
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Nevertheless, the lack of success of clinical trials thus far indicates the need for more 
detailed, region-specific evaluations of pathophysiological dysfunction in FXS. 
Impairments in auditory processing, language development, and communication in FXS 
necessitate a close examination of auditory cortex maturation and function. Such 
assessments will enable the identification of new therapeutic targets along with, 
biomarkers and dynamic windows of vulnerability, while further determining target 
symptoms that can be malleable to correction in FXS patients.  
 
VI. Open questions: E-I circuit maturation impairments in the FXS auditory cortex 
Despite evidence suggesting perturbed E-I balance in the brains of FXS patients, as well 
as the numerous auditory-related phenotypes experienced in both FXS and autism, there 
is a limited understanding of auditory circuit maturation—particularly with the auditory 
cortex—in neurodevelopmental disorders. There is an increasing need to evaluate E-I 
maturation within more specific brain regions to decouple and improve the understanding 
of mechanisms related to complex patient symptomology to ultimately reveal more 
accurate biomarkers, targets and therapeutic paradigms for the treatment of Fragile X 
syndrome. The current literature on critical periods of development, sensory system 
maturation, and E-I abnormalities across FXS and other neurodevelopmental disorders, 
suggest abnormalities related to the plasticity and intracortical connectivity in the 
developing FXS auditory cortex. The work presented in the subsequent chapters of this 
thesis provide the most complete description to date detailing excitatory-inhibitory synaptic 
and circuit development during auditory cortex maturation in Fmr1 KO mice, a mouse 




The work presented in the subsequent chapters of this thesis provide the most complete 
description to date of excitatory-inhibitory synaptic and circuit maturation of the auditory 
cortex maturation in the Fmr1 KO mice, a mouse model of genetic intellectual disability. 
In Chapter 2, we first examine the developmental expression patterns of ionotropic 
glutamate and GABA receptors in the auditory cortex as they relate to key ages in auditory 
circuit maturation. Chapter 3 evaluates physiological maturation in the developing 
auditory cortex, examining intracortical L4-L2/3 circuit excitability and plasticity. We further 
decouple functional alterations with a cell-type specific evaluation of GABAergic 
maturation in the auditory cortex in Chapter 4, and highlight ongoing work glutamate 
maturation in Chapter 5. Together, these characterizations offer a mechanism whereby 
auditory cortex critical periods and auditory processing are impaired in the FXS mouse 
















Figure 1.1: Phosphorylated FMRP blocks translational activity. The phosphorylation status of 
FMRP determines whether FMRP is in its active repressive or inactive de-repressed state. 
Phosphorylated FMRP, via the ribosomal S6 kinase (S6K), is associated with stalled polyribosomes 
that blocks translational activity, whereas dephosphorylation by protein phosphatase 2A (PP2A) 
causes the dissociation of FMRP from polyribosomes to allow translation. Early signaling cascade 
mediated by mGluR signaling has different time course for activation of PP2A (fast) and mTOR 
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In Fragile X syndrome (FXS), excitatory-inhibitory (E-I) imbalance in the developing brain 
is thought to underlie many of the core neurological symptoms of this disorder. Despite 
the myriad of auditory-related phenotypes in both patients and the Fmr1 knock-out (KO) 
mice that relate to impaired auditory processing and plasticity, there have been limited 
characterizations of E-I regulation specific to the developing auditory cortex. Here, we 
examined the expression of ionotropic glutamate and GABA receptors, the fundamental 
regulators of E-I neurotransmission, across key ages in auditory forebrain development, 
specifically comparing subunits known to impart changes in developmental neuronal 
excitability and plasticity during postnatal brain maturation. Consequently, in the naturally 
developing WT auditory cortex, we found dynamic changes in receptor expression that 
occur within finite 3-day intervals related to both ear canal opening and the auditory cortex 
critical period window. Furthermore, in Fmr1 KO mice, we found dysregulated expression 
of developmentally regulated subunits of AMPAR and GABAAR during the postnatal 
maturation of the auditory cortex. These dynamic alterations in the expression of 
ionotropic glutamate and GABA receptors are suggestive of altered receptor function and 
E-I balance specifically in the auditory cortex that could be an underlying contributor to the 










Fragile X syndrome (FXS) is the most common heritable form of intellectual disability and 
autism, with patients exhibiting cognitive deficits, behavioral issues, sensory sensitivity, 
and seizures (Kidd et al., 2014; Hagerman et al., 2017). While a myriad of abnormalities 
has been described in the dysregulated neurodevelopment during FXS, neuronal and 
circuit hyperexcitability is an underlying theme across characterizations in both FXS 
human and Fmr1 knock-out (KO) animal model studies (Heard et al., 2014; Contractor et 
al., 2015; Nelson and Valakh, 2015; Hagerman et al., 2017; Morin-Parent et al., 2019; 
McCullagh et al., 2020). 
 
The abundance of data suggesting excitatory-inhibitory (E-I) imbalance is thought to be 
due to the role of Fragile X mental retardation protein (FMRP) as an RNA binding protein 
that regulates an extensive number of mRNA transcripts, including hundreds of mRNAs 
related to the synaptic proteome (Darnell et al., 2011). Accordingly, analyses of the Fmr1 
KO mouse brain have characterized altered expression of receptors, transporters, 
neurotransmitters, and ion channels, which include both those with and without direct 
FMRP interactions to their respective mRNA transcripts (Li et al., 2002; Schutt et al., 2009; 
Paluszkiewicz et al., 2011; Braat and Kooy, 2015a; McCullagh et al., 2020). However, 
these expression studies have largely focused on the hippocampus, somatosensory 
cortex, cerebellum, brainstem, and amygdala, and indicate region-specific alterations in 
the aforementioned proteins due to the loss of FMRP.  
 
FXS patients often exhibit auditory-specific deficits including impaired language 
development and communication, and altered auditory processing. Despite the range of 
auditory-related phenotypes also found in Fmr1 KO mice, including audiogenic seizure 
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susceptibility (Chen and Toth, 2001), altered auditory processing with enhanced auditory 
cortex excitability (Yun et al., 2006; Rotschafer and Razak, 2013), and impaired tonotopic 
and synaptic plasticity during the auditory cortex critical period (Kim et al., 2013; Yang et 
al., 2014), there have been limited characterizations, to date, examining synaptic protein-
related expression in the auditory cortex. Therefore, we sought to evaluate the 
developmental expression profile of the auditory cortex, hypothesizing that the auditory 
cortex of Fmr1 KO mice would exhibit underlying alterations in the expression of the 
fundamental regulators of excitatory and inhibitory neurotransmission, ionotropic 
glutamate and GABAA receptors, to contribute to the auditory-related phenotypes in FXS.  
 
Ionotropic glutamate and GABAA synaptic receptors are dynamically expressed over the 
course of development to impact neuronal excitability and plasticity. Individual receptor 
subunits are further developmentally regulated where changes in the relative subunit 
distribution influence the permeability, kinetics, and neurotransmitter binding sensitivity of 
receptors (Laurie et al., 1992; Monyer et al., 1994; Isaac et al., 2007; Picton and Fisher, 
2007; Ewald and Cline, 2009). The relatively high expression of AMPAR GluA1 subunit, 
NMDAR GluN2B subunit, and GABAAR a3-subunit in the developing brain, particularly in 
the cortex and hippocampus, generally skews the dynamics of the receptors towards 
enhanced excitability, enabling rapid synaptogenesis and synaptic plasticity (Rakhade 
and Jensen, 2009). As the expression of AMPAR GluA2, NMDAR GluN2A, and GABAAR 
a1-subunits increase postnatally, neuronal excitability is more tightly controlled and is 
associated with diminishing synaptic plasticity across development (Erisir and Harris, 
2003; Fagiolini et al., 2004; Isaac et al., 2007).  
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Alterations in relative ionotropic receptor subunit expression have been found across 
neurodevelopmental disorders and epilepsy and are linked with neurobehavioral deficits, 
E-I imbalance, and synaptic plasticity impairments. Recent studies have demonstrated 
altered AMPAR and NMDAR subunit expression in rodent models of CDKL5 deficiency 
disorder (Tang et al., 2019; Yennawar et al., 2019), while both glutamate and GABAAR 
subunits have been identified to have impaired trafficking and expression in rodent seizure 
models, Dravet syndrome, and tuberous sclerosis (White et al., 2001; Raol et al., 2006; 
Rakhade and Jensen, 2009; Brooks-Kayal, 2011; Hernandez et al., 2019). In the rodent 
auditory cortex, the expression of ionotropic receptor subunits is found to change based 
on environment and aging, and is associated with auditory processing alterations (Cai et 
al., 2010; Guo et al., 2012a; Caspary et al., 2013).  
 
To identify underlying contributors to altered auditory function and excitability in Fmr1 KO 
developing and adult mice, we investigated the developmental expression of ionotropic 
glutamate and GABAA receptors, and the chloride transporters NKCC1 and KCC2 in the 
auditory cortex of Fmr1 KO and WT mice during key ages of auditory forebrain 
development. The following studies sought to achieve both 1) a comprehensive 
examination of the natural WT developmental progression of E-I receptors and chloride 
transporters in the auditory cortex, which, to date, no studies have extensively 
characterized, and 2) identification of any alterations in the Fmr1 KO auditory cortex that 
result in E-I imbalance and contribute to the impaired critical period plasticity. For any 
differentially expressed receptor subunits between WT and KO mice, we further examined 
whether differences manifested by transcriptional, translational, and/or trafficking 
alterations given that the mRNAs of our receptors and transporters of interest included 




Fmr1 WT and Fmr1 KO mice of the congenic FVB background were obtained from The 
Jackson Laboratory (stock # 004828; 004624). Heterozygous females were generated 
from the original breeders, whereby heterozygous female mice were later crossed with 
male mice to obtain Fmr1 WT and KO male littermates. Age-matched WT and KO male 
littermate mice were used for all experiments to avoid the confounding effects of X-
inactivation that would be present in heterozygous females. All procedures were 
performed in accordance with the guidelines of the NIH and with the approval of the 
Institution of Animal Care and Use Committee with the University of Pennsylvania. All 
efforts were made to minimize animal suffering and numbers. 
 
Auditory cortex isolation 
To compare the developmental expression patterns of ionotropic glutamate and GABAA 
receptor subunits, and chloride cotransporters in the auditory cortex, Fmr1 WT and KO 
littermates were sacrificed at P9, P12, P15, P24, and P56. Brains were rapidly removed 
from the skull and the auditory cortex was micro-dissected. Using a coronal brain matrix, 
a 1.5-2.0 mm thick coronal brain slice containing the auditory cortex was extracted as 
identified by stereotaxic coordinates and anatomical landmarks from Paxinos and Franklin 
(2004) and the Allen Brain Atlas. The brain slice was then cut horizontally above the rhinal 
fissure, whereby approximately 15° cuts were made bilaterally to isolate the auditory 




For the analysis of membrane-bound protein expression by western blot, the auditory 
cortex from 2 mice were pooled together for a single sample (n = total number of pooled 
samples), as required for sufficient protein concentration for membrane preparations. 
Samples for whole-cell/total measures of protein expression by western blot, or samples 
for RT-qPCR were from individual mice. 
 
Western blots 
Both membrane and total whole-cell extraction was performed as previously described 
(Talos et al., 2006a; Rakhade et al., 2012; Yennawar et al., 2019). Total protein amounts 
were measured with a Bradford protein assay (Bio-Rad) and samples were then diluted to 
obtain equal amounts of proteins in each sample (15 µg total) in lysis buffer and 4X 
Laemmli Sample Buffer (Bio-Rad). Samples were separated by gel electrophoresis on 
Criterion TGX 4-20% Tris-Glycine precast gels (Bio-Rad), and transferred to PVDF 
membranes (Millipore Immobilon-FL). Primary antibodies used in this study are as follow: 
GluA1 (1:1000, Abcam ab31232); GluA2 (1:1000, Millipore MAB397); NR2A (1:1000, 
Sigma M264); NR2B (1:1000, Thermo MA1-2014); NR1 (1:750; Thermo OMA-04010); 
GABAA a3 (1:1000, Sigma G4291); GABAA a1 (1:750, NeuroMab 75-136); NKCC1 
(1:1000, Millipore AB3560P); KCC2 (1:1000, Millipore 07-432); b-actin (1:5000, Sigma 
A5441). Secondary antibodies used were goat anti-rabbit IRDye 800CW (1:15,000; LI-
COR 926-32212) and goat anti-mouse IRDYE 680LT (1:20,000; LI-COR 926-68024). The 
Odyssey Infrared Imaging System protocols were used for blots and quantification of 
protein expression. b-actin was used for normalization of individual samples, and 
normalized values were expressed as a percentage of mean age-matched WT samples 
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Mice were anesthetized by intraperitoneal injection with pentobarbital and perfused with 
4% paraformaldehyde in PBS and post-fixed for 2 hours. Brains were then cryoprotected 
in 30% sucrose/PBS until saturated. Brains were embedded in OCT, frozen at -80°C, 
cryosectioned to 30 µm thick sections collected in multi-well plates with 0.02% sodium 
azide/PBS. After washing sections in PBS, antigen retrieval was performed by incubation 
of sections in sodium citrate buffer, pH 6.0 for 30 min at 75°C. Sections were then 
maintained in citrate buffer for 15 min at room temperature (RT), washed, and blocked in 
10% normal goat serum/PBS. Primary antibody for the extracellular or topological domain 
targeting GABAAa3 (1:500, alomone AGA-003) or GABAA a1 (1:500, Millipore 06-868) 
was incubated overnight at 4°C in 1% goat serum/PBS. Sections were washed, incubated 
in secondary antibody goat anti-rabbit 594 (1:1000, Invitrogen) for 1 hour at RT and 
washed. Sections were permeabilized with 0.2% Triton/PBS for 5 min, washed, and re-
blocked in 10% goat serum/0.1% Triton/PBS for 1 hour at RT. Sections were incubated 
with anti-VGAT (1:500, Synaptic Systems 131 004) and anti-MAP2 (1:500, abcam 
ab5392) overnight at 4°C in 1% goat serum/0.1% Triton/PBS. Sections were washed, 
incubated in secondary antibodies goat anti-chicken 488 and goat anti-guinea pig 647 
(1:1000, Invitrogen) for 1 hour at RT. Sections were PBS washed, mounted on slides, and 




Images were acquired on a Leica SP5 confocal microscope. Using the hippocampus and 
rhinal fissure as anatomical landmarks, the auditory was approximately localized using 
both the 10X and 20X objectives. Upon localization, the objectives were switched to oil 
immersion at 40X followed by 63X (NA = 1.4) with a digital zoom of 2. Gain, offset, and 
laser intensity settings (Argon, HeNe 594, HeNe 633) were kept identical during imaging 
sessions for P24, and a separate set of settings kept identical across P12 imaging. MAP2 
immunostaining was used to approximate cortical layers based on cell body shape and 
size. Imaging started in deep layers (L6) based on white matter, and then progressed out 
to L2/3. From the same section, images were obtained at 1024x1024 pixels bilaterally 
from both hemispheres (2 images taken from a given mouse), using a line average of 2 
and z-step of 0.25µm where approximately 25-35 z-planes were obtained. 
 
Imaging Process & Analysis 
Image files were blinded and processed using FIJI. Five z-planes with the brightest 
staining were selective from the entire z-plane stack for image processing. Noise was 
reduced from each plane and channel using the despeckling function, followed by smooth 
function. The 5 z-planes were then collapsed into a single image using the Sum Slices of 
Z-project. Background was subtracted using a rolling ball algorithm (40 pixels for P12; 20 
pixels for P24). Channels were auto-thresholded (Over/Under) and switched to an 8-bit 
image. To avoid thresholding artifact, each channel was thresholded at multiple intervals 
of the maximum threshold (95, 90 85, 80, and 75%). Using the Coloc2 plugin (Gao and 
Heldt, 2016; Hernandez et al., 2019; Yennawar et al., 2019), we compared the integrated 
intensity values for total fluorescent intensity, and Mander’s coefficient to quantify co-
localization of VGAT with GABAAa3 or GABAAa1 (Manders et al., 1993). Calculations of 
the coefficients were repeated at each of the additional thresholded intervals against the 
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maximum threshold of the opposite channel to ensure any possible differences were not 
due to thresholding artifacts.  
 
RT-qPCR 
The auditory cortex from P9, 12, 15 and 24 Fmr1 WT and KO mice were isolated, and 
total RNA was extracted using RNeasy Mini Kit (Qiagen). First-strand cDNA was 
synthesized using SuperScript III First-Strand Synthesis System (Invitrogen). qPCR was 
performed using the TaqMan Gene Expression Assay (ThermoFisher) on an Eppendorf 
EP Realplex system on 50ng of cDNA per sample. TaqMan probes for target genes are 
as follows: Gria1: Mm00433753_m1; Gria2: Mm00442822_m1; Gabra1: 
Mm00439046_m1; Gabra3: Mm01294271_m1. Reference/housekeeping genes used are 
as follows: Actb: Mm00607939_s1; Gapdh: Mm99999915_g1; Hprt: Mm03024075_m1. 
 
Measurements were made in triplicate and the expression of each gene was normalized 
by subtracting the Ct for each reference gene from the target gene (DCt = Ct target gene 
– Ct reference gene). The relative gene expression of KO compared to WT was 
determined by first calculating the average DCt for WT samples, and then calculating DDCt 
value for each sample relative to the average DCt for WT. Expression fold change for each 
sample was calculated by 2(-DDCt). 
 
Statistical Analysis 
Statistical analysis was completed using Prism (GraphPad). Data was tested for normality 
using the Shapiro-Wilk normality test. For within age comparisons, statistical significance 
was assessed using a Student’s t test or Mann-Whitney test depending on normality of 
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the data. For Western blots with developmental expression analysis, two-way ANOVA and 
Sidak’s multiple comparisons tests were used to assess significance. Significance for all 
analyses were determined by p < 0.05. Data are reported as mean ± SEM with p values 
reported in Results.  
 
RESULTS 
We examined the developmental expression of AMPA, NMDA and GABAA receptors in 
the auditory cortex across key ages in auditory forebrain development starting at P9, prior 
to ear canal opening, P12 and P15, capturing the start and end of the mouse auditory CP 
(Barkat et al., 2011), P24 and as adults at P56 (Figure 2.1A). We performed western blot 
analysis to compare the expression of membrane-bound AMPAR subunits GluA1 and 
GluA2, NMDAR subunits GluN1, GluN2A and GluN2B, and GABAAR a1 and a3 subunits 
in Fmr1 KO mice compared to WT littermates. These specific subunits are dynamically 
expressed across postnatal development to influence developmental plasticity, exhibit 
altered expression in neurodevelopmental disorders and epilepsy, and are sensitive in 
their expression with the auditory cortex to early environmental exposure (Rakhade and 
Jensen, 2009; Cai et al., 2010; Guo et al., 2012a; Yennawar et al., 2019).  
 
Fmr1 KO mice exhibit elevated AMPAR GluA2:GluA1 protein expression in the 
auditory cortex, prior to ear canal opening 
Although prior studies have examined the expression of ionotropic receptors in the 
developing rodent auditory cortex (Laurie et al., 1992; Behuet et al., 2019), there are no 
analyses to date of membrane-bound protein expression in mice, which can be more 
reflective of physiological function. To evaluate the developmental expression pattern of 
these subunits during the postnatal maturation of the auditory cortex, each of the 
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aforementioned ages were normalized relative to P56 WT levels (Figure 2.1B-D). 
Consistent with AMPAR evaluation in the overall cortex by Yennawar et al. (2019), the 
most prominent developmental changes in GluA1 and GluA2 subunits were observed in 
the auditory cortex within the 1st and 2nd postnatal week (2-way ANOVA, age, p < 0.0001). 
At all ages of WT auditory cortex development, GluA1 expression exceeds its relative adult 
levels, peaking at P15 before declining (Figure 2.1B). Compared to P9 GluA1 expression, 
GluA2 expression is relatively lower at the same age but undergoes rapid increased 
expression between P9 and P12 in WT mice, during the transition of ear canal opening 
(Figure 2.1C). The ratio of GluA2:GluA1, indicative of the maturity of AMPARs and their 
impermeability to calcium (Isaac et al., 2007), developmentally increases through the 4th 
postnatal week in WT mice to reach adult levels (Figure 2.1G). When examining the 
postnatal expression of the AMPAR subunits in the auditory cortex of Fmr1 KO mice, we 
found altered regulation of GluA2:GluA1. Specifically, Fmr1 KO mice exhibited 
significantly elevated GluA2:GluA1 expression before normalizing to WT levels (2-way 
ANOVA, genotype: F(1, 108) = 5.099, p = 0.026; Sidak’s multiple comparisons test: P9 WT: 
63.98 ± 3.17% vs. KO: 82.55 ± 6.28%, p = 0.038; P12 WT: 88.93 ± 2.38% vs. KO: 101.78 
± 3.77%, p = 0.301) (Figure 2.1G). 
 
We further compared relative Fmr1 KO protein expression to their age-matched WT 
littermates to more directly carefully examine AMPAR protein alterations at each age. 
While the levels of GluA1 in Fmr1 KO mice were unaltered compared to WT littermates at 
all ages (Figure 2.1E-G), Fmr1 KO mice exhibit significant differences in membrane-bound 
GluA2 expression selectively at early ages of auditory postnatal development. At P9, prior 
to ear canal opening, Fmr1 KO mice have significantly increased GluA2 levels (WT: 100 
± 5.27%, KO: 127.7 ± 8.9%, p = 0.0146) (Figure 2.1E). When evaluating the ratio of 
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subunits GluA2:GluA1, Fmr1 KO mice have significantly increased GluA2:GluA1 
expression in the auditory cortex at both P9 and P12 (P9, WT: 100 ± 4.75%, KO: 128.9 ± 
9.14%, p = 0.011; P12, WT: 100 ± 2.68%, KO: 113 ± 3.92%, p = 0.015) (Figure 2.1E-F). 
However, no differences in either subunit were observed at P15 or later ages (Figure 2G).  
 
Levels of membrane-bound NMDAR subunits are largely unaltered in the auditory 
cortex of Fmr1 KO mice. 
We also assessed the developmental expression of GluN1, the obligate NMDAR subunit, 
GluN2A and GluN2B to further analyze whether dysregulation of NMDAR expression 
altered the trajectory of ionotropic glutamatergic receptor maturation (Figure 2.2). When 
each of the ages were normalized relative to P56 WT levels, NMDAR subunits exhibited 
the most dynamic developmental regulation within the first 2 postnatal weeks, similar to 
membrane-bound AMPAR expression (Figure 2.2A-D). In WT development, GluN2A is 
expressed at relatively low levels at birth, whereby it subsequently increases rapidly during 
the 2nd postnatal week exceeding adult levels before declining after P15 (Figure 2-1A). 
GluN2B and GluN1 expression are higher at P9 compared to GluN2A, but follow a similar 
developmental trajectory (Figure 2.1B,D). Given the relatively low expression of GluN2A 
at early postnatal ages, the ratio of GluN2B:GluN2A, indicative of NMDAR maturity, 
exhibits a strong developmental downregulation during the 2nd postnatal week (Figure 
2.1C). No genotype differences were observed for any of the subunit measures, where 
developmental expression patterns largely mirrored each other for GluN2A, 
GluN2B:GluN2A, and GluN1 (2-way ANOVA, age, p < 0.0001). While developmental 
expression of GluN2B also had a significant effect of age (2-way ANOVA, age, F(4, 106) = 
4, p = 0.0024), where peak expression occurred during the 2nd postnatal week, Fmr1 KO 
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mice appear to have a shifted peak, where maximal GluN2B expression occurs at an 
earlier age compared to WT mice (Figure 2.2B). 
 
We did not observe any significant differences within the auditory cortex for NMDAR 
expression in direct age-matched comparisons between Fmr1 WT and KO mice except at 
P15 (Figure 2.2H). P15 Fmr1 KO mice had significantly decreased levels of membrane-
bound GluN2A (WT: 100 ± 8.54%, KO: 74.96 ± 7.13%, p = 0.034) and GluN2B (WT: 100 
± 4.56%, KO: 82.67 ± 5.58%, p = 0.029) compared to WT littermates. Given the 
comparable reductions of both subunits, the ratio of GluN2B:GluN2A, indicative of the 
maturity of NMDARs, was unchanged.  
 
Fmr1 KO mice exhibit an altered regulation of GABAAR a-subunit expression during 
auditory cortex maturation 
We evaluated membrane-bound GABAA a-subunit developmental expression patterns 
relative to P56 WT levels, where we again observed a significant effect of age across all 
subunits (2-way ANOVA, age, p < 0.0001) (Figure 2.3A-C). Consistent with Laurie et al. 
(1992), the most prominent developmental changes in a3 and a1-subunits were observed 
in the auditory cortex around ear canal opening. Notably during WT auditory cortex 
development, GABAAa3 peaked in expression at P12, soon after ear canal opening and 
signals the start of the WT auditory CP (Barkat et al., 2011; Hackett et al., 2015), and 
subsequently rapidly declined (Figure 2.3A). GABAAa1 increased most rapidly between 
P9 and P12 in WT mice, peaking at P15, the end of the auditory CP, and maintaining adult 
expression levels (Figure 2.3B). GABAAa1:a3 developmentally increases through the 4th 
postnatal week in WT mice to reach adult levels (Figure 2.3C).  
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Fmr1 KO mice exhibit altered a-subunit developmental patterns in the auditory cortex. 
GABAAa3 was significantly different from WT development (2-way ANOVA, interaction: 
F(4,109) = 2.897, p = 0.025; genotype: F(1,109) = 4.801, p = 0.031), where a3 does not peak 
as highly in the KO auditory cortex (Sidak’s multiple comparisons: P12 WT 302.11 ± 
14.18% vs. KO 255.48 ± 13.25%, p = 0.002) (Figure 2.2A). While there was no significant 
genotype difference for GABAAa1 development, there appeared to be elevated a1 
expression beyond adult levels at P15 and P24 in KO mice (Figure 2.3B). However, the 
GABAAa1:a3 ratio during development is significantly different from Fmr1 KO mice (2-way 
ANOVA, interaction: F(4,108) = 2.601, p = 0.04; genotype: F(1,108) = 2.899, p = 0.092) with 
faster increases to adult WT levels earlier in development (Sidak’s multiple comparisons: 
P24 WT 80.75 ± 4.53% vs. KO 95.25 ± 4.68%, p = 0.066) (Figure 2.3C).  
 
Direct comparisons of Fmr1 KO mice to their age-matched WT littermates showed 
significantly reduced GABAAa3 in Fmr1 KO mice at P12 (WT: 100 ± 4.48%, KO: 85.66 ± 
3.62%, p = 0.021) (Figure 2.3E) Changes in a3-subunit expression may manifest even 
earlier, where earliest trending decreases were observed at P9 (WT: 100 ± 3.58%, KO: 
92.47 ± 1.63%, p = 0.069) (Figure 2.3D), days before the ear canal is open. No differences 
in GABAAa3 were observed at later ages. However, we observed significantly increased 
GABAAa1:a3 levels (WT: 100 ± 4.33%, KO: 119.7 ± 4.7%, p = 0.006) in Fmr1 KO mice at 
P24, along with a trending increase in membrane-bound GABAAa1 at P24 (WT: 100 ± 
5.44%, KO: 123.3 ± 9.85%, p = 0.069) (Figure 2.3G). Neither the GABAAa1 level nor the 
ratio of GABAAa1:a3 subunits were different at the early ages. These collective differences 
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in the a3 and a1 expression suggest a dynamic alteration in GABAAR developmental 
expression in the auditory cortex of Fmr1 KO mice.  
 
Expression of membrane-bound chloride transporters is unaltered in the auditory 
cortex of Fmr1 KO mice. 
Concurrent with subunit changes for GABAergic maturation is the transition from 
depolarizing GABA signaling, when intracellular neuronal chloride concentrations are 
high, to hyperpolarizing GABA, when intracellular chloride concentrations are low, which 
is determined by the relative developmental expression of the chloride transporters 
NKCC1 and KCC2 (Ben-Ari, 2002). In auditory cortex lysates, when each age was 
normalized to P56 WT levels, a significant developmental expression pattern of the 
NKCC1:KCC2 ratio consistent with general brain maturation was observed (2-way 
ANOVA, age, F(4,104) = 51.04, p < 0.0001) (Figure 2.4F). NKCC1:KCC2 levels are relatively 
high early in development and then decrease with age as KCC2 expression significantly 
increases postnatally (Dzhala et al., 2005). Notably in the auditory cortex, NKCC1:KCC2 
exhibits the strongest developmental downregulation between P9 and P12, during the 
transition from a closed to an open ear canal. However, there were no differences in 
membrane-bound NKCC1 or KCC2 levels in Fmr1 KO mice at any age compared to WT 
littermates (Figure 2.4A-E).  
 
Reduced fraction of GABAARa3 staining puncta in P12 Fmr1 KO auditory cortex 
Given the significance of P12 as the start of the normal WT auditory CP, we wanted to 
determine whether the differences we observed by western blot in membrane-bound 
GABAARa3 levels were reflective of synaptic expression across the auditory cortex, or 
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specific to a particular cortical layer. We performed immunohistochemistry of extracellular-
targeting GABAAR a3 or GABAAR a1 staining to examine co-localization with the inhibitory 
presynaptic marker vesicular GABA transporter (VGAT). We quantified the 
immunoreactivity intensities of GABAAR a3, a1 and VGAT, and calculated the fraction of 
VGAT puncta that colocalized with surface GABAAR a3 or a1 using the Mander’s 
coefficient (Manders et al., 1993; Gao and Heldt, 2016; Yennawar et al., 2019). Compared 
with WT mice, P12 Fmr1 KO mice had significantly reduced fluorescence intensity of 
GABAARa3 across all of the cortical layers in the auditory cortex (2-way ANOVA, 
genotype, F(1, 56) = 7.516, p = 0.0082) (Figure 2.5B), indicating reduced expression 
consistent with the differences observed by  western blot (Figure 2.5B). Meanwhile, WT 
and KO mice had similar levels of VGAT immunoreactivity (2-way ANOVA, genotype F(1, 
56) = 0.0066, p = 0.9357) (Figure 2.5C). Thus, when examining the fraction of VGAT+ 
inhibitory puncta co-localizing with GABAARa3, Fmr1 KO mice had significantly reduced 
levels in the auditory cortex (2-way ANOVA, genotype, F(1, 56) = 8.005, p = 0.0065) (Figure 
2.5D). Together with the western blot data, our expression data show that Fmr1 KO mice 
have decreased synaptic a3-subunit-containing GABAARs in the auditory cortex at P12. 
 
Altered transcriptional, translational and trafficking regulation of GABAAR a-
subunits in auditory cortex of Fmr1 KO mice 
As a translational repressor FMRP does not directly bind the mRNAs for AMPARs or 
GABAAR a-subunits; however, it does regulate the translation of mRNAs for hundreds of 
synaptic proteins and epigenetic modifiers (Darnell et al., 2011; Korb et al., 2017). Thus, 
we wanted to elucidate whether transcriptional, translational, and/or trafficking deficits 
yield the altered membrane-bound expression of AMPAR and GABAAR subunits we 
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observed in the auditory cortex of Fmr1 KO mice. To determine whether transcriptional 
dysregulation occurs within the auditory cortex, we measured the relative transcript levels 
of Gria1 and Gria2 (for GluA1 and GluA2, respectively), and Gabra3 and Gabra1 (for 
GABAARa3 and GABAARa1, respectively) from auditory cortex lysates during 
development by RT-qPCR (Figure 2.6). We found that while levels of Gria1 and Gria2 
were not significantly different between Fmr1 WT and KO mice at any age, transcript levels 
were significantly altered for Gabra3 and Gabra1 at select ages. Specifically, the relative 
levels of Gabra3 is significantly reduced in KO mice at both P12 (WT: 1.005 ± 0.035, KO: 
0.758 ± 0.074, p = 0.0096) and P24 (WT: 1.009 ± 0.049, KO: 0.876 ± 0.035, p = 0.039) 
(Figure 2.6C). Additionally, Gabra1 levels are also significantly reduced in Fmr1 KO mice 
at P24 (WT: 1.027 ± 0.089, KO: 0.730 ± 0.061, p = 0.012), with trends toward decreased 
expression at P9 (WT: 1.018 ± 0.064, KO: 0.856 ± 0.059, p = 0.079) (Figure 2.6D). 
Significant differences observed for Gabra3 and Gabra1 were further validated against 
additional housekeeping genes. Notably, the altered transcriptional regulation for GABAAR 
a3 and a1 occurs at P12 and P24, the key ages we observed differences in expression 
for membrane-bound expression. 
 
Given the mRNA level differences, we wanted to also evaluate translational regulation and 
whether it additionally contributes to the altered regulation of AMPAR and GABAAR 
subunit expression in the auditory cortex. We evaluated whole cell auditory cortex 
homogenates by western blots specifically at P12 and P24 from Fmr1 KO and WT 
littermates, where mRNA differences were observed (Figure 2.7). In contrast to the 
membrane preparations described earlier, whole cell homogenates allow the 
measurement of total protein expression. Consistent with the lack of transcriptional 
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differences in Gria1 and Gria2, there were no alterations in total GluA1 or GluA2 
expression in Fmr1 KO mice (Figure 2.7A). Interestingly, despite the decreased Gabra3 
and Gabra1 mRNA levels at the P12 and P24 ages, no significant differences in total 
expression for the individual subunits were observed, suggestive of elevated translational 
regulation in the auditory cortex. However, when specifically evaluating the ratio of 
GABAAR a1:a3, P12 KO mice exhibit significantly increased levels relative to WT 
littermates (WT: 100 ± 6.95%, KO: 120.13 ± 4.44%, p = 0.023) (Figure 2.7B). Such 
changes are reminiscent of the elevated GABAAR a1:a3 observed in membrane-bound 
expression in P24 Fmr1 KO mice.  
 
DISCUSSION 
Auditory forebrain development is characterized by brief, unique epochs that influence the 
maturation of the local auditory circuit – a state when the ear canal is distinctly closed or 
open, regulating the transduction of auditory input, and a 3-day critical period window for 
tonotopic mapping (Barkat et al., 2011). Given both the hyperexcitability described in the 
Fmr1 KO brain along and the range of auditory deficit phenotypes in KO mice, we 
executed a detailed characterization of developmental expression of ionotropic glutamate 
and GABAA receptors and chloride transporters in the auditory cortex to investigate 
possible alterations in excitatory-inhibitory imbalance in the Fmr1 KO mouse.  
 
During normal WT auditory cortex development, we found ionotropic receptor subunits to 
follow the broad patterns of cortical development, but report more detailed dynamic 
changes occurring within 3-day intervals in the auditory cortex, specifically during the 
transition of ear canal opening along with the onset and closure of the critical period. In 
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Fmr1 KO mice, we observed dynamic changes in AMPAR and GABAAR subunits during 
early auditory cortex development. GluA2 expression was elevated in P9 KO mice 
compared to WT, with increased GluA2:GluA1 at P9 and P12. Concurrently, membrane-
bound GABAAR a3-subunit was reduced at P9 and P12, which is further supported by 
decreased GABAAR a3 synaptic puncta immunohistochemistry. GABAARs in P24 Fmr1 
KO mice further exhibit elevated a1:a3 compared to WT littermates. The dysregulation of 
AMPAR and GABAAR expression appear to be multi-factorial, with alterations suggested 
at the transcriptional, translational, and trafficking levels. 
 
Relative to the prior cortical and hippocampal characterizations of AMPAR and GABAAR 
expression in Fmr1 KO mice, our expression profile of these subunits in the auditory cortex 
exhibited several differences. AMPAR expression differences in the literature are highly 
variable, with reports of both decreased and increased GluA1 expression in Fmr1 KO mice 
(Li et al., 2002; Muddashetty et al., 2007; Schutt et al., 2009), and reduced GluA2 mRNA 
with a higher proportion of GluA2-lacking AMPARs in FXS human induced pluripotent 
stem cells (Achuta et al., 2018). GABAAR mRNA and protein expression tend to exhibit 
either similar or reduced a-subunit levels across regions of the forebrain in Fmr1 KO mice 
(D'Hulst et al., 2006; Adusei et al., 2010; Braat and Kooy, 2015a). Our differences 
observed in the auditory cortex could be reflective of region-specific alterations that are 
occurring in the FXS brain, as well as differences in sample preparation, given that we 
specifically measured protein expression of isolated membrane fractions to reflect more 
physiologically-relevant states. Nevertheless, our data interestingly highlight: 1) 
differences in receptor expression occur early in occur early in the development of Fmr1 
KO auditory cortex that later normalize as adults, consistent with the age-dependent 
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alterations observed with the cortical synaptic proteome (Adusei et al., 2010; Tang et al., 
2015), and 2) patterns of relatively more mature subunit expression with elevated 
GluA2:GluA1 and GABAAR a1:a3.  
 
Early in brain development there is a higher proportion of NMDAR-only silent synapses, 
which lack AMPARs and are correlated with the capacity for developmental plasticity 
(Crair and Malenka, 1995; Hanse et al., 2013; Huang et al., 2015). Additionally, of the 
AMPARs that are synaptically present, many tend to lack the GluA2 subunit, whereby the 
presence of these calcium-permeable AMPARs is linked with increasing excitability and 
activating calcium-dependent pathways to facilitate synaptogenesis and synaptic 
maturation during early postnatal development (Kumar et al., 2002; Isaac et al., 2007). 
The increased GluA2 and GluA2:GluA1 expression in the auditory cortex of P9 and P12 
Fmr1 KO mice could be associated with the presence of fewer silent synapses and 
decreased calcium entry, both of which could contribute to the occlusion of plasticity at the 
start of the auditory critical period. Proper GABAergic maturation is also necessary for 
modulating plasticity, as GABA-mediated signaling is required to induce the start of critical 
periods, particularly by GABAAR a1 (Fagiolini et al., 2004; Kalish et al., 2020), but also 
restrict plasticity in adults (Harauzov et al., 2010; Cisneros-Franco et al., 2018). 
Interestingly, we observed decreased GABAAR a3 at P9 and P12, with increased GABAAR 
a1:a3 at P24, which suggest altered a-subunit maturation that further influences the 
induction and capacity for plasticity in conjunction with the AMPAR alterations.  
 
Similar patterns of receptor subunit alterations have been found particularly in models of 
early-life seizures where hyperexcitability is induced very early in postnatal development. 
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Seizures in early life cause both an increased expression of the GABAAR a1 subunit and 
the premature appearance of hyperpolarizing GABA in the hippocampus (Raol et al., 
2006; Galanopoulou, 2008b). However, seizures at older ages or as adults actually 
caused the reverse pattern with elevated GABAAR a3 expression that mimic the more 
immature brain (Brooks-Kayal, 2011). Furthermore, glutamatergic alterations have been 
shown in prior work by our lab where early-life seizures caused a precocious unsilencing 
of NMDAR-only silent synapses via AMPAR insertion in both hippocampal CA1 pyramidal 
neurons and auditory thalamocortical cells to occlude synaptic and tonotopic plasticity, 
respectively (Zhou et al., 2011; Sun et al., 2018). Interestingly, Fmr1 KO mice are known 
to have circuit hyperexcitability that manifest at early ages (Contractor et al., 2015; 
McCullagh et al., 2020), and in particular, are highly susceptible to audiogenic seizures, 
indicative of heightened excitability within the auditory circuit that may drive our observed 
alterations. 
 
Given that FMRP does not directly regulate the mRNA transcripts for GluA1, GluA2 or the 
GABAAR a-subunits, thus precluding the differences as a direct effect of loss of FMRP 
expression, we wanted to further elucidate the level at which subunit dysregulation occurs. 
No differences were observed with AMPAR mRNA transcripts, but there were relatively 
reduced transcript levels of GABAAR a-subunit mRNAs in Fmr1 KO mice, notably at P12 
and P24, ages when we observed significant membrane-bound protein expression 
differences. The reduced Gabra1 and Gabra3 levels in the Fmr1 KO auditory cortex are 
consistent with the reduced expression reported by D'Hulst et al. (2006). However, 
translational upregulation appears to compensate for the reduced transcript levels, as total 
protein levels from whole cell homogenates were unaltered for either GABAAR a1 or 
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GABAAR a3, except for the significantly elevated GABAAR a1:a3 levels at P12, similar to 
the elevated expression observed in membrane-bound expression at P24. The 
unchanged total GABAAR protein expression compared to the differences in membrane-
bound expression are also suggestive of altered receptor trafficking to the membrane. 
Thus, there is altered regulation of the a-subunits of GABAARs at multiple levels, including 
transcriptionally, translationally, and with receptor trafficking (Table 2.1), that is likely 
compensatory or secondary in effect from the core changes elicited by loss of FMRP. 
 
While we executed a comprehensive analysis of developmental expression of membrane-
bound ionotropic glutamate and GABAA receptors in auditory cortex development of both 
WT and Fmr1 KO mice, direct physiological measures must also be examined to 
understand whether these differences yield functional differences in the developing 
auditory circuit. These expression studies are limited by a lack of distinction across cortical 
layers and cell types, including neuronal subtypes and non-neuronal glial cells. In addition, 
we only focused on a small subset of receptor subunits, albeit those that are most 
developmentally regulated and most prominent in the cortex, that could overlook possible 
dysregulation in other subunits that may impact receptor assembly and function. In 
subsequent chapters, we directly investigate functional differences in the auditory cortex 
circuit using electrophysiology to examine cortical layer processing and cell-type specific 





Figure 2.1: Fmr1 KO mice exhibit elevated AMPAR GluA2:GluA1 subunits in the auditory 
cortex, prior to ear canal opening. (A) Timeline of approximate auditory postnatal maturation in 
mice with the ages analyzed for experiments highlighted in yellow. (B-D) Western blot analysis of 
membrane-bound expression of GluA1, GluA2, and GluA2:A1 in the auditory cortex, with all 
timepoints normalized to P56 WT to analyze the developmental expression of the AMPAR subunits. 
(D) Developmental expression of GluA2:A1 exhibits genotype effect with significantly decreased 
expression for KO at P9. (E-G) AMPAR subunit expression normalized relative to age-matched WT 
littermates. (E) GluA2 and GluA2:A1 expression is significantly increased in Fmr1 KO at P9, prior 
to ear canal opening (n = 11 WT, 11 KO). (F) The expression of GluA2:A1 remains significantly 
increased at P12 (n = 10, 11). (G) No differences in the AMPAR subunits are observed at P15 (n 
= 10, 10), or the later ages of P24 (n = 12, 12) and P56 (n = 16, 15), not shown. (H) Representative 
western blots of GluA1 and GluA2, with b-actin used as loading controls. (I) Schematic of 




Figure 2.2: NMDAR subunit expression is similar between Fmr1 WT and KO mice in the 
auditory cortex over development. (A-D) Membrane-bound expression of GluN2A, GluN2B, 
GluN2B:2A, and GluN1 western blot data plotted with all timepoints normalized to P56 WT to 
analyze the developmental expression of NMDAR subunits in the auditory cortex. The 
developmental expression of each subunit exhibits a significant effect of age but not genotype. (E) 
Representative western blots of NMDAR subunits with b-actin used as loading controls. (F-H) 
NMDAR subunits expressed relative to age-matched WT littermates. (F) No differences observed 
between Fmr1 KO and WT at P12 (n = 10 WT, 11 KO). (G) P15 Fmr1 KO mice exhibit significantly 
decreased levels of GluN2A and GluN2B compared to WT, but no differences are observed in 
GluN2B:2A or GluN1 (n = 9, 9). (H) No differences in expression observed at P24 (n = 12, 12). No 




Figure 2.3: Fmr1 KO mice exhibit altered developmental regulation in expression of GABAAR 
a1 and a3 subunits in the auditory cortex. (A-C) Western blot analysis of membrane-bound 
expression of GABAAa3, GABAAa1, and GABAAR a1:a3 with all timepoints normalized to P56 WT 
to analyze the developmental expression of the GABAA a-subunits in the auditory cortex. (A) 
Developmental expression of GABAAa3 exhibits overall interaction between age and genotype with 
a genotype effect, and significantly decreased expression for KO at P12. (C) Developmental 
GABAAR a1:a3 expression exhibits an overall interaction between age and genotype. (D-G) 
GABAAR a- subunits expressed relative to age-matched WT littermates. (D) Fmr1 KO exhibit a 
trending decrease in GABAAa3 expression at P9 (n = 11 WT, 11 KO). (E) GABAAa3 is significantly 
decreased at P12 (n = 10, 11). (F) No differences in expression observed at P15 (n = 10, 10). (G) 
P24 Fmr1 KO exhibit a trending increase in GABAAa1 with significantly increased GABAAR a1:a3 
expression (n = 12, 11). No differences observed at P56 (n = 18, 15), data not shown. (H) 
Representative western blots of GABAAa3 and GABAAa1 with b-actin used as loading controls. * p 





Figure 2.4: The expression of chloride transporters is similar between Fmr1 WT and KO mice 
in the auditory cortex across development. (A-C) Western blot analysis of membrane-bound 
NKCC1, total KCC2 (both dimer and monomer levels), and NKCC1:KCC2 in the auditory cortex, 
normalized relative to age-matched WT littermates. No differences were observed in the levels of 
the individual transporters or the NKCC1:KCC2 ratio at the early developmental ages (P9: n = 11 
WT, 10 KO; P12: n = 10, 11; P15: n = 9, 9). No differences observed at P24 (n = 11, 10) or P56 (n 
= 18, 15), data not shown. (D-F) NKCC1, KCC2, and NKCC1:KCC2 data (same as above) plotted 
with all timepoints normalized to P56 WT to analyze the developmental expression of chloride 
transporters in the auditory cortex. The developmental expression of each transporter exhibits a 
significant effect of age but not genotype. (G) Representative western blots of chloride transporters 




Figure 2.5: Decreased co-localization of GABAAa3 and VGAT in auditory cortex of P12 Fmr1 
KO mice. (A) Representative confocal micrographs of IHC of extracellular targeting GABAAa3 and 
presynaptic VGAT in L2/3. (B-D) Quantification of results using Coloc2 plugin from FIJI (n = 8 WT, 
8 KO). Total fluorescence intensity of (B) GABAAa3 and (C) VGAT immunoreactivity. (D) Mander’s 
coefficient to calculate the fraction of VGAT immunoreactivity that co-localizes with a3. Two-way 
ANOVA indicates a significant genotype effect in (B) and (D), however, there were no significant 
differences in any particular cortical layer as analyzed by Sidak’s multiple comparisons test. No 





Figure 2.6: Altered transcriptional regulation of GABAAR a-subunits in auditory cortex of 
Fmr1 KO mice. Relative mRNA expression across ages by RT-qPCR for AMPAR and GABAAR a-
subunits. Levels were normalized to Gapdh and Actb (not shown), expressed relative to age-
matched WT littermates (n = 8-10 for each age and genotype). (A-B) No significant differences 
were observed in the relative levels of Gria1 or Gria2 for AMPARs at any age. (C-D) Fmr1 KO mice 
had significant differences in transcripts for GABAAR a-subunits in the auditory cortex. (C) Gabra3 
is significantly decreased in both P12 and P24 Fmr1 KO mice. (D) Gabra1 is significant decreased 




Figure 2.7: Elevated whole cell levels of GABAAR a1:a3 in Fmr1 KO mice upon ear canal 
opening. Total levels of AMPAR and GABAAR subunits measured from whole cell auditory cortex 
lysates at P12 and P24. (A) No significant differences were observed in the GluA1, GluA2, or 
GluA2:A1 in either P12 (n = 6 WT, 9 KO) or P24 (n = 6, 7). (B) Fmr1 KO mice exhibited significantly 
increased total GABAAR a1:a3 levels at P12. No differences were observed at P24. (C) 
Representative western blots with b-actin used as loading controls. * p < 0.05. 
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  mRNA Total protein Membrane-bound 
P12 
a3 ¯¯ --- ¯ 
a1 --- --- --- 
a1:a3 n/a ­ --- 
P24 
a3 ¯ --- --- 
a1 ¯ --- ­ (trend) 
a1:a3 n/a --- ­­ 
 
Table 2.1: Fmr1 KO mice exhibit altered transcriptional, translational, and trafficking or 
localization regulation of GABAAR a-subunits in the developing auditory cortex. Summary of 
RT-qPCR and western blot results at P12 and P24 for the a3 and a1-subunits. A lack of differences 
in total protein at either age despite the relative reduced mRNA transcript levels indicate increased 
translational regulation. Differences in membrane-bound levels relative to unchanged whole-cell 
levels indicate likely altered receptor trafficking in Fmr1 KO mice. Increases or decreases in relative 
expression denoted with up and down arrows, respectively, with the number of arrows used to 
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We previously identified altered developmental expression of glutamate and GABAAR 
subunits during the postnatal maturation of the auditory cortex in Fmr1 KO mice, 
suggestive of excitatory-inhibitory imbalance in this region. To understand whether the 
altered expression of ionotropic receptors yields functional differences in the Fmr1 KO 
auditory cortex that could contribute to the various FXS auditory-related phenotypes, we 
examined the physiological maturation of L4 to L2/3 circuit, which is the crucial first stage 
of intracortical sensory processing that refines tonotopic information and integrates input 
from other regions for auditory processing. Using extracellular field recordings and whole-
cell patch-clamp electrophysiology in ex vivo brain slices, we evaluated the maturation of 
basal synaptic transmission and long-term potentiation of L4-L2/3 synaptic connections to 
evaluate excitability and synaptic plasticity in the developing auditory cortex. We report a 
detailed sequence in the postnatal maturation of basal L4-L2/3 synaptic transmission and 
plasticity in WT mice that is closely linked with the opening of the ear canal and auditory 
critical period window. The auditory cortex of Fmr1 KO mice exhibits an aberrant 
developmental regulation of L4-L2/3 circuit excitability and altered synaptic plasticity in 
L2/3 pyramidal neurons that likely contribute to the impaired auditory cortex critical period 




Our developmental expression data measuring membrane-associated ionotropic 
glutamate and GABA receptors suggest dynamic alterations in the auditory cortex of Fmr1 
KO mice indicative of excitatory-inhibitory (E-I) imbalance in early development (Chapter 
2). Specifically, we observed a pattern of dysregulated postnatal maturation of AMPAR 
GluA2 and GABAAR a-subunit expression in the Fmr1 KO auditory cortex. Given their 
roles as the primary mediators of rapid E-I neurotransmission and regulators of 
developmental plasticity, we sought to verify whether such changes manifested in 
functional alterations within the auditory circuit of Fmr1 KO mice. 
 
Fmr1 KO mice have an impaired auditory cortex critical period, as identified from in vivo 
recordings following tone-rearing manipulations (Kim et al., 2013). Specifically, Fmr1 KO 
mice are observed to have significantly diminished tonotopic plasticity in the auditory 
cortex, in contrast to the barrel cortex which has a delayed onset of critical period plasticity 
(Harlow et al., 2010). However, unlike Harlow et al. (2010), direct measurements of early 
postnatal auditory cortex circuit development were not made by Kim et al. (2013) since 
recordings were performed in 3-6-week-old mice after early developmental tone-rearing 
manipulations. Additionally, in Fmr1 KO auditory cortex brain slice preparations, Yang et 
al. (2014) identified failed stabilization of L3/4 long-term potentiation following white matter 
stimulation. However, these studies are also limited in elucidating aberrant circuit 
maturation given that the youngest age of evaluation was P16-20, when the auditory 
tonotopic critical period is already over in normal developing mice (Barkat et al., 2011; 
Yang et al., 2014). Therefore, we sought to 1) directly examine the postnatal 
developmental maturation of circuit and synaptic plasticity in the auditory cortex, 
particularly in relation to ear canal opening and the typical auditory critical period window, 
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and 2) to identify possible physiological differences between Fmr1 KO and WT mice 
related to our ionotropic receptor expression data findings. 
 
We were specifically interested in the synaptic connections from L4 to L2/3 in the auditory 
cortex (Figure 3.1), as this is the first stage of higher-level sensory processing within the 
intracortical circuit (Merzenich et al., 1975; Kanold et al., 2014; Li et al., 2014; Javitt and 
Sweet, 2015). The thalamus relays tonotopically organized projections to L4 of the cortex 
(Barkat et al., 2011; Hackett et al., 2011), which subsequently sends feedforward 
connections to L2/3. The neurons in L2/3 process tonotopic information from L4 and also 
crucially integrate input from other brain regions before sending their own projections to 
deeper layers and other cortical regions (Guo et al., 2012b; Meng et al., 2020). Synaptic 
plasticity of the L4-L2/3 circuit has been more well-defined in other sensory areas like the 
visual cortex (Jiang et al., 2007; Kim et al., 2013; Li et al., 2017), specific to the auditory 
cortex have been limited. Much of the auditory plasticity studies have focused on the 
postnatal maturation of thalamocortical synapses (Hogsden and Dringenberg, 2009; Chun 
et al., 2013; Meng et al., 2014; Sun et al., 2018), with some more recent characterizations 
of the development of L2/3 microcircuit in developing mice (Meng et al., 2020). Therefore, 
we wanted to closely examine the sequence of intracortical maturation of the L4-L2/3 
circuit of the auditory cortex in both Fmr1 KO and WT mice.  
 
In this chapter, we first examine the excitability and short-term plasticity of the L4-L2/3 
auditory cortex microcircuit using extracellular field recordings of brain slices, comparing 
input-output curves for basal synaptic transmission and paired-pulse ratios across 
development in WT and Fmr1 KO mice. We further evaluate synaptic plasticity in the 
auditory cortex of these mice, specifically evaluating L2/3 pyramidal neurons using whole-
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cell patch-clamp electrophysiology. Our studies highlight a clear developmental 
progression in the excitability of basal synaptic transmission and synaptic plasticity of the 
L4-L2/3 auditory cortex circuit that is linked with the opening of the ear canal and the 
critical period window in WT mice, which is altered in developing Fmr1 KO mice. In 
particular, we observe Fmr1 KO mice to have aberrant regulation of L4-L2/3 circuit 
excitability and altered synaptic plasticity in L2/3 pyramidal neurons that likely contribute 





Fmr1 WT and Fmr1 KO mice of the congenic FVB background were obtained from The 
Jackson Laboratory (stock # 004828; 004624). Heterozygous females were generated 
from the original breeders, whereby heterozygous female mice were crossed with WT or 
hemizygous male mice to obtain Fmr1 WT and KO male littermates. Age-matched WT 
and KO male littermate mice were used for all experiments to avoid the confounding 
effects of X-inactivation that would be present in heterozygous females. All procedures 
were performed in accordance with the guidelines of the NIH and with the approval of the 
Institution of Animal Care and Use Committee with the University of Pennsylvania. All 
efforts were made to minimize animal suffering and numbers. 
 
Brain slice preparation 
Acute coronal brain slices for whole-cell electrophysiology were prepared from Fmr1 WT 
and KO littermate mice at the following ages: P9-10, P12-13, P15-16, P21-25, and P40-
45. Animals were rapidly decapitated and brains were quickly removed and placed in 
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chilled cutting solution containing the following (in mM): 220 sucrose, 3 KCl, 1.25 
NaH2PO4, 0.5 CaCl2, 1 MgCl2, 26 NaHCO3, and 10 D-glucose, ~300 mOsm, pH 7.4, 
bubbled with 95% O2/5% CO2 at 4°C. Coronal slices (350 µm) containing the auditory 
cortex, identified by anatomical landmarks, were cut using a vibratome (Leica VT1000S) 
in cutting solution. Slices were incubated in oxygenated ACSF containing the following (in 
mM): 124 NaCl, 5 KCl, 2 CaCl2, 1.2 MgSO4, 1.25 NaH2PO4, 26 NaHCO3, and 10 D-
glucose, ~295 mOsm, and transferred to 32°C for 30 min. Then, slices were kept at room 
temperature for at least 1 hour before recordings.  
 
Extracellular recordings 
Multi-electrode array (MEA) recording systems (MED64 System, Alpha Med Scientific) 
were used to perform extracellular field potential recordings. The MEA probes have 64 
planar electrodes, arranged in an 8x8 pattern with 150 µm interelectrode spacing (MED-
P5155). Slices were transferred to the MEA recording chamber and perfused with ACSF 
at 30-32°C with 3-8 ml/min flow rates. Higher perfusion rates were necessary for older 
animals to improve O2 supply to brain slices and maintain viability (P9-16: ~3-4 ml/min; 
P21-25: ~6 ml/min; P40-45: ~8 ml/min) (Hajos et al., 2009; Reinhard et al., 2014; Panuccio 
et al., 2018). Slices were anchored with a harp and aligned so that the electrodes were 
parallel with the cortical layers of the auditory cortex, as identified by anatomical 
landmarks using the 4X objective of a Nikon Eclipse TE2000-5 microscope. Slices were 
recovered in the recording chamber for 30 min with minimal stimulation (7-10 µA) every 
1-1.5 min to monitor normalization of responses before beginning experiments. 
Stimulations (0.2 ms pulse) were made in L4 with electrodes positioned approximately 
400-450 µm from the pia, with field EPSP (fEPSP) response analysis made from the 
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adjacent electrode positioned in L2/3. For each experiment, the main L4 stimulation 
electrode was selected by identifying the stimulation and recording electrode pair that 
elicited the smallest synaptic response when stimulated at 10 µA or 20 µA to maintain 
consistent recording practices across all experiments. 
 
Input-output (I-O) curves were generated by stimulating L4 at increasing intensities (5 µA 
every 30s) until maximal synaptic response was reached, measured by the maximum 
amplitude of the fEPSP response. Half-maximal stimulus intensities were approximated 
by identifying the minimum intensity that elicited the half-maximal fEPSP amplitude 
determined from I-O curves. Paired-pulse ratios were calculated by dividing the amplitude 
of the second fEPSP by the first fEPSP when two successive stimuli of 500, 200, 100, 50, 
25, 10 and 6 ms intervals were applied every 30 s at the half-maximal stimulus intensity. 
 
Whole-cell electrophysiology 
Whole-cell patch-clamp recordings were made in the auditory cortex, visualized with an 
upright Zeiss Axioscop 2 FsPlus IR-DIC microscope. All recordings were made at room 
temperature with ACSF perfused at a rate of ~2 ml/min. Glass electrodes were pulled (P-
87, Sutter Instruments) with a resistance of 2-5 MW and filled within internal solution 
containing (in mM): 110 Cs methanesulfonate, 10 TEA-Cl, 4 NaCl, 2 MgCl2, 0.5 EGTA, 10 
HEPES, 4 ATP-Mg, 0.3 GTP, 7 phosphocreatine, creatine phosphokinase (17 units/ml), 1 
QX-314, pH 7.3, 270-280 mOsm.  
 
For single-cell LTP studies, eEPSC recordings were made from L2/3 pyramidal neurons 
with stimulations evoked from L4. Pharmacological blockers for GABAARs were not used 
 61 
given that we wanted to examine overall synaptic plasticity of the L2/3 pyramidal neurons; 
thus, eEPSCs were a mixed excitatory-inhibitory response. Stimulation intensities that 
evoked 40-60% of the maximal eEPSC amplitude were used. Cells were held at -60 mV 
for 5 min baseline recording (10 s intervals), followed by pairing where cells were held at 
+30 mV with 5 tetani (0.1 ms pulses, 100 Hz for 500 ms, separated by 830 ms), and 
monitored for 30 min post-pairing at -60 mV. Access resistance was monitored throughout 
each experiment, with applied series resistance compensation of up to 75%, and 
recordings discarded if access resistance was >25 MW or changed >20%. Data was 
collected using Axopatch 200B amplifier and pClamp 10 software (Molecular Devices), 
filtered at 2 kHz and digitized at 20 kHz using a Digidata 1440A analog to digital converter. 
Analysis was performed offline using Clampfit 10.2 (Molecular Devices). eEPSC 
amplitudes were measured, with normalization of eEPSCs to the average amplitude of the 
baseline recording.  
 
Experimental design and statistical analysis 
For all experiments, the sample size and power were determined based on previously 
published work in our laboratory and using StatMate software. Mice were excluded if their 
weight was >2 SDs from the mean weight of age-matched mice. 
 
Statistical analysis was completed using Prism 8 (GraphPad). A comparison of sigmoidal 
curve fits was used for the analysis of input-output curves in MEA experiments, whereas 
a 2-way ANOVA, with Sidak’s multiple comparisons test were used for paired-pulse ratio 
analyses. Data were tested for normality using the Shapiro-Wilk normality test. For within-
age genotype comparisons of LTP studies, statistical significance was assessed using 2-
way repeated measures ANOVA. The level of potentiation was also compared at a 
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midpoint of the LTP recording, where the average eEPSC was calculated from a full 
minute of recordings at 15 min post-pairing, with statistical significance between age-
matched genotypes assessed using a Student’s t test. For comparing changes in decay 
of LTP, a comparison of slopes from linear regressions were performed from 6 to 30 
minutes post-pairing values. Data are reported as mean ± SEM with p values reported in 
Results. All n’s are reported in the figure legends or tables, or within figures themselves. 
 
RESULTS 
Accelerated developmental progression of evoked excitatory synaptic 
transmission in the auditory intracortical circuit of Fmr1 KO mice 
Given the differences in membrane-bound of AMPAR and GABAAR subunit expression in 
the Fmr1 KO auditory cortex (Chapter 2), we further examined whether this manifests in 
altered excitability within the developing auditory cortex circuit. Specifically, we assessed 
possible dysregulation of excitability of L4 to L2/3 basal synaptic transmission, evaluating 
input-output (I-O) curves at each age by plotting stimulation intensity to fEPSP amplitude 
and comparing sigmoidal curve fits. We first examined the natural shifts in excitability 
during postnatal development to elucidate intracortical circuit maturation of the auditory 
cortex by overlaying all of the I-O curves across the ages for each genotype (Figure 3.2A-
B). In WT mice, we observed a clear progression of shifts in the I-O curves that correspond 
with pre- and post-critical period (Figure 3.2A). Specifically, WT I-O curves at P9-10 and 
P12-13 were largely the same (Tukey’s multiple comparisons: P9-10 vs. P12-13, p = 
0.9998), but subsequently exhibited a significant leftward shift after P12-13, indicating 
increased excitability within the circuit (Tukey’s: P12-13 vs. P15-16, p < 0.0001; P15-16 
vs. P21-25, p = 0.5837) (Figure 3.2A). Lastly, a slight rightward shift occurred in the P40-
45 I-O curve (Tukey’s: P21-25 vs. P40-45, p = 0.0316), likely attributable to the slower 
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GABAergic maturation that occurs in the postnatal brain (Rakhade and Jensen, 2009). In 
contrast, the aforementioned developmental shifts occurred at earlier ages in Fmr1 KO 
mice (Figure 3.2B). Fmr1 KO mice displayed a leftward shift in their P12-13 I-O curve 
compared to P9-10 and thus, were already more excitable and similar to P15-16 (Tukey’s: 
P9-10 vs. P12,13, p < 0.0001; P12-13 vs. P15-16, p = 0.9675). The typical rightward shift 
in the I-O curve that yields a slight decreased excitability instead occurred at P21-25 in 
Fmr1 KO mice, thus already being more similar to P40-45 (Tukey’s: P15-16 vs. P21-25, p 
= 0.001; P21-25 vs. P40-45, p = 0.7375). These results suggest that Fmr1 KO mice have 
accelerated developmental shifts in excitability in their intracortical L4 to L2/3 synaptic 
transmission relative to the normal WT auditory CP, where developmental peaks appear 
to occur earlier in Fmr1 KO mice.  
 
We further compared I-O curves of Fmr1 KO mice directly to their age-matched WT 
littermates to more closely examine differences in excitability at each age. First, we found 
that Fmr1 KO mice exhibited dynamic differences in L4-L2/3 excitability across postnatal 
auditory cortex development. While the I-O curves at P9-10 were significantly different 
between genotypes (F(4, 274) = 4.913, p = 0.008), the gain appeared to have more of an 
influence compared to the threshold where KO mice did not rise as quickly compared to 
WT mice (Figure 3.2C-D). The major differences in excitability between WT and KO mice 
occurred at P12-13 and P21-25, where Fmr1 KO were significantly more excitable at P12-
13 in their L4-L2/3 connectivity (F(4, 442) = 11.44, p < 0.0001) (Figure 3.2E). In contrast, at 
P21-25, Fmr1 KO were significantly less excitable in their basal synaptic transmission 
compared to WT (F(4, 329) = 15.15, p < 0.0001) (Figure 3.2G). No differences in excitability 
were observed between genotypes at P15-16 and P40-45.  
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Altered L4-L2/3 presynaptic function in P12 Fmr1 KO mice 
Given the genotype differences in excitability, we next evaluated whether there may be a 
presynaptic component. Intracortical synapses are known to exhibit a mix of synaptic 
facilitation and depression, with synaptic depression as the predominant form of short-
term synaptic plasticity in the L4 to L2/3 circuit in the visual cortex (Abbott et al., 1997; 
Blitz et al., 2004). Therefore, we compared paired-pulse ratios (PPR) of fEPSPs, a 
measure of short-term plasticity that is heavily due to presynaptic transmitter release 
mechanisms, which distinguishes itself from postsynaptic mechanisms. PPRs are 
calculated from the amplitudes of the second fEPSP to the first fEPSP following 2 
consecutive stimuli from a range of interstimulus intervals (Figure 3.2). Consistent with 
previous cortical reports, we broadly observed short-term depression (PPR < 1) in the L4-
L2/3 auditory synaptic circuit across most ages. However, PPR values generally increase 
with postnatal age across most of the interstimulus intervals in both WT (2-way ANOVA, 
interaction effect, F(24,550) = 10.63, p < 0.0001) and Fmr1 KO mice (interaction effect, 
F(24,531) = 7.246, p < 0.0001), suggestive of an overall strengthening of presynaptic firing 
capabilities with synaptic maturation across development. 
 
Differences in PPR are observed between genotypes at P12-13 (2-way ANOVA, 
genotype, F(1,300) = 7.007, p = 0.0085) (Figure 3.2B) and P40-45 (genotype, F(1,175) = 5.138, 
p = 0.025) (Figure 3.2F). While no significant differences can be reported at any individual 
interstimulus intervals following multiple comparisons, there is tendency towards more 
depressed PPR values, particularly at the intervals of 500, 50 and 25 ms. These results 
suggest possible alterations in presynaptic-related excitatory-inhibitory neurotransmission 
within the L4-L2/3 auditory cortex circuit in Fmr1 KO mice.   
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Fmr1 KO mice have an altered progression of synaptic plasticity in L2/3 pyramidal 
neurons of the auditory cortex 
Given the dynamic developmental alterations in L4-L2/3 basal synaptic transmission in 
Fmr1 KO mice, along with differences in short-term plasticity particularly at P12, the start 
of the normal auditory cortex critical period, we further evaluated whether Fmr1 KO mice 
also exhibited alterations in long-term synaptic plasticity in the same L4-L2/3 circuit that 
could contribute to the impaired auditory cortex critical period previously reported in Fmr1 
KO mice (Kim et al., 2013). We analyzed long-term potentiation (LTP) in L2/3 pyramidal 
neurons by examining the potentiation of evoked EPSCs (eEPSCs) using whole-cell 
recordings and a pairing protocol to synchronize presynaptic L4 stimulation and 
postsynaptic neuronal depolarization (+30 mV) (Figure 3.4). The eEPSCs in these LTP 
studies were technically a mixed response, similar to fEPSPs, as GABAergic signaling 
was not pharmacologically blocked to enable us to assess the capabilities of synaptic 
plasticity in the presence of both excitatory and inhibitory signaling. 
 
In WT mice, L2/3 pyramidal neurons of the auditory cortex exhibited age-dependent LTP 
that is in sync with the sequence of postnatal maturation of the auditory circuit, specifically 
ear canal opening and the start of the auditory tonotopic critical period (Barkat et al., 2015). 
Notably, LTP was not induced in L2/3 pyramidal neurons at P9-10, while the ear canal is 
still closed. A potentiated response was initially observed soon after pairing at P9-10, but 
the eEPSC response subsequently decreased often resulting in a depressed eEPSC 
amplitude (84.40 ± 11.87% compared to baseline, 15 min after pairing) (Figure 3.4C). 
Starting at P12, which is soon after the ear canal opens and the start of the auditory cortex 
critical period, LTP was induced in the L4-L2/3 synaptic circuit (128.29 ± 5.67%) (Figure 
3.4D). LTP was still capable of being induced at the later ages, but there was a gradual 
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decline in LTP magnitude with age (P15-16: 116.66 ± 4.36%; P21-26: 110.38 ± 5.89%). 
The age-dependent regulation of synaptic plasticity in WT mice was also observed with 
changes in the LTP decay slopes and spread of amplitude responses (Figure 3.4G). P9-
10 mice had a sharp decline in decay (linear regression, slope: -1.43 ± 0.19) with high 
variability in eEPSC response. The decay slope relatively attenuated at P12 (-0.39 ± 0.08), 
and subsequently increased with age (P15-16: -0.47 ± 0.05; P21-25: -0.79 ± 0.07), with 
notable decreases in variability across maturation. These results indicate that in the 
auditory cortex, the synaptic plasticity of L4 inputs to L2/3 pyramidal neurons is timed to 
maximize LTP for immediately after ear canal opening, which subsequently decreases in 
its capacity with age.   
 
We further compared the developmental regulation of L4-L2/3 synaptic plasticity in Fmr1 
KO mice at the same ages. Similar to P9-10 WT mice, Fmr1 KO mice were also unable to 
readily induce LTP. However, L2/3 pyramidal neurons in the KO tended to not have as 
depressed eEPSC responses following pairing (93.44 ± 12.50% compared to baseline, 15 
min after pairing) (Figure 3.4C). P12 Fmr1 KO mice were able to express LTP, but 
exhibited greater variability in their eEPSC responses and their ability to sustain 
potentiation compared to their age-matched WT littermates (KO: 109.35 ± 8.59%; WT: 
128.29 ± 5.67%; t test, p = 0.075) (Figure 3.4D). The significant variability of eEPSCs were 
also observed pre-pairing in the average baseline eEPSC responses, with P12 KO mice 
exhibiting significantly increased variance in the raw amplitudes comparing to WT mice  
(WT: 404.3 ± 14.42 pA; KO: 333.1 ± 67.51; comparison of variances: F(10,11) = 20.08, p < 
0.0001) (Figure 3.5B).  However, similar to WT mice, LTP was more reliably maintained 
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at older ages in KO mice with reduced variability (P15-16: 123.16 ± 4.23%; P21-25: 109.50 
± 4.32%).  
 
We next evaluated the developmental progression of the decay slopes of LTP in Fmr1 KO 
mice. Compared to the decay slopes of WT mice, KO mice exhibited a significantly altered 
post-maturational sequence, where P9-10 KO mice do not have a steep decay slope like 
WT mice (linear regression, -0.52 ± 0.17, p = 0.0004). Fmr1 KO mice had a stronger decay 
at P12-13 compared to WT littermates (-0.75 ± 0.12, p = 0.0097), and also do not exhibit 
the age-dependent increase in decay slope values (P15-16: -0.61 ± 0.07, p = 0.113; P21-
25: -0.12 ± 0.06, p < 0.0001). Our findings highlight that Fmr1 KO mice have an altered 
regulation of L2/3 pyramidal neuron synaptic plasticity during the early postnatal 
maturation of the auditory cortex.  
 
DISCUSSION 
Our electrophysiology data provides a detailed characterization of normal L4-L2/3 
microcircuit maturation in developing WT mice, and further reveal significant functional 
differences in L4-L2/3 synaptic signaling within the auditory cortex of Fmr1 KO mice during 
early postnatal development. We found that the maturation of L4-L2/3 basal synaptic 
transmission and synaptic plasticity is closely tuned with both ear canal opening and the 
auditory cortex critical period for tonotopic plasticity. Furthermore, we found that Fmr1 KO 
mice exhibit dynamic alterations in both the excitability and synaptic plasticity of the L4-
L2/3 circuit across auditory cortex development.   
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We evaluated the L4-L2/3 circuit of the auditory cortex given its involvement in early-stage 
cortical auditory processing and tonotopic plasticity (Barkat et al., 2011; Li et al., 2014; 
Javitt and Sweet, 2015), and characterized a natural progression of excitability in WT 
mice. The most dramatic I-O curve shift occurred at the end of the critical period (P15-16), 
where excitability significantly increased. At P40-45, excitability decreased but I-O curves 
remained more excitable overall compared to the P9-13 mice. These shifts are consistent 
with the broad maturational patterns of excitability in the developing brain (Rakhade and 
Jensen, 2009). Additionally, the I-O curve development shifts are also consistent with E-I 
frequency tuning development in the rat auditory cortex, where excitatory response to 
tonal frequency tuning matures to adult levels by P15, while inhibitory response tuning 
develops around P25-30 (Dorrn et al., 2010). Recently, Meng et al. (2020) evaluated intra- 
and interlaminal connectivity of L2/3 neurons in the developing mouse auditory cortex. A 
transient hyperconnectivity of inputs from L4 were reported, comparable to the 
developmental hyperexcitability we observed with our I-O curves. However, the reported 
hyperconnectivity occurs at P12-16 (Meng et al., 2020), whereas we observed increased 
excitability at P15-24 before decreasing in excitability at P40-45. This difference in the age 
window of excitability and connectivity could be related to technical variations where 1) we 
conducted field recordings with synaptic responses from neuronal populations across the 
layers, whereas Meng et al. examined synaptic responses in individual L2/3 neurons 
following laser-scanning photostimulation of caged glutamate; and 2) the ages were 
grouped differently with P12-16 as a single group by Meng et al., whereas we more 
granularly evaluated P12-13 and P15-16 separately. Such experimental design 
differences could skew the characterization of timescales when examining synaptic 
excitability and strength, given the dynamic synaptogenesis and synaptic maturation 
rapidly occurring during early development. 
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Nevertheless, our WT data highlight a clear developmental sequence in the maturation of 
auditory cortex L4 to L2/3 basal synaptic transmission that is altered in Fmr1 KO mice. 
Changes in excitability are dynamic across development, whereby KO mice are 
significantly more excitable at P12 and less excitable at P24 compared to WT littermates. 
Such physiological differences are consistent with the altered expression of membrane-
bound AMPAR and GABAAR subunits described in Chapter 2, providing direct functional 
evidence of E-I imbalance within the intracortical auditory circuit of Fmr1 KO mice that 
could contribute to the auditory-related phenotypes characterized in the FXS mouse 
model.  
 
Paired-pulse measures in L2/3 from L4 stimulation resulted in synaptic depression, 
consistent with other cortical studies (Abbott et al., 1997; Varela et al., 1997). Short-term 
synaptic depression is largely believed to be related to depletion of a readily releasable 
pool of vesicles or presynaptic calcium influx (Blitz et al., 2004). We found that at P12-13 
Fmr1 KO mice had significantly different paired-pulse ratios, where values were more 
depressed compared to WT. This suggests the presence of a presynaptic dysregulation 
potentially related to presynaptic vesicle pools and calcium influx, which can alter the 
firing, regulation and synaptic strength of L2/3 neurons to contribute to functional E-I 
deficits (Varela et al., 1997).  
 
Our eEPSC-LTP studies of L2/3 pyramidal neurons in the auditory cortex also reveal a 
developmental sequence of L4-L2/3 synaptic plasticity that is dysregulated in Fmr1 KO 
mice. Many of the previous developmental studies examining LTP in the auditory cortex 
have largely focused on the thalamocortical synapses of L4 given their tonotopic 
projections and their highly restrictive plasticity window, a common feature that is shared 
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across other primary sensory cortices (Crair and Malenka, 1995; Isaac et al., 1997; 
Feldman et al., 1999; Jiang et al., 2007; Chun et al., 2013; Sun et al., 2018). However, 
few studies have directly evaluated age-dependent LTP of the L4-L2/3 circuit in the 
auditory cortex, which is crucial for the processing of L4 tonotopic information (Guo et al., 
2012b; Meng et al., 2020). Our LTP data in WT mice indicate that the synaptic plasticity 
of L2/3 pyramidal neurons from L4 synaptic input is closely timed with the opening of the 
ear canal and the start of the auditory cortex critical period. LTP was not capable of being 
induced in P9-10 WT mice, but was robustly induced starting P12, followed by an age-
dependent decline in its magnitude. These findings differ from plasticity studies in the 
visual cortex, where LTP is capable of being induced in L2/3 by as early as P8 in mice 
(Jiang et al., 2007; Li et al., 2017). Interestingly, our results closely correlate with Meng et 
al. (2020) where peak synaptic strength from L4 connections occur at P12-16 in the 
auditory cortex, suggesting region-specific variations that are closely tied to the maturation 
of the overall auditory system. 
 
Fmr1 KO mice exhibit aberrant maturational patterns in the developmental progression of 
LTP in the auditory cortex compared to WT mice. While LTP was also capable of being 
induced starting at P12 in Fmr1 KO mice, there were several notable deviating features. 
Specifically, P9-10 KO neurons did not have as depressed of responses following pairing 
relative to WT mice, and P12-13 KO neurons have more variability in their synaptic 
responses and their ability to sustain potentiation. Such alterations are more pronounced 
when examining the decay slopes of LTP, where the clear developmental pattern 
observed in WT mice is visibly altered in the postnatal progression of Fmr1 KO mice. Thus, 
our findings highlight abnormal patterns of LTP during early postnatal ages that could 
influence the regulation and capacity for synaptic plasticity in the Fmr1 KO auditory cortex.  
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Prior studies that identified impaired L4 plasticity in the auditory cortex of Fmr1 KO mice 
found that altered mGluR-mediated signaling contributed to the deficits (Kim et al., 2013; 
Yang et al., 2014). However, our differences in developmental LTP could also be related 
to the differences in the maturation of L4-L2/3 basal synaptic transmission we described 
earlier, along with potential functional maturational differences of ionotropic glutamatergic 
and GABAergic signaling. For example, alterations in the Fmr1 KO barrel cortex critical 
period are linked to maturational differences for GABAAR reversal potentials and NMDAR-
silent synapses, which are well-known modulators of developmental plasticity (Feldman 
et al., 1999; Hensch, 2005; Galanopoulou, 2008a; Harlow et al., 2010; He et al., 2014; He 
et al., 2019). Such properties and their potential dysregulation have not been evaluated in 
the auditory cortex to date. Therefore, in subsequent chapters, we directly investigate 
specific features of GABAergic and glutamatergic functional maturation using 
electrophysiology to examine their influence on altered E-I balance and auditory circuit 















Figure 3.1: Intracortical circuit of the auditory cortex. (A) Schematic of mouse brain showing 
tonotopic projections from the thalamus. Adapted from Kehayas and Holtmaat (2017). (B) 
Intracortical circuitry within the auditory cortex. Thalamic inputs (medial geniculate body, MGB) to 
L4, which subsequently sends feedforward projections to L2/3. Neurons in L2/3 also receive input 
from other brain regions, and further send projections to both deep cortical layers (L5 and L6) as 




Figure 3.2: Fmr1 KO mice exhibit dynamic changes in excitability in L4 to L2/3 basal synaptic 
transmission during auditory cortex development. I-O curves of stimulation intensity to fEPSP 
amplitude, normalized to maximum amplitude and fit with sigmoidal curves. (A-B) Overlay of I-O 
curves for WT and KO mice to evaluate developmental shifts in excitability. (C) Stimulation 
intensities for half-maximal response from curve fits in (A) and (B). Different shaded colors in the 
table indicate significantly different curves within each genotype. Fmr1 KO mice appear to have 
accelerated shifts in developmental excitability. (D-H) Top: representative fEPSP traces in L2/3 
extracellular recordings from L4. Bottom: comparison of I-O curves at each age between WT and 
Fmr1 KO mice. (E) Fmr1 KO mice are significantly more excitable at P12-13 and (G) significantly 
less excitable at P21-24. (I) Representative DIC image of coronal slice with MEA overlaid on the 




Figure 3.3: Altered presynaptic regulation of L4-L2/3 auditory cortex circuit in P12 Fmr1 KO 
mice. (A-F) Paired-pulse ratios (PPR) from MEA fEPSP recordings across developmental ages to 
measure differences in short-term plasticity driven by presynaptic mechanisms. L4-L2/3 largely 
have short-term depression (PPR < 1). Fmr1 KO mice exhibit a significant difference in PPRs at 
P12-13 (B) and P40-45 (F), with a trend towards more depressed PPR values particularly at 25, 
50, and 500 ms. (C) Representative fEPSP traces at P12-13 of interstimulus intervals of 25 and 50 
ms. The number of slices and mice analyzed for each age and genotype are reported in Figure 3.1. 




Figure 3.4: Fmr1 KO mice exhibit an altered progression of L4-L2/3 synaptic plasticity during 
auditory cortex maturation. (A-B) Representative eEPSC traces from L2/3 pyramidal neurons 
with averaged recordings from baseline (pre-pairing) and averaged recordings from 15 min post-
pairing from the auditory cortex of (A) WT and (B) Fmr1 KO mice across development.  (C-F) Time 
course of normalized eEPSC amplitude change in LTP experiments. (C) P9-10 mice fail to exhibit 
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LTP in the L4-L2/3 circuit. (D-F) LTP is capable of being induced from P12-25. (G-H) Overlay of 
the averaged decay data (6-30 min post-pairing) by genotype. In WT mice, LTP does not occur 
until P12, whereby enhancement is attenuated with age. Fmr1 KO mice exhibit an altered pattern 
of synaptic plasticity with increased variability. P9-10: n = 9 slices, 7 WT mice & 10 slices/7 KO 
mice; P12-13: n = 12 slices/7 WT mice & 11 slices/7 KO mice; P15-16: n = 11 slices/8 WT mice & 
10 slices/6 KO mice; P21-25: n = 10 slices/7 WT mice & 9 slices/7 KO mice.  
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Figure 3.5: Fmr1 KO mice exhibit significantly greater variability in the average baseline 
eEPSC response at P12. (A-D) The average eEPSC amplitude was calculated for each cell from 
the baseline recordings of eEPSC-LTP experiments in Figure 3.4. While no difference was 
observed in the overall amplitudes of eEPSCs in L2/3 pyramidal neurons for L4 stimulation across 
the developmental ages, (B) P12 KO mice exhibited significantly increased variability in the size of 
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ABSTRACT 
Fragile X syndrome (FXS) is the leading monogenic form of intellectual disability and 
autism, with patients exhibiting numerous auditory-related phenotypes during their 
developmental period, including communication, language development, and auditory 
processing deficits. Despite studies describing an excitatory-inhibitory imbalance in the 
auditory circuit and an impaired auditory cortex critical period in FXS, evaluation of 
inhibitory synaptic transmission in the auditory circuit in FXS models remain limited. Thus, 
given the critical roles of GABAergic signaling in the regulation of critical periods, network 
excitability, and auditory processing, we investigated the functional maturation of GABAA 
receptor (GABAAR)-mediated inhibitory synaptic transmission in the auditory cortex. We 
characterized normal GABAAR intracortical circuit development patterns in wild-type mice, 
and further identified their dysregulation in developing Fmr1 knock-out (KO) mice. Using 
extracellular field recordings in ex vivo brain slices, we identified an enhanced age-
dependent GABAAR antagonist sensitivity that contributes to the altered excitability of L4-
L2/3 basal synaptic transmission in Fmr1 KO mice. In addition, L2/3 pyramidal neuron 
patch-clamp recordings from Fmr1 KO mice identified further GABAergic dysregulation 
with enhanced GABAAR a1-specific pharmacological sensitivity, altered GABAAR reversal 
potentials maturation, and impaired presynaptic GABA regulation. Together, our results 
suggest alterations in the maturation of GABAAR signaling in the auditory cortex of Fmr1 
KO mice that involve both postsynaptic and presynaptic mechanisms, which could 
underlie features of E-I imbalance and disrupted plasticity that subsequently contributes 
to the auditory phenotypes of FXS.   
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INTRODUCTION 
Fragile X syndrome (FXS) patients have deficits in auditory processing (Van der Molen et 
al., 2012; Rotschafer and Razak, 2014), communication, and language development 
(Finestack et al., 2009; Hersh et al., 2011), as well as hypersensitivity to sensory stimuli 
(Miller et al., 1999), making the auditory cortex a region of particular interest. Fmr1 KO 
mice also exhibit auditory phenotypes, including susceptibility to audiogenic seizures 
(Chen and Toth, 2001), altered auditory processing (Yun et al., 2006; Rotschafer and 
Razak, 2013), delayed parvalbumin cell development in early auditory cortex development 
(Wen et al., 2018), and impaired tonotopic and synaptic plasticity during the auditory 
cortex critical period (Kim et al., 2013; Yang et al., 2014). However, despite these 
extensive phenotypes suggestive of excitatory-inhibitory (E-I) imbalance, studies directly 
examining the maturation of synaptic transmission in the auditory cortex of Fmr1 KO mice 
are limited.   
 
In Chapter 2, we described altered developmental expression of AMPAR and GABAAR 
subunits in the Fmr1 KO auditory cortex, and in Chapter 3, we presented synaptic 
excitability and plasticity differences within L4-L2/3 of the auditory cortex. Given the broad 
E-I deficits in this auditory intracortical circuit, we sought to investigate whether Fmr1 KO 
mice more specifically experience dysregulation of GABAergic maturation in the auditory 
cortex. The postnatal maturation of GABAergic signaling is crucial for regulating 
excitability in the brain, where the developing brain uniquely transitions from depolarizing 
excitatory to hyperpolarizing inhibitory GABAA receptor-mediated signaling to achieve E-I 
balance (Galanopoulou, 2008a; Rheims et al., 2008; Rakhade and Jensen, 2009). 
Inhibitory GABA action is also critical in inducing and ultimately restricting experience-
dependent plasticity in sensory cortices, where signaling mediated by GABAAR a1-
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containing circuits were specifically found to be necessary for inducing visual cortex 
plasticity (Fagiolini and Hensch, 2000; Fagiolini et al., 2004; Jang et al., 2009; Kalish et 
al., 2020). Similarly, in the auditory cortex, the maturation of synaptic inhibitory properties 
coincides with critical periods that can be further modulated by environmental exposure, 
and is further necessary for features of proper auditory processing (Wehr and Zador, 2003; 
de Villers-Sidani et al., 2007; Dorrn et al., 2010; Barkat et al., 2011; Sanes and Kotak, 
2011; Takesian et al., 2012; Mowery et al., 2016; Blackwell and Geffen, 2017; Kalish et 
al., 2020).  
 
In this chapter, we investigated the functional maturation of L4-L2/3 inhibitory synaptic 
transmission across key ages in auditory forebrain development in WT and Fmr1 KO mice 
using electrophysiology. We established maturational patterns of the GABA inhibitory 
circuit in the auditory cortex of WT mice that were dysregulated by the loss of FMRP in 
Fmr1 KO mice. L2/3 neurons of Fmr1 KO mice exhibited enhanced developmental 
sensitivity to pharmacological GABAAR modulators. Furthermore, L2/3 pyramidal neurons 
show altered maturation of GABAAR reversal potentials and voltage-dependent 
conductance, with additional impairments related to L4 presynaptic GABA release 
mechanisms. Taken together, our findings provide direct evidence for altered presynaptic 
and postsynaptic GABAergic regulation in the developing Fmr1 KO auditory cortex that 
contribute to the impaired E-I circuit and plasticity maturation in the auditory forebrain that 





Fmr1 WT and Fmr1 KO mice of the congenic FVB background were obtained from The 
Jackson Laboratory (stock # 004828; 004624). Heterozygous females were generated 
from the original breeders, whereby heterozygous female mice were later crossed with 
WT or hemizygous male mice to obtain Fmr1 WT and KO male littermates. Age-matched 
WT and KO male littermate mice were used for all experiments to avoid the confounding 
effects of X-inactivation that would be present in heterozygous females. All procedures 
were performed in accordance with the guidelines of the NIH and with the approval of the 
Institution of Animal Care and Use Committee with the University of Pennsylvania. All 
efforts were made to minimize animal suffering and numbers.  
 
Brain slice preparation 
Acute coronal brain slices for extracellular, whole-cell, and perforated-patch 
electrophysiology were prepared from Fmr1 WT and KO littermate mice at the following 
ages: P9-10, P12-13, P15-16, P21-25, and P40-45. Animals were rapidly decapitated and 
brains were quickly removed and placed into a chilled cutting solution containing the 
following (in mM): 220 sucrose, 3 KCl, 1.25 NaH2PO4, 0.5 CaCl2, 1 MgCl2, 26 NaHCO3, 
and 10 D-glucose, ~300 mOsm, pH 7.4, bubbled with 95% O2/5% CO2 at 4°C. Coronal 
slices (350 µm) containing the auditory cortex, identified by anatomical landmarks, were 
cut using a vibratome (Leica VT1000S) in cutting solution. Slices were incubated in 
oxygenated ACSF containing the following (in mM): 124 NaCl, 5 KCl, 2 CaCl2, 1.2 MgSO4, 
1.25 NaH2PO4, 26 NaHCO3, and 10 D-glucose, ~295-300 mOsm, and transferred to 32°C 





Multi-electrode array (MEA) recording systems (MED64 System, Alpha Med Scientific) 
were used to perform extracellular field potential recordings. The MEA probes have 64 
planar electrodes, arranged in an 8x8 pattern with 150 µm interelectrode spacing (MED-
P5155). Slices were transferred to the MEA recording chamber and perfused with ACSF 
at 30-32°C with 3-8 ml/min flow rates. Higher perfusion rates were necessary for older 
animals to improve O2 supply to brain slices and maintain viability (P9-16: ~3-4 ml/min; 
P21-25: ~6 ml/min; P40-45: ~8 ml/min) (Hajos et al., 2009; Reinhard et al., 2014; Panuccio 
et al., 2018). Slices were anchored with a harp and aligned so that the electrodes were 
parallel with the cortical layers of the auditory cortex, as identified by anatomical 
landmarks using the 4X objective of a Nikon Eclipse TE2000-5 microscope. Slices were 
recovered in the recording chamber for 30 min with minimal stimulation (7-10 µA) every 
1-1.5 min to monitor normalization of responses before beginning experiments. 
Stimulations (0.2 ms pulse) were made in L4 with electrodes positioned approximately 
400-450 µm from the pia, with field EPSP (fEPSP) response analysis made from the 
adjacent electrode positioned in L2/3. For each experiment, the main L4 stimulation 
electrode was selected by identifying the stimulation and recording electrode pair that 
elicited the smallest synaptic response when stimulated at 10 µA or 20 µA to maintain 
consistent recording practices across all experiments. 
 
Input-output (I-O) curves were generated by stimulating L4 at increasing intensities (5 µA 
every 30s) until maximal synaptic response was reached, measured by the maximum 
amplitude of the fEPSP response. Half-maximal stimulus intensities were approximated 
by identifying the minimum intensity that elicited the half-maximal fEPSP amplitude 
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determined from I-O curves. Paired-pulse ratios were calculated by dividing the amplitude 
of the second fEPSP by the first fEPSP when two successive stimuli of 500, 200, 100, 50, 
25, 10 and 6 ms intervals were applied every 30 s at the half-maximal stimulus intensity. 
For experiments analyzing sensitivity to picrotoxin (PTX, Sigma P1675), slices were 
incubated in ACSF with 5 µM PTX for 30 min after initial baseline I-O and paired pulse 
recordings, before resuming recordings (Jang et al., 2009). In PTX experiments the first 
peak was measured, as the synaptic response often showed multiple peaks. All data 
collection and analysis were performed in Mobius (MED64). 
 
Whole-cell electrophysiology 
Whole-cell patch-clamp recordings were made from L2/3 pyramidal neurons in the 
auditory cortex, visualized with an upright Zeiss Axioscop 2 FsPlus IR-DIC microscope. 
Recordings were made at room temperature with ACSF perfused at a rate of ~2 ml/min. 
Glass electrodes were pulled (P-87, Sutter Instruments) with a resistance of 2-4 MW and 
filled with internal solution containing (in mM): 135 CsCl, 10 EGTA, 10 HEPES, 5 ATP-
Mg, 5 QX-314 (pH 7.3, 290-295 mOsm) (Zhou et al., 2013). To isolate sIPSCs, cells were 
voltage-clamped at a holding potential of -60 mV and recorded for 10-15 min in the 
presence of 20 µM NBQX (Tocris) and 50 µM D-AP5 (Abcam). In experiments examining 
sensitivity to a selective a1-subunit GABAAR agonist, we recorded 10 min of traces 
following 6 min of zolpidem (100 nM, Sigma). mIPSCs were additionally recorded in the 
presence of 1 µM tetrodotoxin (TTX, Tocris). Paired-pulse ratios of evoked IPSCs were 
calculated from an average of 5 sweeps following L4 stimulation using interstimulus 
intervals of 400, 200, 90, 70, 50 and 20 ms. Access resistance was monitored throughout 
each experiment, with applied series resistance compensation of 65%, and recordings 
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discarded if access resistance was >25 MW or changed >20%. Data was collected using 
Axopatch 200B amplifier and pCLAMP 10 software (Molecular Devices), filtered at 2 kHz 
and digitized at 20 kHz using a Digidata 1440A analog to digital converter.  
Analysis was performed offline using Clampfit 10.2 (Molecular Devices). Each trace was 
first low-pass filtered at 1 kHz (Gaussian). The s/mIPSC events were detected 
automatically with a threshold of 5-6 pA (2 times the root mean square of the noise), 
depending on the noise level (Rakhade et al., 2008; Zhou et al., 2011; Sun et al., 2013), 
and were visually confirmed. The weighted decay time constant (tdw) was calculated by 
first fitting a double-exponential function on the average s/mIPSC trace for each neuron 
that excluded multiple overlapping sIPSC events: f(t) = Afaste-t / τfast + Aslowe-t / tslow and then 
using the fit values in the following equation: tdw = [(Afast × tfast) + (Aslow × tslow)] / (Afast + 
Aslow) (Vislay et al., 2013; Zhou et al., 2013).  
 
Perforated patch electrophysiology. EGABA was measured using perforated patch 
recordings. Gramicidin (Sigma-Aldrich Inc.) was dissolved in methanol to 10 mg/ml, and 
diluted in the internal pipette solution to a final concentration of 150 µg/ml (Ostroumov et 
al., 2016). The membrane integrity within pipette tips was confirmed by the presence of 
the sodium currents of recorded neurons (not being blocked by the QX-314 inside of the 
electrodes). Evoked IPSCs (eIPSCs) in L2/3 pyramidal neurons were recorded at holding 
potentials between -100 mV and 0 mV, with stimulation at the border of L3 and L4, 
increasing in 10 mV steps with access resistance continuously monitored. All recordings 
were performed in the presence of NBQX and D-AP5. Given that during early postnatal 
ages L2/3 pyramidal neurons have a high input resistance that exhibit an age-dependent 
decrease (P9-10: 523.9 ± 20.56 MW; P12-13: 503.5 ± 36.01 MW; P15-16: 350.5 ± 27.51 
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MW; P21-25: 216.6 ± 14.65 MW), it was necessary to correct the holding potential values 
for I-V plots (Rheims et al., 2008). The following formula was used: 
𝑉∗ = 𝑉$%&' ×	*
𝑅,
𝑅, + 𝑅.
/ (1 + %	𝑐ℎ𝑎𝑛𝑔𝑒	𝑅9:) 
where Vhold is the command membrane holding potential; Rm is the average membrane 
resistance during P9-10 perforated-patch recordings; Ra is the average access resistance 
during P9-10 recordings; and % change in Rin is the percent change in input resistance 
for a given age from P9-10’s Rin for proper age-dependent corrections. Reversal potentials 
were estimated from the intersection of current-voltage plots, where the amplitudes of the 
eIPSCs were plotted against the modified voltage holding potentials (V*). 
 
Western blot analysis 
Fmr1 WT and KO littermates were sacrificed at P24. Brains were rapidly removed from 
the skull and the auditory cortex was micro-dissected. Using a coronal brain matrix, a 1.5-
2.0 mm thick coronal brain slice containing the auditory cortex was extracted as identified 
by stereotaxic coordinates and anatomical landmarks from Paxinos and Franklin (2004) 
and the Allen Brain Atlas. The brain slice was then cut horizontally above the rhinal fissure, 
whereby approximately 15° cuts were made bilaterally to isolate the auditory cortex. 
Tissue was flash-frozen in chilled ethanol and stored at -80°C until homogenization. 
 
Total whole-cell extraction was performed as previously described (Talos et al., 2006b; 
Rakhade et al., 2012; Yennawar et al., 2019). Total protein amounts were measured with 
a Bradford protein assay (Bio-Rad) and samples were then diluted to obtain equal 
amounts of proteins in each sample (15 µg total) in lysis buffer and 4X Laemmli Sample 
Buffer (Bio-Rad). Samples were separated by gel electrophoresis on Criterion TGX 4-20% 
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Tris-Glycine precast gels (Bio-Rad), and transferred to PVDF membranes (Millipore 
Immobilon-FL). Primary antibodies used in this study are as follow: NKCC1 (1:1000, 
Millipore AB3560P); KCC2 (1:1000, Millipore 07-432); KCC2 pS940 (1:2000, Novus 
NBP2-29513); b-actin (1:5000, Sigma A5441). Secondary antibodies used were goat anti-
rabbit IRDye 800CW (1:15,000; LI-COR 926-32212) and goat anti-mouse IRDYE 680LT 
(1:20,000; LI-COR 926-68024). The Odyssey Infrared Imaging System protocols were 
used for blots and quantification of protein expression. b-actin was used for normalization 
of individual samples, and normalized values were expressed as a percentage of mean 
age-matched WT samples. 
 
Experimental Design and Statistical analysis 
For all experiments, the sample size and power were determined based on previously 
published work in our laboratory and using StatMate software. Mice were excluded if their 
weight was >2 SDs from the mean weight of age-matched mice.  
 
Statistical analysis was completed using Prism 8 (GraphPad). Data were tested for 
normality using the Shapiro-Wilk normality test. For within-age comparisons, statistical 
significance was assessed using a Student’s t test or Mann-Whitney test depending on 
normality of the data. For developmental expression analysis, two-way ANOVA and 
Sidak’s multiple comparisons tests with adjusted p values were used to assess 
significance. A comparison of sigmoidal curve fits was used for the analysis of input-output 
curves in MEA experiments, whereas a 2-way ANOVA with Sidak’s multiple comparisons 
test were used for paired-pulse ratio analyses. Changes in amplitude and tdw following 
zolpidem were analyzed using paired t test or Wilcoxon matched-pairs signed rank 
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depending on the normality of the data. Data are reported as mean ± SEM with p values 




Fmr1 KO mice have an enhanced age-dependent sensitivity to picrotoxin 
In Chapter 3, we reported alterations in the excitability of evoked basal synaptic 
transmission of the L4-L2/3 circuit in the Fmr1 KO auditory cortex. Specifically, KO mice 
exhibited significantly increased excitability at P12-13, and decreased excitability at P21-
25 compared to their age-matched WT littermates. Given that GABAARs affect network 
excitability and are crucial regulators of critical periods, we wanted to assess whether 
altered GABAergic signaling contributed to these I-O curve differences in WT and Fmr1 
KO mice. In a subset of slices, we measured I-O curves following incubation with a 
subthreshold concentration (5 µM) of the GABAAR antagonist picrotoxin (PTX), which did 
not cause epileptiform discharge (Jang et al., 2009; Stebbings et al., 2016). By analyzing 
the shifts of the I-O curves to PTX, we identified the GABAA signaling component, 
examining the evolution and strength of inhibition over auditory cortex development, and 
identifying potential differences in pharmacological sensitivity within the L4-L2/3 auditory 
cortex circuit reflective of GABAAR expression differences (Figure 4.1).  
 
In the auditory cortex of WT mice, PTX did not alter the I-O curves either P9-10 or P12-13 
(Figure 4.1A-B). However, at P15-16 in WT mice, PTX exposure resulted in a paradoxical 
significant decrease in fEPSP amplitudes, manifested by suppressed I-O curves 
compared to the ACSF baseline (F(4,163) = 3.803, p = 0.0055) (Figure 4.1C). Although this 
was not the typical response we anticipated to a GABAAR antagonist, which normally 
 89 
increases excitatory tone, this was indicative of the presence of depolarizing GABAA 
prevalent in early brain development. This depolarizing response progresses towards a 
typical mature GABAAR antagonist response with age. At P21-25, I-O curves for WT mice 
were not suppressed and rather had no major changes after PTX (F(4,161) = 0.7609, p = 
0.5522) (Figure 4.1D); however, at P40-45, PTX increased the fEPSP amplitudes of the I-
O curves, indicating the action of hyperpolarizing GABA (F(4,231) = 5.088, p = 0.0006) 
(Figure 4.2E). 
 
Fmr1 KO mice also showed a similar progression from depolarizing to hyperpolarizing 
PTX-induced I-O curve changes across development, although there were several notable 
differences from WT mice. Unlike the lack of change in WT mice at P12-13, Fmr1 KO mice 
exhibited diminished excitability in response to PTX with significantly suppressed I-O 
curves compared to ACSF baseline (F(4,164) = 4.162, p = 0.0031) (Fig 4.1G). This was the 
same age where we saw increased L4-L2/3 excitability in KO mice, suggesting that 
depolarizing GABA may contribute to the enhanced excitability in Fmr1 KO mice (Figure 
4.1B). By P15-16, KO mice did not have any significant I-O changes to PTX (F(4,198) = 
1.603, p = 0.175) (Figure 4.1H), which was an age in the WT that showed PTX-induced 
suppression of I-O curves. Furthermore, Fmr1 KO mice displayed PTX-induced 
hyperexcitability starting at P21-25 where I-O curves shifted to significantly increased 
fEPSP responses to PTX (P21-25: F(4,220) = 4.771, p = 0.001; P40-45: F(4,240) = 7.039, p < 
0.0001) (Figure 4.1I-J), suggesting the presence of hyperpolarizing GABA in the circuit at 
an earlier age than WT. 
 
Notably, the ages at which Fmr1 KO mice exhibit significantly different PTX-induced I-O 
curves compared to WT littermates, are those ages in which we observed the overall 
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excitability differences between genotypes (Figure 4.1), suggesting that altered 
GABAergic signaling heavily contributes to the P12-13 hyperexcitability and the P21-25 
decreased excitability. Additionally, when examining the pattern of PTX-induced I-O curve 
shifts across development, we found that both the depolarizing and hyperpolarizing 
GABAAR signaling response occurred at earlier stages in the Fmr1 KO mice compared to 
WT (i.e., P12 KO looks like P15 WT; P21 KO looks like P40 WT). Consistent with the 
faster developmental L4-L2/3 basal synaptic transmission, Fmr1 KO mice also undergo 
an overall pattern of accelerated age-dependent pharmacological sensitivity to a GABAAR 
antagonist at the network level within the auditory cortex.  
 
Maturation of cortical inhibitory synapses in Fmr1 KO pyramidal neurons 
With the altered regulation of L4-L2/3 GABAergic maturation and expression of GABAAR 
a-subunits in the Fmr1 KO mice auditory cortex, we next asked whether the development 
of inhibitory synaptic function in the auditory cortex was specifically altered in L2/3 
pyramidal neurons of Fmr1 KO mice. We performed whole-cell patch-clamp recordings 
from ex vivo slice preparations across four developmental age groups, measuring sIPSC 
properties using a high-chloride internal solution and measuring inward currents while 
pyramidal cells were voltage-clamped at -60 mV in the presence of ionotropic glutamate 
receptor antagonists (Figure 4.2; Table 4.1). Consistent with the overall progression of 
sIPSC properties across development in the rodent cortex (Bosman et al., 2005; Takesian 
et al., 2012), WT mice exhibited both a clear age-dependent increase in the frequency of 
sIPSCs, and decrease in the weighted decay t, indicative of faster decay kinetics (Figure 
4.2C-D). The sIPSC amplitudes were unchanged across WT development (Figure 4.2B). 
Fmr1 KO mice exhibited similar developmental maturational patterns of sIPSCs, where 
amplitudes and weighted decay t measures were largely unchanged when compared to 
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their age-matched WT littermates. While the sIPSC frequencies across development in 
Fmr1 KO mice were largely comparable to WT, Fmr1 KO mice did exhibit a trending 
increase (p = 0.063) for the frequency at the P12-13 age (Figure 4.2C; Table 4.1), 
suggestive of possible alterations during ear canal opening related to the developmental 
progression of sIPSC maturation in Fmr1 KO mice. 
 
Fmr1 KO mice exhibit enhanced sensitivity to GABAAR a1-specific agonist 
The decay kinetics of IPSCs are highly dependent on the subunit composition of 
GABAARs. The a2- and a3-subunits that are highly expressed at birth mediate relatively 
long-lasting currents, while the a1-subunit, strongly upregulated postnatally to become the 
predominant a-subunit, mediates faster, more mature IPSCs (Bosman et al., 2005; 
Pangratz-Fuehrer et al., 2016). In addition to measuring the weighted decay t of sIPSCs 
(Figure 4.2D) to functionally assess the relative contribution of a1 and a3 subunits, we 
can also examine pharmacological sensitivity using subunit-specific agonists.  
 
In a subset of the L2/3 pyramidal neurons from Figure 4.2, we analyzed changes in both 
sIPSC amplitude and weighted decay t in response to zolpidem, a positive modulator of 
a1-containing GABAARs (Sanna et al., 2002; Baur and Sigel, 2007), across auditory cortex 
development (Figure 4.3; Table 4.2). At P9-10, zolpidem did not cause any significant 
changes to the amplitude of sIPSCs in either WT or Fmr1 KO mice as expected, although, 
it significantly increased the decay kinetics in both groups (Figure 4.3C-D). At P12-13 the 
start of the normal auditory critical period, zolpidem continued to not elicit amplitude 
changes in WT neurons; however, it did significantly increase sIPSC amplitudes in Fmr1 
KO pyramidal neurons (Table 4.2). Additionally, while zolpidem significantly increased 
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decay t for both genotypes at P12-13, KO mice exhibited a slightly more enhanced 
sensitivity (WT: p = 0.0133; KO: p = 0.0074). By P15-16, WT mice exhibited significantly 
increased amplitudes to zolpidem that persisted to P21-25. Fmr1 KO mice also had 
significant increases in amplitude at P15-16 but failed to show a significant amplitude 
enhancement to zolpidem at P21-25. However, neurons were still very responsive to 
zolpidem at both P15-16 and P21-25 with significantly stronger decay t enhancements, 
consistent with the expected age-dependent increase in sensitivity. Overall, our whole-cell 
patch-clamp data suggests that while the maturation of sIPSC properties in L2/3 pyramidal 
cells of the auditory cortex in Fmr1 KO mice was largely similar to that of natural WT 
development, there exist some alterations where Fmr1 KO mice have enhanced zolpidem 
sensitivity. This is consistent with our expression data where we observed both decreased 
membrane-bound GABAAR a3-subunit and elevated total whole-cell GABAAR a1:a3 
expression at P12 (Chapter 2), suggestive of altered a-subunit regulation in the Fmr1 KO 
auditory cortex. 
 
Altered developmental voltage-dependent eIPSC conductance in Fmr1 KO mice 
Since Fmr1 KO mice have a delayed developmental switch in GABAAR polarity in the 
somatosensory cortex (He et al., 2014), and our MEA studies indicate an altered age-
dependent sensitivity to PTX, we wanted to further evaluate whether the Fmr1 KO auditory 
cortex exhibits altered EGABA maturation. We performed gramicidin-perforated patch 
recordings from L2/3 pyramidal neurons to measure EGABA across development (Figure 
4.4). Consistent with other rodent developmental GABA maturation studies in cortical 
neurons (Rheims et al., 2008), the auditory cortex of WT mice also exhibits an age-
dependent transition of EGABA from depolarizing to hyperpolarizing values (P9-10: -53.68 
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± 1.39 mV; P12-13: -52.58 ± 2.40 mV; P15-16: -66.04 ± 3.09 mV; P21-25: -75.07 ± 3.4914 
mV) (Figure 4.4C). Notably, the largest EGABA change occurred between P12 and P15, 
which is between ear canal opening with the start of the auditory critical period and its 
closure (Tukey’s multiple comparisons: P12-13 vs. P15-16, p = 0.006; P15-16 vs. P21-25, 
p = 0.1774). Fmr1 KO mice also exhibit similar maturational changes in the auditory cortex, 
with no significant differences between WT and KO at any age (P9-10: -49.85 ± 2.47 mV; 
P12-13: -56.29 ± 1.68 mV; P15-16: -71.64 ± 1.46 mV; P21-25: -79.85 ± 2.64 mV) (Figure 
4.4C). KO mice also have the largest EGABA change between P12 and P15 (Tukey’s: P12-
13 vs. P15-16, p = 0.0004; P15-16 vs. P21-25, p = 0.2965). Interestingly, when we 
excluded the P9-10 group to specifically examine EGABA for ages after ear canal opening, 
where the auditory circuit is more robustly modulated by the mediation of auditory input, 
there was a significant difference between Fmr1 KO and WT mice, where KO mice tended 
to have more hyperpolarized EGABA values (2-way ANOVA, genotype effect, F(1,83) = 5.0, p 
= 0.0276). These data suggest that Fmr1 KO mice exhibit alterations of larger inhibition 
after the critical period onset, which may contribute to the critical period dysplasticity in the 
auditory cortex.  
 
The I-V plots were further normalized and averaged for each of the age groups for 
developmental age-group comparisons to assess altered patterns of the relative eIPSC 
magnitudes in Fmr1 KO compared to WT mice across development (Figure 4.4D-G). The 
I-V plots for WT mice indicated a clear and statistically significant developmental 
progression in the rectification pattern of the I-V curves. In P9-10 WT mice, there was a 
strong outward rectification of the GABAAR current beginning around -40mV, consistent 
with the voltage-dependent activation and modulation of GABAARs (Figure 4.4D) (Pavlov 
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et al., 2009; O'Toole and Jenkins, 2012). At P12-13, the outward rectification became 
significantly diminished at the depolarizing holding potentials (Figure 4.4E), which 
subsequently transitioned into an inward rectification at the later P15-16 and P21-25 ages 
in WT mice (Figure 4.4D-F). In contrast, Fmr1 KO P9-10 mice did not have a strong 
outward rectification like the age-matched WT mice (segmented linear regression, F(3,297) 
= 14.70, p < 0.0001). Rather, the I-V curve is already inwardly rectifying and similar to that 
of P12-13. The later KO ages continued to become more inwardly rectifying with age like 
the WT mice, although at P15-16, KO mice were not as strongly inwardly rectifying 
compared to WT (F(3,283) = 11.96, p < 0.0001). However, the rectification patterns were 
comparable to WT at P21-25 (F(3,312) = 0.9949, p = 0.3955). The perforated-patch clamp 
experiments collectively suggest that auditory cortex L2/3 pyramidal neurons of Fmr1 KO 
mice undergo dysregulated developmental transitions in their rectification of evoked 
GABAAR currents prior to ear canal opening, and also have a tendency towards more 
hyperpolarized GABAAR reversal potentials during postnatal development compared to 
WT mice. 
 
Increased phosphorylation of KCC2 in Fmr1 KO auditory cortex at P24 
Given the more hyperpolarized GABAAR reversal potentials in Fmr1 KO mice, we wanted 
to identify potential mechanisms contributing to these alterations. While the membrane-
bound expression of the chloride transporters NKCC1 and KCC2 were unaltered in the 
developing auditory cortex of Fmr1 KO mice (Chapter 2), post-translational modifications 
of KCC2 can further impact the regulation of chloride transporters and thus EGABA. Notably, 
the phosphorylation of KCC2 at serine 940 (S940) stabilizes KCC2 at the cell surface by 
reducing internalization and enhances its activity (Lee et al., 2007; Medina et al., 2014). 
Given the more hyperpolarized EGABA values in L2/3 pyramidal neurons of Fmr1 KO mice 
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following ear canal opening, we measured the levels of pS940 KCC2 at P24, a 
developmental age where mice express more adult-like levels of the chloride transporters 
(Figure 2.4E), and KO mice exhibit enhanced sensitivity to picrotoxin (Figure 4.1I). 
Western blot analysis of whole-cell lysates of the auditory cortex revealed unaltered 
expression of NKCC1:KCC1 (WT: 100 ± 10.01%, KO: 101.1 ± 10.8%, p = 0.94), consistent 
with the membrane-bound preparations (Figure 4.5B). However, we found that Fmr1 KO 
mice had significantly elevated levels of pS940 KCC2 (WT: 100 ±  13.4%; KO: 138.8 ± 
12.9%, p = 0.035), whereas total KCC2 levels were unchanged (WT: 100 ± 12%; KO: 
132.5 ± 16.4%, p = 0.148). Our findings suggest that the phosphorylation of KCC2 at S940 
is elevated in the auditory cortex of P24 Fmr1 KO mice, which in turn could increase 
membrane stability and function to enhance inhibitory GABA signaling. 
 
P12 Fmr1 KO mice exhibit impaired inhibitory presynaptic regulation of L2/3 
pyramidal neurons  
Much of our data reveal alterations in GABAergic postsynaptic maturation in L2/3 
pyramidal neurons of the Fmr1 KO auditory cortex. While some of these changes appear 
to be consistent with differences in postsynaptic GABAA a-subunit or chloride transporter 
expression, there may also be a presynaptic component. To further characterize 
dysregulation of GABA-mediated signaling in Fmr1 KO animals, we additionally examined 
L2/3 pyramidal neuron mIPSCs and paired-pulse ratios (PPR) of eIPSC to identify 
possible presynaptic contributions. We specifically examined the P12 auditory cortex 
given the increasing trend in sIPSC frequency observed in Fmr1 KO mice (Figure 4.2C). 
mIPSCs were measured in the presence TTX to block action potentials (Figure 4.6A-D). 
The median amplitudes of mIPSCs were similar between Fmr1 WT and KO mice (WT: 
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19.43 ± 1.102 pA, KO: 19.11 ± 0.7328 pA, p = 0.8138), as were the weighted decay t (WT: 
14.54 ± 0.6811 ms, KO: 15.14 ± 0.7443, p = 0.5562) (Figure 4.6B, D). Unlike the trending 
increase of sIPSC frequency in Fmr1 KO mice, there was no difference in mIPSC 
frequency (WT: 1.080 ± 0.1712 Hz, KO: 1.065 ± 0.1225 Hz, p = 0.6768) (Figure 4.6C), 
which suggests that presynaptic- or network activity-driven action potential events likely 
contribute to the trending sIPSC frequency difference (Malkin et al., 2014). 
 
sIPSC and mIPSCs of L2/3 pyramidal neurons include synaptic events mediated by both 
local L2/3 and interlaminar L4 input; therefore, we sought to more specifically evaluate 
whether there were L4 inhibitory presynaptic deficits. We compared the paired pulse ratios 
(PPR) of eIPSCs in L2/3 pyramidal neurons from stimulation evoked in L4 with a range of 
interstimulus intervals (Figure 4.6E-F). Both P12-13 WT and KO mice generally exhibit 
paired-pulse depression (PPR < 1), but Fmr1 KO mice have significantly more depressed 
responses compared to WT littermates (2-way ANOVA, genotype effect, F(1,198) = 6, p = 
0.012) (Figure 4.6F). Notably, the intervals at which more depressed responses were 
observed in Fmr1 KO mice are at 400, 50, and 20 ms, similar to the intervals where more 
enhanced paired-pulse depression were observed in our Chapter 3 fEPSP paired-pulse 
measures (Figure 3.3B). Our findings suggest that the L4-L2/3 circuit maturation in Fmr1 
KO mice are further impacted by impairments in L4 inhibitory presynaptic mechanisms. 
 
DISCUSSION 
FXS patients exhibit language development, communication, and auditory processing 
deficits suggestive of altered auditory cortex development and function, which require 
circuit modification during critical periods that is dependent on inhibitory maturation (Sanes 
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and Kotak, 2011; Miyakawa et al., 2019; Kalish et al., 2020). Fmr1 KO mice have disrupted 
auditory plasticity, processing and excitability (Kim et al., 2013; Rotschafer and Razak, 
2014; McCullagh et al., 2020); however, dysregulation related to GABAergic signaling 
maturation in the auditory cortex has not been carefully examined. Here, we characterized 
auditory intracortical maturation of inhibitory transmission during the critical period in both 
WT and Fmr1 KO mice, identifying circuit and synaptic GABAA transmission patterns. In 
KO mice, we uncovered changes in auditory cortex L4-L2/3 excitability mediated by 
GABAergic alterations that are accompanied by dysregulation of presynaptic and 
postsynaptic inhibitory synaptic maturation in L2/3 pyramidal neurons, and 
pharmacological sensitivity differences. The impairments are dynamic across the duration 
of auditory cortex development, with some deficits first manifesting prior to ear canal 
opening, and others distinctly occurring at the start of the typical WT auditory critical period 
window or later juvenile ages.    
 
Inhibitory GABAergic tone both induces and restricts developmental critical period 
plasticity (Fagiolini et al., 2004; Harauzov et al., 2010). In Chapter 3 we evaluated auditory 
cortex L4-L2/3 basal synaptic transmission, given its involvement in early-stage cortical 
auditory processing and tonotopic plasticity (Barkat et al., 2011) and characterized Fmr1 
KO mice to have dynamic changes in excitability, where L4-L2/3 was significantly more 
excitable at P12-13 and less excitable at P21-25. Here, we identified that these excitability 
changes are likely in part attributable to developmental differences GABA signaling. In 
response to subthreshold concentrations of PTX, Fmr1 KO mice exhibited enhanced 
developmental transitions from depolarizing to hyperpolarizing responses to PTX that 
were consistent with the L4-L2/3 excitability deficits in basal synaptic transmission. Such 
alterations could be related to the hyperexcitability present in the Fmr1 KO brain 
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(Contractor et al., 2015), which may potentially drive an accelerated switch from 
depolarizing to hyperpolarizing GABA as occurs in hippocampal CA1 neurons following 
early-life seizures (Galanopoulou, 2008b; Brooks-Kayal, 2011).  
 
We further analyzed GABA-mediated inhibitory maturation of L2/3 pyramidal neurons, 
given their crucial role in integrating both L4 tonotopic information and input derived from 
other brain regions (Guo et al., 2012a; Meng et al., 2020). Notably, we observed 
differences at P12, the start of the WT critical period soon after ear canal opening. Fmr1 
KO L2/3 pyramidal neurons exhibited a trending increase in sIPSC frequency; however, 
mIPSC frequency were not different, suggesting that action potentials from increased 
spontaneous network activity contributed to the frequency difference. Despite the 
increased network activity, there are still defects related to inhibitory regulation of 
excitatory neurons that are consistent with the impaired inhibitory control of L2/3 neurons 
in the barrel cortex of Fmr1 KO mice (Paluszkiewicz et al., 2011). We found P12 Fmr1 KO 
mice to have significantly enhanced eIPSC paired-pulse depression in L2/3 pyramidal 
neurons in the auditory cortex compared to WT mice, suggestive of altered presynaptic 
mechanisms related to GABA vesicles or calcium influx that impairs inhibitory regulation 
(Wilcox and Dichter, 1994; Cea-Del Rio and Huntsman, 2014). Given that fast-spiking 
inhibitory interneurons distinctly display short-term depression to repetitive stimulation 
(Beierlein et al., 2003), it is likely that our observed deficits are related to the impaired 
development of parvalbumin cell numbers and perineuronal nets in the developing 
auditory cortex of Fmr1 KO mice (Wen et al., 2018).  
 
While parvalbumin cell numbers are reduced in the developing Fmr1 KO auditory cortex 
(Wen et al., 2018), as is GABAAR a3-subunit protein surface expression at P12 (Figures 
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2.3 and 2.5), compensatory inhibitory synaptic development likely occurs given that sIPSC 
and mIPSC properties in L2/3 pyramidal neurons were largely similar to WT. This lack of 
s/mIPSC properties could be related to adaptive mechanisms from homeostatic feedback 
during circuit development and/or compensatory GABAAR subunit incorporation to 
maintain GABAergic signaling (Bosman et al., 2005; Kralic et al., 2006; Mullins et al., 
2016). Indeed, despite similar s/mIPSC amplitudes, we found L2/3 pyramidal neurons of 
Fmr1 KO mice to exhibit enhanced sensitivity to the a1-specific agonist zolpidem, 
suggesting that the incorporation of the a1-subunit may be increased in a subset of 
synaptic GABAARs in the auditory cortex of KO mice, thereby causing enhanced zolpidem 
sensitivity but no difference in decay t measures. Interestingly, in the basolateral 
amygdala, Fmr1 KO mice exhibit dynamic alterations in sIPSC properties and diminished 
zolpidem sensitivity across development (Vislay et al., 2013), indicating KO mice exhibit 
regional differences in inhibitory neurotransmission development that may be intricately 
influenced by local cell types and circuitry. 
 
Altered GABA maturation of L2/3 pyramidal neurons was observed related to the transition 
from depolarizing to hyperpolarizing GABA-mediated signaling (Ben-Ari, 2002). Although 
multiple cortical regions have been examined (Rheims et al., 2008; He et al., 2014), few 
characterizations of this transition are specific to the mouse auditory cortex, especially in 
the L4-L2/3 synaptic network. We analyzed EGABA of L2/3 pyramidal neurons and found 
KO mice had more hyperpolarized EGABA when examining ages with open ear canals. 
Interestingly, while we did not find differences in the overall levels of NKCC1 or KCC2 in 
the auditory cortex (Figure 2.4), we observed elevated phosphorylated S940-KCC2 levels 
in P24 KO mice. Phosphorylation of this residue both stabilizes KCC2 at the membrane 
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and increases its activity (Lee et al., 2007; Medina et al., 2014), which could enhance the 
extrusion of chloride ions resulting in more hyperpolarizing EGABA and stronger inhibitory 
action and sensitivity, consistent with the enhanced hyperpolarizing action of PTX in P21-
25 Fmr1 KO mice compared to age-matched WTs (Figure 4.1D, I). While the expression 
of KCC2 positively regulates the expression of GABAAR a1-subunit (Succol et al., 2012), 
the potential effects of KCC2 phosphorylation on GABAAR a-subunit expression is 
currently not known.  Our results contrast the maturation of Fmr1 KO L4 stellate cells of 
the barrel cortex, which exhibit a delayed GABA polarity switch (He et al., 2014); however, 
the robustness of this phenotype is questionable as EGABA was similar when measured by 
Domanski et al. (2019).  
 
Our eIPSC I-V plots identified a WT developmental progression previously unreported in 
the auditory cortex. L2/3 pyramidal neuron eIPSCs transitioned from outward to inwardly 
rectifying with age, similar to the developmental regulation of GABA currents in rat intrinsic 
cardiac ganglion neurons, which may be related to additional chloride current-related 
mechanisms for controlling neuronal excitability (Fischer et al., 2005). Chloride channels 
and various GABAAR subunits can influence rectification (Verdoorn et al., 1990; Smith et 
al., 1995; Jensen et al., 2002; Pavlov et al., 2009), with the a3-subunit also capable of 
eliciting I-V changes. Development RNA-editing of a3 that renders more a1-like properties 
switches I-V plots from an outwardly rectifying to a linear curve (Rula et al., 2008; Nimmich 
et al., 2009). Meanwhile, Fmr1 KO mice lacked the outward rectification and instead 
revealed inward rectifications that resembled older developmental ages, which is 
consistent with the a-subunit regulation that we observe across our data. Such rectification 
differences related to voltage-dependent conductance can make pyramidal neurons more 
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excitable and generate action potentials (Pavlov et al., 2009) to further dysregulate 
GABAergic inhibition. 
 
We evaluated GABAergic transmission on L2/3 pyramidal neurons, but a comprehensive 
understanding of inhibitory dysregulation in FXS auditory cortex development 
necessitates examining different cell types and cortical layers (Kalish et al., 2020). Fmr1 
KO L4 barrel cortex has deficits in excitatory drive onto inhibitory neurons (Gibson et al., 
2008). Thus, evaluating both local inhibitory input and excitatory projections on inhibitory 
interneurons would further reveal auditory cortex GABA impairments. Additionally, 
Goswami et al. (2019) showed local L2/3 auditory cortex hyperexcitability in P19-23 Fmr1 
KO mice, attributing this to increased intrinsic excitability but did not directly measure. 
Given our observations of decreased L4-L2/3 excitability in P21-25 KO mice, 
characterizing intrinsic properties could establish whether L2/3 hyperexcitability is 
compensatory for decreased synaptic excitability at earlier intracortical stages. 
 
Overall, critical period plasticity and GABAergic maturation require the appropriate timing, 
transition, kinetics and magnitude of both depolarizing and hyperpolarizing GABA across 
development (Ben-Ari, 2002; Succol et al., 2012; He et al., 2014; Deidda et al., 2015). 
Thus, when collectively examining the developmental regulation of GABAergic signaling 
in Fmr1 KO mice, we identified alterations to both presynaptic and postsynaptic GABAA 
mechanisms, as well as chloride transporter dynamics. Our findings clearly indicate that 
the maturation of GABA-mediated synaptic transmission is altered in the developing 
auditory cortex, which likely underlie part of the E-I circuit imbalance and the manifestation 






Figure 4.1: The auditory cortex of Fmr1 KO mice exhibits an accelerated age-dependent shift 
in their sensitivity to picrotoxin (PTX). I-O curves from MEA field recordings were analyzed in 
the presence of 5 µM. (A-E) Top: representative traces from Fmr1 WT mice at 40 µA stimulation. 
Bottom: I-O curves before and after PTX, normalized to the maximum amplitude in ACSF and fit 
with sigmoidal curves. (C) Fmr1 P15-16 WT mice exhibit decreased fEPSP amplitudes following 
PTX, likely due to the presence of depolarizing GABAA. (E) Fmr1 WT exhibit significantly increased 
fEPSP amplitudes to PTX at P40-45, indicating PTX’s blockade of inhibitory hyperpolarizing 
GABAA. (F-J) Representative traces and I-O curves from Fmr1 KO mice. (G) Fmr1 KO mice exhibit 
significantly decreased responses to PTX at P12-13 but not at (H) P15-16. (I-J) At both P21-25 and 
P40-45, Fmr1 KO mice exhibit significantly increased amplitudes to PTX. The number of slices and 
mice analyzed for each age and genotype are indicated in each graph. ** p < 0.01, *** p < 0.001, 




Figure 4.2: Increasing trend for sIPSC frequency in P12-13 Fmr1 KO mice. (A) Representative 
traces of sIPSCs recorded across development from L2/3 pyramidal neurons in the auditory cortex. 
(B) Amplitudes of sIPSCs are unaltered in Fmr1 KO mice at any age. (C) P12 KO mice exhibit a 
trend towards increased sIPSC frequency. (D) No differences in the weighted decay t (tdw) were 
observed between WT and KO mice at any age. Developmental maturation of inhibitory 
transmission is observed with increasing tdw times across ages. All values are summarized in Table 




Figure 4.3: Fmr1 P12 KO mice exhibit enhanced sensitivity to zolpidem (ZOLP). (A-B) 
Representative traces of averaged sIPSCs from L2/3 pyramidal neurons before and after 100 nM 
zolpidem. (C) The effects of ZOLP on sIPSC amplitude across ages. No effects observed at P9-
10, but significantly increased amplitude following ZOLP observed in Fmr1 KO mice starting at P12-
13. (D) The τdw of averaged sIPSCs significantly increases with ZOLP across all ages for both WT 
and KO mice. The average values are summarized in Table 2. * p < 0.05, ** p < 0.01, *** p < 0.001, 




Figure 4.4: Fmr1 KO mice exhibit altered voltage-dependent eIPSC conductance in L2/3 
pyramidal neurons during auditory cortex development. (A-B) Representative example of (A) 
GABAAR I-V plot and (B) traces of eIPSC gramicidin-perforated patch recordings from P9 WT and 
KO mice. EGABA is estimated from linear fit from I-V plot. (C) Group data of EGABA from I-V plots 
across all Fmr1 WT and KO mice and ages. (D-G) Averaged GABAA I-V plots across ages for WT 
and KO mice to evaluate developmental regulation of GABAAR responses. Currents for each cell 
were normalized to the eIPSC peak amplitude of the first holding potential. P9-10: n = 13 cells/5 
WT mice and 15 cells/6 KO mice. P12-13: n = 15 cells/5 WT mice and 17 cells/6 KO mice. P15-16: 
n = 13 cells/5 WT mice and 14 cells/6 KO mice. P21-25: n = 16 cells/6 WT mice and 14 cells/5 KO 
mice. **** p < 0.0001.  
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Figure 4.5: Elevated phosphorylation of KCC2 S940 in P24 Fmr1 KO mice. (A) Representative 
western blots of whole-cell lysates of auditory cortex probed for pS940, total KCC2 and NKCC1, 
with b-actin used as loading controls. (B) A significant increase in pS940, normalized to b-actin, 
was found P24 KO mice relative to WT littermate controls (n = 6 WT, 7 KO). No differences were 
found in the levels of NKCC1:KCC2, total KCC2 or NKCC1 (not shown), consistent with the lack of 




Figure 4.6 Altered presynaptic regulation of inhibitory transmission in L2/3 pyramidal 
neurons of P12 Fmr1 KO mice in the auditory cortex. (A-D) mIPSC analysis of L2/3 pyramidal 
neurons in the auditory cortex. (A) Representative mIPSC traces. (B-D) mIPSC amplitude, 
frequency, and weighted decay t are unaltered in P12-13 Fmr1 KO mice. N = 17 cells/5 WT mice 
and 17 cells/5 KO mice. (E-F) Paired pulse ratio analysis of eIPSC at P12-13. (E) Representative 
traces from interstimulus intervals of 20 and 50 ms. (F) Fmr1 KO mice have significantly different 
eIPSC paired pulse ratios compared to WT mice, with more depressed PPR values. N = 16 cells/3 
WT mice and 19 cells/3 KO mice. * p < 0.05  
 108 
 Genotype  (n = cells/mice) Amplitude (pA) Frequency (Hz) 
Weighted Decay t 
(ms) 
P9-10 
WT (22/9) 24.01± 2.18 0.56 ± 0.10 25.42 ± 2.12 
KO (24/7) 23.07 ± 1.46 0.47 ± 0.07 23.19 ± 1.57 
 p = 0.7192 p = 0.4478 p = 0.3976 
P12-13 
WT (22/9) 20.20 ± 0.98 1.63 ± 0.12 16.86 ± 1.06 
KO (21/8) 20.68 ± 1.52 1.97 ± 0.16 16.75 ± 0.87 
 p = 0.7881 p = 0.0634 p = 0.9381 
P15-16 
WT (25/10) 21.36 ± 0.96 4.49 ± 0.32 11.55 ± 0.37 
KO (21/7) 21.16 ± 0.78 4.33 ± 0.28 11.41 ± 0.32 
 p = 0.8778 p = 0.7214 p = 0.7894 
P21-25 
WT (20/10) 24.70 ± 1.44 6.65 ± 0.34 10.08 ± 0.43 
KO (21/10) 23.33 ± 1.36 7.50 ± 0.39 9.77 ± 0.23 
 p = 0.4919 p = 0.1086 p = 0.5206 
 
Table 4.1: Summary of sIPSC median amplitudes, frequency and weighted decay t. All values 
are mean ± SEM. Student’s t test or Mann-Whitney was performed for each age, with p values 
listed.   
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  Amplitude Weighted Decay t (ms) 
 Genotype  (n = cells/mice) ACSF ZOLP p-value ACSF ZOLP p-value 
P9-10 




































0.59 < 0.0001 






0.37 < 0.0001 
P21-25 






0.42 < 0.0001 






0.53 < 0.0001 
 
Table 4.2: Summary of sIPSC pharmacological sensitivity to zolpidem in the auditory cortex. 
Group mean ± SEM reported for median amplitude and weighted decay t for ACSF and ZOLP for 
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The identification of excitatory-inhibitory (E-I) imbalance in a circuit necessitates a careful 
assessment of potential alterations in both excitatory and inhibitory synaptic transmission. 
In the Fmr1 KO mouse, we identified alterations in the developmental patterns of 
excitability and synaptic plasticity in the L4 to L2/3 circuit of the auditory cortex, and further 
characterized dysregulation of inhibitory GABA maturational patterns in L2/3 pyramidal 
neurons. Given that the proper maturation of excitatory glutamatergic signaling is crucial 
for the regulation of developmental excitability and plasticity, we sought to evaluate 
AMPAR maturation in L2/3 pyramidal neurons during the postnatal development of the 
auditory cortex in WT and Fmr1 KO mice. To date, studies of functional glutamatergic 
synaptic development in the Fmr1 KO auditory cortex are limited. Therefore, we 
specifically examined the postnatal maturation of 1) NMDAR-only “silent” synapses that 
postnatally convert to “functional” AMPAR-containing synapses, which is an underlying 
factor in the capacity for developmental plasticity, and 2) AMPAR GluA2 subunits that 
render AMPARs impermeable to calcium, which modulate neuronal excitability and 
plasticity in early development. The data presented in this chapter is preliminary, with 
further experimentation needed. Here, we demonstrate feasibility and the consideration 




The functional maturation of GABAergic inhibitory signaling is necessary for the regulation 
of cortical critical periods and the development and maintenance of proper auditory 
processing (Wehr and Zador, 2003; Hensch, 2005; Blackwell and Geffen, 2017). In 
Chapter 4, we detailed the postnatal maturational patterns of GABAAR-mediated signaling 
in the developing auditory cortex, focusing on the inhibitory regulation of L2/3 pyramidal 
neurons. Fmr1 KO mice exhibit alterations in these developmental patterns, with 
dysregulation of both postsynaptic and presynaptic GABAergic function. However, 
another crucial regulator of developmental excitability and plasticity is the postnatal 
activity-dependent maturation of excitatory glutamatergic signaling (Rakhade and Jensen, 
2009).  
 
Changes and refinements in AMPAR and NMDAR excitatory circuits also modulate critical 
periods (Hensch, 2005; Oswald and Reyes, 2008). The neonatal brain has a high 
proportion of NMDAR-only silent synapses that are functionally “silent” at due to the 
magnesium block at resting membrane potential. Their activity-dependent conversion to 
functional synapses via AMPAR insertion is correlated with the capacity for synaptic 
plasticity and the refinement of relevant connections, particularly for thalamocortical 
synapses of sensory cortices (Crair and Malenka, 1995; Isaac et al., 1997; Harlow et al., 
2010; Hanse et al., 2013). Alterations in silent synapse maturation are known to disrupt 
synaptic plasticity and manifest in functional deficits, as we previously reported that 
hyperexcitability from early-life seizures can disrupt auditory tonotopic critical period 
plasticity and hippocampal synaptic plasticity by prematurely unsilencing glutamatergic 
synapses (Zhou et al., 2011; Sun et al., 2018). Conversely, a persistence of silent 
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synapses in the barrel cortex of Fmr1 KO mice results in a temporal delay of its critical 
period (Harlow et al., 2010).  
 
Additionally, the postnatal and activity-dependent regulation of AMPAR subunits further 
influence developmental excitability and plasticity (Liu et al., 2004; Isaac et al., 2007). In 
particular, the GluA2 subunit is expressed at relatively low levels early in postnatal 
development, thereby causing many AMPARs to lack GluA2 and be calcium-permeable. 
However, the prevalence of GluA2-lacking AMPARs in early development are necessary 
for permitting enhanced excitability and activation of calcium-dependent pathways to 
facilitate synaptogenesis and synaptic plasticity (Isaac et al., 2007; Rakhade and Jensen, 
2009). Alterations in GluA2 subunit expression have been identified across 
neurodevelopmental disorders (Salpietro et al., 2019; Yennawar et al., 2019), and 
AMPARs are also dynamically regulated in the auditory cortex based on environmental 
exposure, with associated with alterations in auditory processing in cortical neurons (Cai 
et al., 2010; Guo et al., 2012a; Hackett et al., 2015).  
 
In Chapter 2, we identified altered expression of membrane-bound AMPARs in the 
auditory cortex of Fmr1 KO mice. Specifically, GluA2 levels were increased in P9 KO mice 
relative to WT, before ear canal opening, as well as increased GluA2:GluA1 at both P9 
and P12. Additionally, in Chapter 3, we identified alterations in the developmental 
progression of synaptic plasticity and excitability within the L4-L2/3 circuit in Fmr1 KO 
mice. Given the importance of AMPAR regulation to developmental excitability and 
plasticity, we sought to investigate whether Fmr1 KO mice exhibit functional deficits in 
AMPARs in the developing auditory cortex to complement our functional studies that 
examined inhibitory maturation. We specifically evaluated AMPAR maturational properties 
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by examining sEPSCs, silent synapses, and AMPAR I-V plots for GluA2 analysis in L2/3 
pyramidal neurons. The data presented in this chapter is preliminary and ongoing; 
therefore, they are presented without any statistical analyses. Here, we demonstrate 
feasibility and our consideration for a more complete evaluation of E-I circuit analysis in 




Fmr1 WT and Fmr1 KO mice of the congenic FVB background were obtained from The 
Jackson Laboratory (stock # 004828; 004624). Heterozygous females were generated 
from the original breeders, whereby heterozygous female mice were crossed with WT or 
hemizygous male mice to obtain Fmr1 WT and KO male littermates. Age-matched WT 
and KO male littermate mice were used for all experiments to avoid the confounding 
effects of X-inactivation that would be present in heterozygous females. All procedures 
were performed in accordance with the guidelines of the NIH and with the approval of the 
Institution of Animal Care and Use Committee with the University of Pennsylvania. All 
efforts were made to minimize animal suffering and numbers. 
 
Brain slice preparation 
Acute coronal brain slices for whole-cell electrophysiology were prepared from Fmr1 WT 
and KO littermate mice at the following ages: P9-10, P12-13, P15-16, and P21-25. 
Animals were rapidly decapitated and brains were quickly removed and placed in chilled 
cutting solution containing the following (in mM): 220 sucrose, 3 KCl, 1.25 NaH2PO4, 0.5 
CaCl2, 1 MgCl2, 26 NaHCO3, and 10 D-glucose, ~300 mOsm, pH 7.4, bubbled with 95% 
O2/5% CO2 at 4°C. Coronal slices (350 µm) containing the auditory cortex, identified by 
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anatomical landmarks, were cut using a vibratome (Leica VT1000S) in cutting solution. 
Slices were incubated in oxygenated ACSF containing the following (in mM): 124 NaCl, 5 
KCl, 2 CaCl2, 1.2 MgSO4, 1.25 NaH2PO4, 26 NaHCO3, and 10 D-glucose, ~295 mOsm, 
and transferred to 32°C for 30 min. Then, slices were kept at room temperature for at least 
1 hour before recordings.  
 
Whole-cell electrophysiology 
Whole-cell patch-clamp recordings were made in the auditory cortex, visualized with an 
upright Zeiss Axioscop 2 FsPlus IR-DIC microscope. All recordings were made at room 
temperature with ACSF perfused at a rate of ~2 ml/min. Glass electrodes were pulled (P-
87, Sutter Instruments) with a resistance of 2-5 MW and filled within internal solution 
containing (in mM): 110 Cs methanesulfonate, 10 TEA-Cl, 4 NaCl, 2 MgCl2, 0.5 EGTA, 10 
HEPES, 4 ATP-Mg, 0.3 GTP, 7 phosphocreatine, creatine phosphokinase (17 units/ml), 1 
QX-314, pH 7.3, 270-280 mOsm.  
 
For sEPSC recordings, cells were voltage-clamped at a holding potential of -60 mV and 
recorded for 10 min in the presence of 60 µM picrotoxin to block GABAA receptors. Access 
resistance was monitored throughout each experiment, with applied series resistance 
compensation of up to 75%, and recordings discarded if access resistance was >25 MW 
or changed >20%. Data was collected using Axopatch 200B amplifier and pClamp 10 
software (Molecular Devices), filtered at 2 kHz and digitized at 20 kHz using a Digidata 
1440A analog to digital converter. Each trace was first low-pass filtered at 1 kHz 
(Gaussian). Events were detected automatically with a threshold of 5-6 pA (2 times the 
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root mean square of the noise), depending on the noise level (Rakhade et al., 2008; Zhou 
et al., 2011; Sun et al., 2013), and were visually confirmed. 
 
To examine postsynaptic silent synapses, synaptic responses in the L2/3 pyramidal 
neurons were evoked by stimulating L4 in the presence of 60µM picrotoxin. Cells were 
first held at -60 mV and stimulated using a threshold stimulation intensity that elicited 
detectable synaptic responses with about a 40-60% failure rate from 50 consecutive trials 
(Zhou et al., 2011; Sun et al., 2018). Cells were then stimulated with the same intensity at 
+40 mV for another 50 trials. The fraction of silent synapses was calculated by using the 
corresponding eEPSC failure rates at -60 and +40 mV in the following formula: (1 – ln(F-
60)/ln(F+40)), as per published methods (Liao et al., 1995; Sun et al., 2018).  
 
For evoked AMPAR I-V plot recordings, 0.1 mM spermine was added to the internal 
recording solution, with 60 µM picrotoxin and 50 µM D-AP5 added to the bath to isolate 
AMPAR-mediated currents. L2/3 pyramidal neurons were held from -80 to +40 mV, 
increasing in 20 mV, with evoked stimulations at the L3/4 border. Data were obtained from 
the average 4-8 recordings per cells, with amplitudes of AMPA-mediated EPSC responses 
normalized to -80 mV holding voltage.  
 
Experimental design and statistical analysis 
For all experiments, the sample size and power were determined based on previously 
published work in our laboratory and using StatMate software. Statistical analysis was 
completed using Prism 8 (GraphPad). Data were tested for normality using the Shapiro-
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Wilk test. Data are reported as mean ± SEM with p values reported in Results. All n’s are 
reported in the figure legends or tables, or within figures themselves. 
 
RESULTS 
Maturation of cortical excitatory synapses in L2/3 pyramidal neurons in the 
developing auditory cortex 
Given the significantly elevated levels of membrane-bound GluA2 in the auditory cortex of 
P9 Fmr1 KO mice compared to age-matched WT littermates, we wanted to examine 
whether there were changes in synaptic AMPAR in L2/3 pyramidal neurons. We 
performed whole-cell patch-clamp recordings from ex vivo slice preparations of WT and 
KO mice across development, measuring sEPSCs while cells were voltage-clamped at -
60mV (Figure 5.1), which isolate for AMPAR-mediated events given that NMDAR-
mediated currents require depolarized holding potentials. Consistent with the overall 
progression of sEPSC properties across development in the rodent cortex (Kroon et al., 
2019), WT mice exhibit a clear age-dependent increase in the frequency of sEPSCs 
(Figure 5.1C; Table 5.1). There is also a subtle developmental increase in the median 
amplitude of sEPSCs, perhaps between P9-10 and P12-13 (Figure 5.1B). Fmr1 KO mice 
also appear to follow a similar age-dependent regulation in sEPSC frequency and 
amplitude, with more elevated sEPSC frequencies at the older developmental ages of 
P15-16 and P21-25; however, no conclusions can be drawn given the preliminary nature 
of these experiments.  
 
Measuring the fraction of silent synapses in auditory cortex L2/3 pyramidal neurons  
The auditory thalamocortical synapses of L4 pyramidal neurons exhibit a maturation of 
NMDAR-only silent synapses that correspond to the auditory cortex critical period. We 
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sought to evaluate their maturation in auditory cortex L2/3 pyramidal neurons, which 
crucially integrate input from L4 tonotopy and other brain regions (Guo et al., 2012b; Meng 
et al., 2020). The maturation of silent synapses can be monitored by measuring the 
proportion of silent synapses across development, which can be calculated by using a 
protocol of minimally evoked EPSCs. Specifically, cells are first held at -60 mV and 
stimulated using a minimal stimulus intensity that results in evoked synaptic responses 
with ~50% failure rate. The holding potential is then raised to +40 mV and again stimulated 
with the same stimulus intensity (Figure 5.2A-D), whereby we use the difference in failure 
rates to calculate the proportion of silent synapses (Liao et al., 1995; Sun et al., 2018).    
 
Silent synapse recordings were performed at P12-13 and P15-16 (Figure 5.2), though it 
is our intention to also evaluate the P9-10 and P21-25 ages for a more comprehensive 
evaluation. In most of the L2/3 pyramidal neurons recorded, we found a decrease in failure 
rates when we raised the holding potential from -60 to +40 mV (Figure 5.2E-F). The 
preliminary recordings from WT neurons exhibit an age-dependent decrease in the 
fraction of silent synapses present (P12-13 WT: 44.55 ± 7.99%; P15-16 WT: 23.16 ± 
14.63%) (Figure 5.2G). The preliminary recordings from Fmr1 KO did not this change 
(P12-13 KO: 29.43 ± 11.71%; P15-16 KO: 37.84 ± 7.41%).  
 
The calculation of silent synapses is dependent on the failure rates at the -60 and +40 mV 
holding potentials. However, these initial recordings presented some technical challenges, 
where it was often difficult to find a stimulus intensity that elicited ~50% failure rate at -60 
mV. Minimal changes in stimulation quickly transitioned from >90% to <20% failure rate. 
These challenges may be related to the differences in synaptic organization within the 
cortex, where L2/3 pyramidal neurons do not have a unidirectional dendritic fiber input 
 119 
compared to thalamocortical synapses of L4 or the Schaffer collateral pathway from CA3 
to CA1 of the hippocampus (Zhou et al., 2011; Sun et al., 2018). For our preliminary 
calculations in Figure 5.2, we included cells with <20% failure rate at -60 mV. However, 
future analyses will be kept to cells that are able to achieve the initial ~50% failure rate at 
-60 mV, given that a low initial failure rate could result in a skewed calculation that does 
not capture a true physiological difference in failure rates between the two holding 
potentials.  
 
AMPAR GluA2 subunit maturation in L2/3 pyramidal neurons in the auditory cortex 
To more directly examine whether there were functional differences in the maturation of 
the GluA2 subunit in Fmr1 KO mice, related to the elevated GluA2:GluA1 membrane-
bound levels, we examined AMPAR I-V relationships in L2/3 pyramidal neurons across 
development in the auditory cortex (Figure 5.3). GluA2-containing or GluA2-lacking 
AMPARs can be distinguished based on the rectification of their I-V curves. Spermine, 
included in the intracellular solution, causes a voltage-dependent channel block in GluA2-
lacking AMPARs that results in an inward rectification, whereas GluA2-containing 
AMPARs will have a more linear I-V relationship (Pellegrini-Giampietro, 2003; Isaac et al., 
2007). The degree of rectification can be compared quantitatively by calculating the 
rectification index, which is the ratio of the peak absolute amplitude of AMPAR-eEPSC at 
-60 to +40 mV.  
 
Given that the GluA2 subunit postnatally increases in expression, we would expect to 
observe a developmental progression in AMPAR I-V plots, transitioning from inwardly 
rectifying to more linear I-V curves. Unexpectedly, we did not identify a dramatic 
developmental pattern in L2/3 pyramidal neurons in WT mice from our preliminary 
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recordings (Figure 5.3). There was a minor decrease in the rectification index between 
WT mice at P9-10 (3.498 ± 0.636) and P12-13 (3.072 ± 0.312), but the subsequent ages 
were similar (P15-16: 2.908 ± 0.529; P21-25: 2.946 ± 0.588) (Figure 5.3F). Interestingly, 
Fmr1 KO mice appear to exhibit more of a developmental decrease in their AMPAR 
rectification index (P9-10 KO: 3.073 ± 0.423; P12-13: 4.209 ± 0.858; P15-16: 1.842 ± 
0.187; P21-25: 1.993 ± 1.630); however, any conclusions related to genotypes cannot be 
made as this data is very preliminary. 
 
DISCUSSION 
The developmental maturation of glutamatergic and GABAergic signaling is critical in 
mediating the regulation of developmental excitability and plasticity for optimal circuit 
formation. In a subset of our preliminary data, we can identify broad developmental 
patterns related to glutamatergic maturation in L2/3 pyramidal neurons of the auditory 
cortex. Continued functional analysis of AMPAR maturation is warranted to 1) better 
characterize cell-type and layer-specific developmental patterns during the postnatal 
maturation of the mouse auditory cortex in its intracortical formation, and 2) to 
comprehensively understand whether there are alterations in excitatory synaptic 
maturation in the Fmr1 KO mouse that could contribute to the deficits related to E-I circuit 
development and the auditory phenotypes in these mice.  
 
Our initial assessment of glutamatergic maturation includes analysis of spontaneous 
AMPAR-mediated postsynaptic currents, silent synapses, and GluA2 subunits. Across 
these measures, sEPSCs exhibited the strongest developmental regulation of AMPARs 
with a clear age-dependent increase in frequency, consistent with the maturational 
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properties of L2/3 pyramidal neurons of other cortical regions (Tatti et al., 2017; Kroon et 
al., 2019). sEPSC amplitudes also exhibit a developmental increase, mainly between P9-
10 and P12-13 mice, albeit a relatively subtle increase in comparison to the changes in 
frequency. Nevertheless, these increases in synaptic AMPAR-mediated currents are 
related to both synaptogenesis of excitatory glutamatergic synapses, and the 
strengthening of individual synapses with increasing number of synaptic AMPARs 
(Huttenlocher et al., 1982; Garner et al., 2002; Rakhade and Jensen, 2009). 
 
Given the low frequency in AMPAR-sEPSCs we measured during early development, we 
hypothesize that there will be a high proportion of NMDAR-only silent synapses at P9 and 
P12 in the auditory cortex L2/3 pyramidal neurons. As sEPSC frequency increases, we 
expect the number of silent synapses to concordantly decrease. Indeed, the initial 
calculations show a decrease in the number of silent synapses between P12 and P15 in 
WT mice, but we lack measures in P9-10 mice, which could more interestingly reveal the 
magnitude of silent synapse loss during the transition to an open ear canal compared to 
the progression during the auditory cortex tonotopic critical period. Such evaluations of 
WT development would be even more interesting when compared to the Fmr1 KO auditory 
cortex, given that L4 of the barrel cortex of KO mice is characterized by a delayed 
persistence of silent synapses and thus a delayed barrel cortex critical period window 
(Harlow et al., 2010). Neither our LTP experiments of L4-L2/3 synaptic plasticity in ex vivo 
brain slices (Chapter 3), nor the in vivo tone-rearing experiments by Kim et al. (2013) 
indicated a delayed plasticity window in the auditory cortex of Fmr1 KO mice. Thus, the 
patterning of silent synapse maturation could reveal the basis of the aberrant 
developmental synaptic plasticity in Fmr1 KO mice.  
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Alterations in the GluA2 AMPAR subunit are also another mechanism by which synaptic 
excitability and plasticity are impacted (Chater and Goda, 2014). Interestingly, in our WT 
mice, we did not observe a strong developmental decrease in the rectification index at the 
ages we tested, representative of more linear AMPAR I-V plots and thus GluA2-containing 
calcium-impermeable AMPARs. This was unexpected as pyramidal neurons are 
described to rapidly lose calcium-permeable AMPARs after P14 in rodents (Diering and 
Huganir, 2018), and we specifically evaluate earlier and older postnatal ages. In addition, 
despite the elevated membrane-bound expression of GluA2 we found between the 1st and 
2nd postnatal weeks in Fmr1 KO mice, our preliminary data did not indicate functional 
differences of GluA2-containing AMPARs in the KO L2/3 pyramidal neurons. Such 
discrepancies could be related possible cell-type specific alterations, as GABAergic 
interneurons and glial cells, including both astrocytes and oligodendrocytes, are known 
express have a high fraction of GluA2-lacking AMPARs (Isaac et al., 2007; Diering and 
Huganir, 2018; Ceprian and Fulton, 2019), which could be where the differences manifest. 
Given that neural progenitors derived from induced pluripotent stem cells of FXS-patients 
exhibited a higher proportion of GluA2-lacking AMPARs (Achuta et al., 2018), it would be 
curious as to whether we observe cell-type or region-specific alterations in the Fmr1 KO 
mice.  
 
A continued, thorough evaluation of AMPAR maturation in the auditory cortex is necessary 
to identify alterations in the development of auditory circuitry in the developing Fmr1 KO 
mice. Synaptic evaluations in the auditory brainstem of Fmr1 KO mice revealed enhanced 
excitatory connectivity in neurons of the lateral superior olive (Garcia-Pino et al., 2017). 
Notably, significantly increased sEPSC frequency was observed in P14 and P21 mice with 
increased immunostaining of vesicular glutamate transporters, which could suggest that if 
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glutamatergic alterations are indeed present in the Fmr1 KO auditory cortex, they may 
follow the disrupted auditory brainstem circuit and instead have differences in the auditory 
cortex at these later ages. Nevertheless, a continued evaluation of functional AMPAR 







Figure 5.1: Postnatal maturation of sEPSCs in L2/3 pyramidal neurons of the auditory cortex 
in WT and Fmr1 KO mice. (A) Representative traces of sEPSCs recorded across development. 
(B-C) Summary of median amplitudes and average frequencies across animals. (C) sEPSC 
frequencies have a developmental increase. All values and n’s are summarized in Table 5.1.  
 125 
 
Figure 5.2: NMDAR-only silent synapses in L2/3 pyramidal neurons in WT and KO mice in 
the auditory cortex. (A-D) Representative minimal L4-evoked eEPSCs in L2/3 pyramidal neurons 
at P12. (A, C) eEPSC traces at +40 mV and -60 mV (only showing 20 out of 50 sweeps). (B, D) 
Summary of eEPSC responses across all stimulation trials. (E-F) Summary of failure rates at -60 
mV and +40 mV holding potentials at P12-13 and P15-16 in WT and Fmr1 KO mice. (G) Fraction 
of calculated silent synapses. N = P12-13: 6 cells/2 WT mice & 2 cells/1 KO mouse; P15-16: 3 




Figure 5.3: AMPAR-isolated I-V plots in L2/3 pyramidal neurons of the developing auditory 
cortex. (A-D) I-V plot relationships of peak responses of AMPAR-eEPSCs across membrane 
holding potentials of -80 to +40 mV, with currents normalized to -80 mV. (E) Representative AMPAR 
eEPSC traces at -60 and +40 mV in WT and Fmr1 KO mice at P9 and P15. (F) The rectification 
index (the ratio of current evoked at -60 and +40 mV) across ages. P9-10: n = 6 cells/2 WT mice & 
10 cells/3 KO mice; P12-13: n = 10 cells/3 WT mice & 4 cells/2 KO mice; P15-16: n = 3 cells/1 WT 
mouse & 5 cells/2 KO mice; P21-25: n = 5 cells/2 WT mice & 2 cells/1 KO mouse  
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 Genotype  (n = cells/mice) Amplitude (pA) Frequency (Hz) 
P9-10 
WT (4/2) 7.77 ± 0.19 0.16 ± 0.05 
KO (3/1) 8.32 ± 0.26 0.27 ± 0.08 
P12-13 
WT (13/5) 9.30 ± 0.26 1.26 ± 0.22 
KO (4/2) 8.90 ± 0.26 1.85 ± 0.40 
P15-16 
WT (5/2) 8.35 ± 0.37 1.67 ± 0.39 
KO (5/2) 9.07 ± 0.40 4.26 ± 0.61 
P21-25 
WT (6/2) 9.05 ± 0.37 4.33 ± 0.64 
KO (2/1) 8.89 ± 0.13 9.61 ± 4.34 
 
Table 5.1: Summary of sEPSC median amplitudes and frequency from L2/3 pyramidal 





Impairments in language development, communication, and auditory processing are 
pervasive in Fragile X syndrome (FXS) and many autism spectrum disorders. However, 
there are currently no treatments capable of profoundly improving or mitigating such 
deficits despite the perturbations that have been broadly characterized in the FXS brain. 
Therefore, a more comprehensive evaluation of region-specific circuit development is 
necessary to 1) understand how brain circuits uniquely alter across brain areas; 2) identify 
when alterations first manifest and if such changes are lasting or dynamic; 3) correlate or 
causally link neuronal circuit changes to the broader phenotypes; and 4) uncover new 
therapeutic targets and windows for targeted treatment. The data presented in this 
dissertation carefully examined these criteria, and provide evidence of altered excitatory-
inhibitory (E-I) circuit maturation in the auditory cortex of Fmr1 KO mice during early 
postnatal maturation, which ultimately provide valuable insight when considering the 
development of therapies for FXS.  
 
Our results present an in-depth analysis of the regulation of ionotropic receptor protein 
expression, and physiological maturation patterns in the naturally developing auditory 
cortex of wild-type mice. While there exist reports that have examined auditory cortex 
maturation, such studies have differed in their use of animal models (Bi et al., 2006; Xu et 
al., 2007; Takesian et al., 2010, 2012), and the cell types, cortical layers, or age windows 
evaluated (Hackett et al., 2015; Blundon et al., 2017; Deng et al., 2017; Cisneros-Franco 
et al., 2018; Sun et al., 2018; Takesian et al., 2018). In particular, we utilized more granular 
age windows to enable neuronal circuit characterization related to the dynamics of ear 
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canal opening, and both the start and end of the auditory cortex critical period for tonotopy. 
We presented developmental protein expression of membrane-bound glutamate and 
GABAA receptors, which are more reflective of physiologic function compared to prior 
expression studies that examined total protein expression from whole-cell lysates (Xu et 
al., 2007) or developmental mRNA transcript expression (Hackett et al., 2015). We further 
detailed L4 to L2/3 synaptic circuit maturation, while thoroughly characterizing the 
maturation of inhibitory regulation of L2/3 pyramidal neurons in the mouse auditory cortex. 
 
This extensive characterization of natural auditory cortex development in WT mice 
revealed maturational patterns in E-I circuit maturation that were clearly dysregulated and 
improperly coordinated in Fmr1 KO mice, particularly in relation to GABAergic maturation. 
Alterations were found in the molecular and cellular expression of GABAAR a-subunits in 
Fmr1 KO mice, along with various GABAAR-mediated postsynaptic and presynaptic 
modifications that collectively manifest in impairments of L4-L2/3 circuit excitability and 
plasticity. Our continued evaluation of glutamatergic circuit maturation in Fmr1 KO mice 
will enable us to further complement our findings to comprehensively identify how both 
excitatory and inhibitory signaling are dysregulated across auditory circuit maturation. 
 
FMRP is necessary for the postnatal maturation of auditory cortical circuits  
One of the overarching features related to the impairments we characterized in the Fmr1 
KO mice is that deficits in the auditory cortex first manifest during early postnatal 
development. This is largely consistent with other alterations in the Fmr1 KO auditory 
cortex, such as the impaired tonotopic critical period plasticity (Kim et al., 2013), and 
altered developmental EEG and auditory event-related potential phenotypes (Wen et al., 
2019). Additionally, Fmr1 KO mice have delayed parvalbumin cell maturation in the 
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auditory cortex, where reduced parvalbumin cell numbers at P14 were thought to impact 
the regulation of network excitation (Wen et al., 2018). We complement this finding and 
confirm functional deficits related to GABAergic regulation in the developing auditory 
cortex, where at approximately the same age window (P12-13), our studies revealed 
decreased expression of GABAAR a3-subunit, altered presynaptic deficits in GABA-
mediated inhibition, and altered postsynaptic regulation including enhanced 
pharmacological sensitivity to GABAAR modulators. Furthermore, we find that these 
alterations are not persistent, and rather are dynamic across postnatal maturation, 
consistent with the developmental evaluations of inhibitory synaptic transmission in the 
auditory brainstem and amygdala of Fmr1 KO mice (Vislay et al., 2013; Garcia-Pino et al., 
2017).   
 
The combination of these GABAergic impairments ultimately underlies circuit defects in 
L4 to L2/3 within the developing auditory cortex. Such defects included differences in 
excitability of L4-L2/3 basal synaptic transmission, and an altered developmental 
progression of L4-L2/3 LTP (Chapter 3). Specifically, P12-13 pyramidal neurons had high 
variability in their synaptic eEPSC response at baseline. Additionally, LTP, though capable 
of being induced, was visibly less stable compared to P12-13 WT mice. Alterations in 
GABAAR signaling are well-characterized to regulate both network excitability and 
plasticity (Hensch, 2005; Brooks-Kayal, 2011), suggesting that our alterations also 
underlie some of the auditory-related phenotypes in FXS. GABA-mediated disruptions of 
critical periods are described in neurodevelopment, where enhanced GAD67 expression 
in Mecp2-null mice causes a precocious visual critical period (Krishnan et al., 2015), and 
Gad65-null mice are incapable of inducing auditory critical periods unless inhibitory GABA 
signaling is pharmacologically induced (Kalish et al., 2020). Furthermore, disruptions in 
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inhibitory GABA signaling elicit auditory processing deficits, consistent with the FXS 
auditory phenotypes (Wehr and Zador, 2003; Caspary et al., 2013; Kim et al., 2013; 
Rotschafer and Razak, 2013; Blackwell and Geffen, 2017; Cisneros-Franco et al., 2018).  
 
For a more comprehensive evaluation of GABAergic dysregulation in the auditory circuit 
of FXS, the functional maturation of inhibitory neurons themselves must also be evaluated. 
Our work thus far has largely focused on the regulation of E-I synaptic input onto L2/3 
pyramidal neurons. By also examining GABAergic neurons, including their intrinsic 
properties, and the direct excitatory and inhibitory synaptic input onto inhibitory 
interneurons, we can further elucidate the altered E-I circuit dynamics in FXS that impact 
the regulation of auditory plasticity and processing. Additionally, examination of 
connectivity across the different cortical layers is also necessary to fully capture 
intracortical dysregulation. This can lead to a better understanding of the underlying 
mechanisms related to the differences that manifest with more global measures, like EEGs 
or event-related potentials, which are more feasible in use for patients.  
 
Secondary phenotypes resulting from loss of FMRP expression 
While hyperexcitability is generalizable across the Fmr1 KO brain, the global loss of FMRP 
yields region-specific alterations. For example, the critical periods of the various sensory 
cortices are altered in differing manners. In the somatosensory cortex of Fmr1 KO mice, 
the critical period is characterized by a delay, where the temporal window for 
thalamocortical LTP is shifted approximately 3 days later than in WT mice (Harlow et al., 
2010). Such alterations are linked to a persistence of NMDAR-only silent synapses and a 
delayed GABA polarity switch (Harlow et al., 2010; He et al., 2014). In the auditory cortex, 
there is a general impairment of tonotopic plasticity, with no temporal delay (Kim et al., 
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2013). Notably, in the visual cortex, Fmr1 KO mice showed faster ocular dominance 
plasticity responses, where monocular deprivation caused substantial open-eye 
potentiation in a shorter period compared to WT mice (Dolen et al., 2007). In both the 
auditory and visual cortex, deficits in critical periods were corrected by either 
pharmacological or genetic reductions of mGluR-mediated signaling. However, no 
additional evaluations related to underlying synaptic mechanisms were performed. 
Interestingly, the sensory critical periods occur at different ages in development, with the 
barrel cortex from P3-7 (Harlow et al., 2010), auditory tonotopy from P12-15 (Barkat et al., 
2011), and binocular plasticity from P19-32 (Gordon and Stryker, 1996). Thus, the 
distinctions of the types of critical period abnormalities in Fmr1 KO mice may be a result 
of adaptive synaptic and circuit maturation occurring across brain development as a result 
of the more direct alterations caused by the loss of FMRP expression.  
 
The alterations we have characterized in our studies of the developing auditory cortex of  
Fmr1 KO mice are also likely secondary to the genetic mutation rather than a direct cause 
of FMRP loss, given that neither the AMPAR or GABAAR a-subunits are not direct FMRP 
targets (Darnell et al., 2011). The aberrant regulation of GABAAR-mediated signaling could 
instead be from the hyperexcitability in the developing FXS brains, as occurs following 
early-life seizures that increase a1-subunit expression, accelerate GABA polarity 
switches, and occlude plasticity (Ben-Ari, 2002; Galanopoulou, 2008b; Brooks-Kayal, 
2011; Sun et al., 2018). Prior to hearing onset, Fmr1 KO mice have enhanced excitatory 
connectivity in the auditory brainstem (Garcia-Pino et al., 2017; Rotschafer and Cramer, 
2017) that could drive enhanced excitability in higher auditory regions and disrupt synaptic 
maturation. The barrel cortex in KO mice is also hyperexcitable (Contractor et a., 2015), 
potentially influencing excitability given the integration of somatosensory and auditory 
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cortex circuitry (Fu et al., 2003). Such hypotheses could be tested by broadly modulating 
hyperexcitability strictly during the first postnatal week of Fmr1 KO mice, particularly using 
known treatment paradigms that have corrected barrel cortex defects (He et al., 2019).  
Subsequent analysis can be performed to test whether it this restricted early treatment is 
sufficient to correct the phenotypes we have characterized in the L4-L2/3 auditory circuit.  
 
Implications for the development of new FXS therapies 
The past several decades have been plagued by failures in once promising clinical trials 
in Fragile X syndrome. Given this broad lack of success, our findings underscore the need 
to 1) develop age-specific therapies, particularly focusing on targeting patients early in 
development; 2) consider combinatorial treatments that are dynamic with age; and 3) 
utilize more rigorous biomarkers and redefine clinical endpoints that are reflective of what 
is truly malleable at certain developmental ages.  
 
Both our work and those of others highlight that molecular, cellular and physiological 
alterations in the brain manifest early in Fmr1 KO development, with the critical periods 
themselves altered in their normal function. Correcting the course of FXS disease 
pathophysiology early during brain development could be more efficacious given that 
circuits are more malleable during these age windows, and that this early correction could 
subsequently attenuate the secondary effects of the core pathology. However, the cohorts 
of patients in many of the past clinical trials have often included adults or older adolescent 
ages, who would be well beyond their windows for the various critical periods. While there 
is an overall consensus that future trials must include younger patients with more tailored 
age groups, such animal model studies reaffirm this as a strong priority in future clinical 
trial designs.  
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Circuit hyperexcitability is a broad, persistent phenotype characterized across ages in the 
Fmr1 KO brain (Contractor et al., 2015). However, the synaptic and neuronal alterations 
underlying the circuit deficits are both multifactorial and dynamic across ages. We 
observed in our work and those of others that many changes in the Fmr1 KO brain are 
neither persistent nor permanent across multiple ages, and they often have disruptions to 
numerous regulators of circuits (Harlow et al., 2010; Vislay et al., 2013; He et al., 2014; 
Contractor et al., 2015; Garcia-Pino et al., 2017; Wen et al., 2018; Wen et al., 2019). While 
this increases the overall complexity of a single-target approach, this does raise the 
question as to whether a more combinatorial “cocktail” approach that adapts with age is 
ultimately more appropriate. Perhaps modulating the function of chloride transporters, 
whether with the NKCC1 inhibitor bumetanide or with regulators of KCC2 activity, could 
be beneficial early in development when deficits were first identified in the somatosensory 
cortex (He et al., 2019). However, later in development, a direct targeting of the GABA-
mediated system could be more efficacious, as altered presynaptic and postsynaptic 
regulation have been characterized to occur across FXS (Braat and Kooy, 2015b, a). 
Interestingly, a clinical trial has recently been completed in 2018 that actually targeted two 
different pathways that are well-characterized to be aberrant in FXS (Protic et al., 2019). 
However, the results of the combined treatment using lovastatin and minocycline 
(LovaMix, NCT02680379) have not been published.  
 
Earlier we alluded to the notion of identifying and correcting core versus secondary 
disease pathology in FXS. There are increasing discussions that have centered on 
whether some of the physiological phenomena that are being characterized in the animal 
model, particularly at later ages, are adaptive or homeostatic mechanisms to 
counterbalance the core hyperexcitability caused by loss of FMRP (Mullins et al., 2016; 
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Cea-Del Rio et al., 2020). Such evaluations and interpretations are critical for therapy 
design and drug targeting, where a drug’s mechanism of action in relation to disease 
pathology and the relevant time windows must be considered. Given FMRP’s main 
function as a mRNA translational regulator, whose transcripts span from synaptic proteins 
to epigenetic regulators thus enabling extensive dysregulation (Bagni and Greenough, 
2005; Darnell et al., 2011; Alpatov et al., 2014; Korb et al., 2017), it is unlikely that the 
deep, core underlying pathology can be addressed without gene therapy early in life where 
the expression of FMRP is increased (Hampson et al., 2019; Shitik et al., 2020).  
 
However, this does not exclude the potential beneficial effects derived from downstream 
targeting in FXS. Many proteins for which FMRP exerts direct translational control are 
altered in their expression and activity in FXS. For example, matrix metalloproteinase-9 
(MMP-9), a secreted endopeptidase, is directly regulated by FMRP and is found to have 
elevated levels and activity in both patients and the Fmr1 KO model. Genetic reductions 
of MMP-9 levels and pharmacological attenuation of its activity have demonstrated 
beneficial effects in rescuing several auditory-related phenotypes in the FXS mouse 
model, and were positively associated with improvements of some clinical measures in 
early clinical trials (Dziembowska et al., 2013; Wen et al., 2018; Lovelace et al., 2020). 
Other downstream targets that are also altered via indirect mechanisms of FMRP loss of 
expression could still aid in the attenuation of E-I imbalance in the brain. Interestingly, 
there is currently a clinical trial recruiting for volunteers to examine AZD7325, a positive 
modulator of GABAAR a2 and a3, in adults with Fragile X syndrome (NCT03140813). The 
targeting of the GABAAR a3 subunit is highly consistent with our findings where we 
observed its reduced expression during early development in the auditory cortex.     
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Nevertheless, with these various approaches for the treatment of FXS, it is also highly 
critical to reconsider the clinical endpoints that are used to evaluate the relative success 
of investigational therapies. Our work, in conjunction with the established literature, 
continues to prove the prevalence of region-specific alterations that manifest in the rodent 
brain caused by loss of expression of FMRP. While disruptions to global brain function 
certainly contribute to the neuropsychiatric symptoms, it may be necessary to decouple 
the alterations and identify more explicit biomarkers linked to specific symptoms or brain 
regions. More specific biomarkers or symptoms may actually be positively modulated by 
the drug under investigation, but are not captured with the broader endpoints, such as 
improvements of behavioral symptoms. Lastly, the identification of region-specific 
biomarkers could enable the understanding of age-dependent cascades in FXS 
pathophysiology that reveal what symptoms are possibly more malleable given the 
patient’s age, and ultimately, what therapies might yield greater success. These 
developmental characterizations are comprehensively being performed in the FXS rodent 
model. However, for improved translational applications that more precisely elucidate the 
pathophysiology in humans, it is likely necessary to move towards FXS models in non-
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